endovasculares.es
Últimas Noticias
Noticias del Sector
Intact Vascular’s Tack Endovascular System® Secures CE Mark for Repair of Dissections Following Angioplasty Below the Knee
January 17, 2017 - WAYNE, Pa.--(BUSINESS WIRE)--Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that it has attained the CE (Conformité Européenne) Mark for the Tack Endovascular System to repair arterial dissections foll...
17-01-2017Medtronic Announces CE Mark and European Launch of Recaptureable TAVI System Now Available for Severe Aortic Stenosis Patients with Large Anatomies
Larger Device Offers Treatment to Patients Without a Previous TAVI OptionDUBLIN - Jan. 17, 2017 - Medtronic plc (NYSE:MDT) today announced the CE (Conformité Européenne) mark and European launch of the CoreValve(TM) Evolut(TM) R 34 mm valve-the largest sized transcatheter aortic valve implantation...
17-01-2017
10 January 2017 BTG plc (LSE: BTG), the global specialist healthcare company, today announced the first patients diagnosed with Pulmonary Embolism (PE) to be treated in Hong Kong using the newly available EKOS® system. The EKOS® system includes an ultrasonic device that uses acoustic pulses to...
11-01-2017Spectranetics Names Scott Hutton as General Manager, Vascular Intervention
COLORADO SPRINGS, Colo., Jan. 11, 2017 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC), (“the Company”) today announced that Scott Hutton has been named General Manager, Vascular Intervention, effective January 23rd, 2017. In this role, Mr. Hutton will report directly to Scott Dr...
11-01-2017
Teleflex (TFX) Receives FDA 510(k) Clearance for its Arrow® VPS Rhythm™ Device with Optional TipTracker™ Technology510(k) Clearance for the Arrow® VPS Rhythm™ Device expands Teleflex’s Catheter Tip Navigation and Placement portfolio to now include familiar ECG-only technology for the elimi...
10-01-2017Lombard Medical Announces Regulatory Approval in Japan for IntelliFlex™ LP Delivery System for the Aorfix™ Abdominal Aortic Aneurysm Endovascular Stent Graft Read more: http://www.nasdaq.com/press-release/lombard-medical-announces-regulatory-approva
Exclusive Japanese Partner Medico’s Hirata Anticipates Market Share Gain Following Launch in Early 2017OXFORDSHIRE, England--(BUSINESS WIRE)--Jan. 5, 2017-- Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms ...
09-01-2017American Heart Association launches Center of Excellence accreditation for hospitals offering advanced treatment for heart disease
Hospitals receive AHA/ACC evidence-based guidance in treating the most complex heart patients December 27, 2016 Categories: Program News DALLAS, Dec. 27, 2016 – Beginning Jan. 1, 2017, the American Heart Association (AHA) will offer advanced accreditation for hospitals that meet the high...
09-01-2017Abbott Completes the Acquisition of St. Jude Medical
ABBOTT PARK, Ill., Jan. 4, 2017 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has completed the acquisition of St. Jude Medical, Inc., establishing the company as a leader in the medical device arena. The transaction provides Abbott with expanded opportunities for future growth and is an imp...
05-01-2017Intact Vascular Closes on Additional Series B Funding to Advance Development of the Tack Endovascular Syste for Peripheral Artery Disease Treatment
January 3, 2017 - WAYNE, Pa.--(BUSINESS WIRE)--Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that current investors New Enterprise Associates, Quaker Partners and H.I.G. BioHealth Partners have exercised their right to in...
05-01-2017Endologix Provides Physicians with Updated Information about the AFX® Endovascular AAA System
IRVINE, Calif., Dec. 30, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, today issued a letter to physicians with updated information about the AFX® Endovascular AAA System. Guidance to Physicians The voluntary le...
01-01-2017
ABBOTT PARK, Ill., Dec. 30, 2016 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it intends to close the acquisition of St. Jude Medical, Inc., on Wednesday, Jan. 4, 2017. The announcement follows receipt of all regulatory clearances necessary for closing. The transaction establishes Abbott as a ...
01-01-2017
IRVINE, Calif., Dec. 27, 2016 (GLOBE NEWSWIRE) — Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced a temporary hold on shipments of its AFX® Endovascular AAA System to complete an investigation of a manufacturing issue with some s...
27-12-2016TRIBUTE VIDEO: ENDOVASCULAR TV 5 YEARS!
...
23-12-2016
p.p1 {margin: 0.0px 0.0px 21.0px 0.0px; line-height: 16.0px; font: 14.0px 'Helvetica Neue'; color: #444444; -webkit-text-stroke: #444444}p.p2 {margin: 0.0px 0.0px 21.0px 0.0px; line-height: 17.0px; font: 14.0px 'Helvetica Neue'; color: #444444; -webkit-text-stroke: #444444}p.p3 {margin: 0.0px 0.0px ...
19-12-2016Endologix Receives Australian Therapeutic Goods Administration (TGA) Approval for AFX®2 Bifurcated Endograft System
IRVINE, Calif., Dec. 19, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that the Australian Therapeutic Goods Administration (TGA) has approved the AFX®2 Bifurcated Endograft System for inclusion on the A...
19-12-2016FDA Bans Powdered Gloves
The US Food and Drug Administration (FDA) on Friday issued a final rule banning powdered medical gloves beginning on 19 January 2017.FDA proposed the ban in March, citing mounting evidence that such gloves posed serious risks to patients, including airway and wound inflammation, post-surgical adhesi...
16-12-2016Terumo signs to acquire St Jude Medical and Abbott’s vascular closure business
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; line-height: 14.0px; font: 12.0px Times; -webkit-text-stroke: #000000}span.s1 {font-kerning: none}TOKYO, JAPAN – Dec. 7, 2016 -- Terumo Corporation (TSE: 4543) announced today that it has reached an agreement with Abbott and St. Jude Medical, Inc. to acquire ...
07-12-2016Medtronic's Endurant(TM) II/IIs Stent Graft System Receives CE Mark for Use with ChEVAR Parallel Graft Technique
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; line-height: 28.0px; font: 16.0px Helvetica; color: #858484; -webkit-text-stroke: #858484}span.s1 {font-kerning: none}span.s2 {font-kerning: none; color: #00bce4; -webkit-text-stroke: 0px #00bce4}span.s3 {text-decoration: underline ; font-kerning: none}DUBLIN ...
06-12-2016Teleflex to acquire Vascular Solutions in US$1 billion deal
p.p1 {margin: 0.0px 0.0px 12.0px 72.4px; line-height: 25.0px; font: 16.0px 'Helvetica Neue'; color: #323333; -webkit-text-stroke: #323333}p.p2 {margin: 0.0px 0.0px 0.0px 0.0px; line-height: 18.0px; font: 16.0px 'Helvetica Neue'; color: #4e4e4e; -webkit-text-stroke: #4e4e4e; min-height: 18.0px}span.s...
05-12-2016Final Patient Enrolled for Iliofemoral Venous Stent Study
BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Medical has completed enrollment in the first clinical study of an iliofemoral venous stent conducted in the United States under an FDA-approved Investigational Device Exemption (IDE).“This has the opportunity to help many patients.”Tweet thisThe VIVO Cli...
15-11-2016Gore Global Registry for Endovascular Aortic Treatment Completes Enrollment
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; line-height: 18.0px; font: 12.0px Arial; color: #050605; -webkit-text-stroke: #050605}p.p2 {margin: 0.0px 0.0px 0.0px 0.0px; line-height: 37.0px; font: 31.0px Arial; color: #050605; -webkit-text-stroke: #050605}span.s1 {font-kerning: none}span.s2 {font-kerning:...
15-11-2016LeMaitre Vascular Acquires Restore Flow Allografts
p.p1 {margin: 0.0px 0.0px 10.8px 0.0px; line-height: 16.2px; font: 11.0px Arial}p.p2 {margin: 0.0px 0.0px 0.0px 0.0px; line-height: 14.0px; font: 12.0px Courier}span.s1 {font-kerning: none}span.s2 {font-kerning: none; color: #175788}BURLINGTON, Mass., Nov. 10, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascu...
10-11-2016Merit Medical Receives 510(k) Clearance for the SwiftNINJA™ Steerable Microcatheter
p.p1 {margin: 0.0px 0.0px 10.8px 0.0px; text-align: justify; line-height: 16.2px; font: 11.0px Arial; -webkit-text-stroke: #000000}p.p2 {margin: 0.0px 0.0px 10.8px 0.0px; line-height: 16.2px; font: 11.0px Arial; -webkit-text-stroke: #000000; min-height: 12.0px}p.p3 {margin: 0.0px 0.0px 0.0px 0.0px; ...
07-11-2016
COLORADO SPRINGS, Colo., Nov. 02, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation(NASDAQ:SPNC) announced today that it has submitted to the Food & Drug Administration (FDA) its Pre-Market Approval (PMA) application for the Stellarex drug-coated angioplasty balloon (DCB). Stellarex is designed...
02-11-2016
COLORADO SPRINGS, Colo., Nov. 02, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation(NASDAQ:SPNC) today announced that Dr. Sean Lyden presented the final 12-month results of the Stellarex Drug-coated Balloon (DCB) ILLUMENATE Pivotal Trial at the Transcatheter Cardiovascular Therapeutics (TCT) co...
02-11-2016Neuravi Secures €15 Million to Fund Expansion
p.p1 {margin: 0.0px 0.0px 21.0px 0.0px; line-height: 16.0px; font: 14.0px 'Helvetica Neue'; color: #444444; -webkit-text-stroke: #444444}p.p2 {margin: 0.0px 0.0px 21.0px 0.0px; line-height: 17.0px; font: 14.0px 'Helvetica Neue'; color: #444444; -webkit-text-stroke: #444444}p.p3 {margin: 0.0px 0.0px ...
02-11-2016St. Jude Medical Shareholders Approve Merger with Abbott
ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, today announced that, based on the preliminary voting results from St. Jude Medical’s Annual Meeting of Shareholders held earlier today, St. Jude Medical shareholders approved the merger agreemen...
26-10-2016Avinger Launches Upgraded Lightbox Imaging Console
REDWOOD CITY, Calif., Oct. 25, 2016 -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced the U.S. launch of an enhanced version of the company’s Lightbox imaging console. The Lightbox provides a dual display of images to ...
25-10-2016
DUBLIN - Oct. 24, 2016 - Medtronic plc (NYSE: MDT) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the HawkOne(TM) Directional Atherectomy System in a new size for treating patients with peripheral artery disease (PAD). The HawkOne system is designed to remove plaque from t...
24-10-2016Veryan Medical announces the completion of subject enrolment into the MIMICS-2 clinical study
Imperial Innovations Group plc (AIM: IVO or ‘the Group’, ‘Innovations’) notes that portfolio company Veryan Medical (‘Veryan’ or the ‘Company’) has completed enrolment into the MIMICS-2 clinical study of its BioMimics 3D® Self-Expanding Stent System (BioMimics 3D).The MIMICS-2 study...
24-10-2016Vascular Solutions Receives 510(k) Clearance for Fluent™ Inflation Device
MINNEAPOLIS, Oct. 21, 2016 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for the Fluent inflation device for use during cardiovascular procedures to create, maintain, and monitor pressure in...
21-10-2016Akesys Medical and Elixir Medical Announce First Human Implant of the PRAVA™ Bioresorbable Scaffold for Peripheral Vascular Disease
SUNNYVALE, Calif.--(BUSINESS WIRE)--Akesys Medical, a drug-device company focused on pioneering innovative solutions for peripheral artery disease, has announced their first clinical trial and successful implant of the breakthrough PRAVA™ Sirolimus Eluting Bioresorbable Peripheral Scaffold System ...
20-10-2016
REDWOOD CITY, Calif., Oct. 19, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced that the company has received expanded indications from the U.S. Food and Drug Administration (FDA) recognizing the ...
19-10-2016
ABBOTT PARK, Ill. and ST. PAUL, Minn., Oct. 18, 2016 /PRNewswire/ -- Abbott (NYSE: ABT) and St. Jude Medical, Inc. (NYSE: STJ) announced today an agreement in principle to sell certain products to Terumo Corporation. The transaction reflects a purchase price of approximately $1.12 billion and is sub...
18-10-2016Corindus Vascular Robotics to Feature CorPath® System at TCT 2016 Breakfast Symposium
WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular robotics, will sponsor a breakfast symposium entitled 'Robotic Therapy – Current Applications & Future Vision' on Monday, October 31 at 7:00 a.m. at the upcoming Transcathe...
18-10-2016InspireMD Announces Independent Study Published in the Journal of Endovascular Therapy That Continues to Support the Clinical Benefit and Utility of the CGuard Embolic Prevention System
BOSTON, MA--(Marketwired - Oct 17, 2016) - InspireMD, Inc. (NYSE MKT: NSPR) (NYSE MKT: NSPR.WS) ("InspireMD" or the "Company"), a leader in embolic prevention systems (EPS), neurovascular devices and thrombus management technologies, today announced the online publication of positive clinical data i...
17-10-2016BTG and Mirada Medical announce CE Mark Certification for Simplicit90Y dosimetry software in Europe
BTG plc (LSE: BTG), an international specialist healthcare company, with Mirada Medical Ltd, a leading global brand in medical imaging software, today announced CE Mark certification for Simplicit90Y™ dosimetrysoftware, designed to optimise the planning of 90Y selective internal radiation therapy ...
14-10-2016
DUBLIN - Oct. 14, 2016 - Medtronic plc (NYSE: MDT) today announced that it has notified customers of a voluntary recall of certain lots of its Pipeline(TM) embolization device, Alligator(TM) retrieval device and X-Celerator(TM) hydrophilic guidewire. The recall also includes the stylet containing Ul...
14-10-2016Ipsilateral Ulnar Compression Significantly Reduces Risk of Radial Artery Occlusion After Transradial PCI
Samir B Pancholy (UPDATED) Compressing the ulnar artery in addition to standard patent hemostasis significantly lowers the risk of radial artery occlusion after a transradial-access coronary intervention, a new study shows.In a trial of 3,000 patients undergoing diagnostic cardiac catheterization, t...
13-10-2016New European Society of Medical Oncology (ESMO) Biliary Cancer Guidelines Indicate Selective Internal Radiation Therapy (SIRT) with Y-90 Microspheres as an Option for Post-Chemotherapy Treatment of Intrahepatic Cholangiocarcinoma (iCCA)
Sirtex Medical Limited (ASX: SRX) announced today that the European Society of Medical Oncology (ESMO) has indicated the use of SIRT using yttrium-90 (Y-90) microspheres as an option in for the treatment of intrahepatic cholangiocarcinoma (iCCA), a form of primary liver cancer that starts in the bil...
11-10-2016Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer
'Ian is one of the world's leading cardiac device clinical investigators and he has been an advisor to Boston Scientific for many years,' said Mike Mahoney, chairman and chief executive officer, Boston Scientific. 'His strong relationships within the global research and clinical community and his tr...
10-10-2016
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX), a leading global provider of medical devices for critical care and surgery, has announced it has received FDA 510(k) clearance to market its Arrow® JACC with Chlorag+ard® Technology and TightTrack™ tunneler.“At Teleflex, we are com...
10-10-2016St. Jude Medical Announces FDA Clearance and Launch of the New PressureWire X Guidewire Designed to Optimize PCI Procedures in Patients With Complex Anatomies
The St. Jude Medical fractional flow reserve technology has demonstrated improved patient outcomes and reduced costs associated with percutaneous coronary intervention proceduresST. PAUL, Minn.--(BUSINESS WIRE)-- St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the...
10-10-2016First Commercial Placements of the Angel® Catheter in the United States
GOLDEN, Colo., Oct. 5, 2016 /PRNewswire/ -- Bio2 Medical is pleased to announce that the Angel® Catheter, a new device for the prevention of pulmonary embolism (PE), was placed in two patients at St. Mary's Medical Center in West Palm Beach, Florida, by Lawrence Lottenberg, MD FACS and Robert Borre...
05-10-2016Ra Medical Systems Receives Approval in Europe for DABRA Atherectomy and Pharos Laser Phototherapy Systems
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc., a private medical device company developing excimer laser treatment for cardiovascular and dermatological diseases, announces that it has received CE Marking approval for both the DABRA atherectomy system with catheter, and the Pharos exci...
05-10-2016Profusa, Inc. Receives CE Mark to Market the Lumee Oxygen Platform™ for Continuous, Real-time Monitoring of Tissue Oxygen
SOUTH SAN FRANCISCO, Calif., Oct. 3, 2016 /PRNewswire/ -- Profusa, Inc., a developer of tissue-integrated biosensors for continuous monitoring of body chemistry, today announced that it received the CE Mark to market its Lumee Oxygen Platform™ for continuous, real-time monitoring of tissue oxyge...
05-10-2016AstraZeneca reports top-line results from the Brilinta EUCLID trial in patients with peripheral artery disease
AstraZeneca today announced top-line results from the EUCLID trial. Brilinta (ticagrelor) did not demonstrate a benefit over clopidogrel in a symptomatic peripheral artery disease (PAD) patient population and therefore did not meet the primary endpoint of the trial.The EUCLID trial included 13,885 p...
04-10-2016Regulatory Approvals of Medical Devices in the EU versus the U.S.: quicker and worse…? by Dr. Frank Criado
Frank J Criado, MD, FACS, FSVMA recent study by TJ Hwang et al (published online in the BMJ last August) suggests that medical devices first approved in the European Union (EU) are associated with increased risks of post-marketing safety alerts and recalls when compare with those first approved by t...
03-10-2016First Heart Valve That Enables Cardiovascular Restoration Successfully Implanted in Three Patients in "Xplore-I" Clinical Trial
"Three children's hearts are now beating with a Xeltis Valve." Laurent Grandidier, CEO, Xeltis Click here for video about how the Xeltis restoring technology worksZURICH, Switzerland and EINDHOVEN, The Netherlands, October 3, 2016 - Xeltis, a Swiss-Dutch clinical-stage medical device company, announ...
03-10-2016New Technology Add-On Payment Awarded for GORE® EXCLUDER® Iliac Branch Endoprosthesis
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced the U.S. Centers for Medicare and Medicaid Services (CMS) has granted the GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE) new technology status. Beginning October 1, 2016, facilities using the IBE in conjunct...
29-09-2016
DUBLIN - September 28, 2016 - Medtronic plc (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) has cleared the TrailBlazer(TM) angled support catheter for use in the peripheral vascular system. Support catheters such as the Trailblazer are often used in endovascular procedu...
28-09-2016Heart team at Zurich University Hospital use Cardioband for tricuspid repair for the first time
A team led by Francesco Maisano, co-director of the University Heart Center at the University Hospital Zurich (UHZ) and professor for Heart Surgery at the University of Zurich, made up of heart surgeons and cardiologists used new catheter technology to repair a leaky tricuspid valve for the very fir...
26-09-2016Zilver® PTX® with Thumbwheel Delivery System Launched in France
LIMERICK, Ireland--(BUSINESS WIRE)--Cook Medical launches Zilver® PTX® drug-eluting peripheral stent thumbwheel delivery system in France. The French Health Ministry has now approved reimbursement for the Zilver PTX thumbwheel delivery system.The rotating thumbwheel system, which is available for ...
22-09-2016LUTONIX® Global Real-World Registry 24-Month Outcomes Presented at VIVA 2016
MURRAY HILL, N.J.--(BUSINESS WIRE)--C. R. Bard, Inc. (NYSE:BCR) announced the presentation of the final 24-month results from the LUTONIX® Global Real-World Registry at the Vascular Intervention Advances (VIVA) 2016 Meeting. These results are the first reported final 24-month outcomes for “real-w...
22-09-2016NEW Intelliflex Low Profile Delivery System by Lombard Medical
....
20-09-2016
FLAGSTAFF, Ariz. & LAS VEGAS--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced positive results from a prospective, multicenter Investigational Device Exemption (IDE) Clinical Study of the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface* in Japan. The device demon...
20-09-2016Claret Medical submits application for FDA approval of its cerebral protection device
SANTA ROSA, Calif.--(BUSINESS WIRE)--Claret Medical®, an innovator in filter-based cerebral embolic protection technologies, today announced its filing of a marketing application with the US Food and Drug Administration (FDA) for clearance of the Sentinel® Cerebral Protection System (CPS). The Sen...
20-09-2016
DUBLIN and LAS VEGAS - September 19, 2016 - Medtronic today reinforced the superior durability, consistency, and safety of the IN.PACT Admiral drug-coated balloon (DCB) in patients with peripheral arterial disease (PAD). The new data, presented in a series of late-breaking clinical trial presentatio...
19-09-2016
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced the first implant of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE) in the pivotal study. The patient was enrolled by Himanshu Patel, MD, section head of adult cardiac surgery at the University of Michigan...
19-09-2016Shockwave Medical Announces FDA Clearance of the Company’s Lithoplasty® System, the First and Only Technology to Use Sound Waves to Treat Calcified Peripheral Artery Disease
FREMONT, Calif.--(BUSINESS WIRE)--Shockwave Medical, a pioneer in the treatment of calcified cardiovascular disease, today announced clearance from the U.S. Food and Drug Administration (FDA) of the Lithoplasty® System for the treatment of calcified plaque in patients with peripheral artery disease...
16-09-2016
MIMICS-3D is a prospective, multicentre, observational registry to evaluate the BioMimics 3D Self-Expanding Stent System in the treatment of peripheral arterial disease. The Registry will evaluate safety, effectiveness and device performance within a real-world clinical population in a minimum of 50...
15-09-2016Silk Road Medical Announces New Medicare Coverage Option for TransCarotid Artery Revascularization (TCAR) Procedures
Silk Road Medical has announced the Centers for Medicare and Medicaid Services (CMS) has extended coverage for the transcarotid artery revascularisation (TCAR) procedure under the existing National Coverage Determination 20.7. TCAR is eligible for coverage when patients are treated with any FDA-appr...
15-09-2016Essential Medical Inc. Announces Closing on $14.9M Series B Funding
MALVERN, Pennsylvania, September 14, 2016 /PRNewswire/ --Essential Medical, Inc., a privately held medical device company addressing the rapidly growing large bore vascular closure market, announced today that it has completed a Series B financing of $14.9M. The round was led by Amzak Health along w...
14-09-2016
DUBLIN - Sept. 13, 2016 - Medtronic plc (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) approved the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) as a treatment for in-stent restenosis (ISR) in patients with peripheral artery disease (PAD). This is the first DCB tha...
13-09-2016CIRSE 2016: BIOTRONIK Showcases Positive Results for Lower Limb Intervention
PresseBox) (Barcelona, Spain / Buelach, Switzerland, 12.09.2016) Data Establishes Viability of BIOTRONIK Combination Therapy with Passeo-18 Lux Drug-Coated Balloon and Pulsar-18 Bare Metal Self-Expanding Stent Presented at Scientific SymposiumBIOTRONIK showcased the efficacy of its lower limb interv...
12-09-2016Philips introduces next generation interventional oncology solution OncoSuite* for advanced tumor analysis and therapy in Europe
Optimized to support minimally invasive treatment of liver cancer – the second most deadly cancer, accounting for 745,000 annual deaths worldwide [1]Features world’s first optimized imaging for radiopaque beads (LC Bead LUMITM)** for tumor treatment, minimizing damage to surrounding healthy tiss...
09-09-2016Vivasure Medical Announces €16.2M ($18.3M) in Financing to Advance Commercialization of Closure Device in European Union and United States
GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical™, a company developing a novel bioabsorbable technology for percutaneous vessel closure, today announced that the company has completed a Series C financing of €16.2M ($18.3M). The round was led by LSP (Life Sciences Partners) of The Netherlands...
09-09-2016VENITI® Closes on $25M from Boston Scientific
FREMONT, Calif. and ST. LOUIS, Sept. 8, 2016 /PRNewswire/ -- VENITI, Inc., a leader in the advancement of treatment for deep venous disease, has closed on $25 million in Series D equity financing from Boston Scientific Corporation. The funds will allow VENITI to complete the VIRTUS Trial and regulat...
08-09-2016
GALWAY, Ireland--(BUSINESS WIRE)--Neuravi, a company dedicated to improving clinical outcomes for stroke patients,today announced Conformité Européenne (CE) Mark approval and launch of the company’s newly available enhancements to the EmboTrap stent retriever platform, the EmboTrap® II Revascul...
08-09-2016GORE® VIABAHN® Endoprosthesis Marks 20 Years of Proven Performance
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) is celebrating the 20th anniversary of the introduction of the GORE® VIABAHN® Endoprosthesis, the market-leading stent-graft for the treatment of complex peripheral vascular disease. The device has been engineered to effective...
07-09-2016Balt International Acquires Blockade Medical LLC
PARIS--(BUSINESS WIRE)--BALT International announced today that it has acquired Blockade Medical LLC, a privately held company focused on the development of catheter based therapeutic devices for the treatment of cerebral aneurysms. The terms of the acquisition were not disclosed.“Blockade Medical...
06-09-2016CardioVascular Coalition Urges Increased Awareness of Peripheral Artery Disease (PAD) this September
WASHINGTON, Sept. 1, 2016 /PRNewswire-USNewswire/ -- The CardioVascular Coalition (CVC), a leading group of community-based cardiovascular and endovascular care providers, physicians, and manufacturers created to advance community-based solutions designed to improve awareness, prevention, and interv...
01-09-2016Cardiovascular Systems Launches the Take A Stand Against Amputation Program in Time for September Peripheral Artery Disease (PAD) Awareness Month
ST. PAUL, Minn.--(BUSINESS WIRE)--September marks Peripheral Artery Disease (PAD) Awareness Month. Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), has launched a public awareness and patient advocacy program, Take A Stand Against Amputation, to provide education about the disease and treatment op...
01-09-2016
W.L. Gore & Associates said today it is launching its DrySeal Flex introducer sheath designed for use with its Gore Excluder iliac branch endoprosthesis device, which is used for the endovascular treatment of common iliac artery aneurysms or aortoiliac aneurysms.The newly-launched device is designed...
30-08-2016Bluegrass Vascular announces CE mark approval and successful commercial use of Surfacer Inside-Out access catheter system
SAN ANTONIO, Aug. 30, 2016 /PRNewswire/ -- Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced that it has received CE Mark approval and is launching limited commerci...
30-08-2016Getinge Group & GE Launch New Angiography Integrated Solution for Hybrid OR Procedures in United States
WAYNE, N.J., Aug. 25, 2016 /PRNewswire/ -- Getinge Group today announced the launch of a new, highly flexible angiography solution for surgery, interventional and Hybrid operating room (OR) procedures in the United States. Jointly developed with GE Healthcare, a leader in providing transformational ...
25-08-2016
Lombard Medical Technologies (NSDQ:EVAR) said yesterday that it’s bailing out of the U.S. market after an FDA decision requiring a 50-patient clinical study of its Intelliflex low-profile delivery system for the Aorfix stent graft.Lombard said it eliminated its U.S. sales force and moved most of i...
22-08-2016Cardiovascular Systems Releases 30-Day Results from Liberty 360° Study in Late-Breaking Presentation at 2016 Amputation Prevention Symposium
ST. PAUL, Minn. & CHICAGO--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII), today released procedural and 30-day results from its LIBERTY 360° study in a late-breaking presentation at the 2016 Amputation Prevention Symposium (AMP) in Chicago.“Early findings in this novel, all-co...
20-08-2016
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today the first two patients with abdominal aortic aneurysms ("AAA") have been treated with the Ovation Alto™ Abdominal Stent Graft System. The patients were treated by Andrew Holden, MD,...
17-08-2016Cook Medical Issues Global Recall of Roadrunner® UniGlide® Hydrophilic Wire Guides due to raw materials issue
DSM Biomedical B.V., the Netherlands, Cook Medical’s supplier of hydrophilic coating for the Roadrunner® Uniglide® Hydrophilic Wire Guide, recalled certain lots of material due to concerns about a potential contamination by glass particles ranging in size of approximately 4 to 280 µm. Cook rece...
15-08-2016TOBA One-Year Clinical Study Results Published in the Journal of Vascular Surgery
WAYNE, Pa.--(BUSINESS WIRE)--Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that the one-year results from its Tack Optimized Balloon Angioplasty (“TOBA”) clinical study were published in the July 2016 edition of the J...
15-08-2016Boehringer Ingelheim launches RE-VECTO global program to capture data on Praxbind® usage in clinical practice
Ingelheim, Germany, August 15, 2016 – Boehringer Ingelheim today announces its global RE-VECTO program for Praxbind® (idarucizumab), the specific reversal agent for Pradaxa® (dabigatran etexilate).1,2 Praxbind® is approved to reverse the anticoagulant effects of Pradaxa® in rare critical care ...
15-08-2016
REDWOOD CITY, Calif., Aug. 11, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR) (the “Company”), a leading developer of innovative treatments for peripheral artery disease (“PAD”), today announced the pricing of its public offering of 8,572,000 shares of its common stock at a price to th...
11-08-2016CE Mark Granted to FlowAid Medical FA100 SCCD
NEW YORK--(BUSINESS WIRE)--FlowAid Medical Technologies Corp., a U.S.-based company, has received CE mark approval for its FA100 SCCD Sequential Contraction Compression Device.The FA100 SCCD is a breakthrough in the delivery of sequential compression therapy. After many years of R&D and the involvem...
10-08-2016
COLORADO SPRINGS, Colo., Aug. 10, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation(NASDAQ:SPNC) today announced that Professor Marianne Brodmann of Medical University Graz, Austria, presented the final 12-month results of the Stellarex Drug-coated Balloon ILLUMENATE European Randomized Clinica...
10-08-2016InSeal Medical Ltd. Announces CE Mark Approval for the InClosure Large Bore Vascular Closure Device
InSeal Medical Ltd., a privately held medical device company, announced today that it has received CE Mark approval for its InClosure VCD, a large bore vascular closure device. The InClosure VCD is a first-in-class, intravascular closure device based on InSeal Medical's proprietary and patented tech...
08-08-2016J. Aaron Grantham, MD, Joins Corindus Vascular Robotics as Chief Medical Officer
Dr. Grantham will lead initiatives to educate the interventional cardiology community on benefits of robotic therapyWALTHAM, MA - August 3, 2016 – Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular robotics, today announced that J. Aaron Grantham, MD, a le...
03-08-2016GORE® TIGRIS® Vascular Stent Gains FDA Approval for Treatment of Peripheral Artery Disease
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced the U.S. Food and Drug Administration (FDA) approval of the GORE® TIGRIS® Vascular Stent, a dual-component stent with a unique fluoropolymer / nitinol design. The GORE TIGRIS device, which gained CE Mark approv...
02-08-2016
BTG plc (LSE: BTG), a global specialist healthcare company, today announced that it has obtained European Conformity (CE) Mark from the Notified Body British Standards Institution (BSI) following completion of the reclassification of DC Bead® and DC BeadM1™ as Class III medical devices under Rule...
02-08-2016
Essential Medical, Inc., a privately held medical device company addressing the vascular closure market, announced today that it has received Investigational Device Exemption (IDE) approval from the FDA to begin the U.S. clinical trial for X-Seal, the company's 6F Vascular Closure Device.The single-...
01-08-2016FDA approves Vasorum’s Celt ACD vascular closure device
Vasorum said today that it won pre-market approval from the FDA for its Celt ACD vascular closure device.The Dublin-based company said the Celt ACD is designed to close punctures to the femoral artery after catheterization, using a biocompatible implant on both the inside and outside of the arterial...
21-07-2016STENTYS Enrolls First Patient in Left Main Clinical Trial
PRINCETON, N.J. and PARIS – July 19, 2016 – STENTYS (FR0010949404 — STNT), a medical technology company commercializing the world's first and only Self-Apposing® coronary stent, today announces that it has commenced enrolling patients in the TRUNC trial, which is designed to evaluate the long...
20-07-2016Contego Medical Completes Enrollment of Paladin Clinical Registry
RALEIGH, N.C., July 20, 2016 /PRNewswire/ -- Contego Medical, LLC announced today that it has completed enrollment in the Paladin® Carotid PostDilation Balloon System Registry in Europe. The registry involved 5 centers with 100 total patients, and represents the first prospective clinical evaluat...
20-07-2016
MALVERN, Pennsylvania, July 18, 2016 /PRNewswire/-- Essential Medical, Inc., a privately held medical device company addressing the rapidly growing large bore vascular closure market, announced today that it has received CE Mark approval for MANTA, the company's Large Bore Vascular Closure Device. N...
18-07-2016
TUSTIN, Calif. and ALISO VIEJO, Calif., July 14, 2016 /PRNewswire/ -- MicroVention, Inc., a wholly owned subsidiary of Tokyo-based Terumo Corporation, announced today that Terumo Corporation has completed the acquisition of Sequent Medical, Inc., a privately-held medical device firm based in Aliso V...
14-07-2016Medtronic Receives FDA Approval for IN.PACT Admiral DCB 150 mm Lengths
DUBLIN - July 13, 2016 - Medtronic plc (NYSE: MDT) has received U.S. Food and Drug Administration (FDA) approval for the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) in longer, 150 mm lengths. The new 150 mm length balloon, available in four, five, and six mm diameters, will provide greater tre...
13-07-2016National Institute for Health and Care Excellence (NICE) issues approval via Interventional Procedure Guidance IPG557 for endovenous mechanochemical ablation for varicose veins in the United Kingdom
QUINCY, Mass., July 13, 2016 /PRNewswire/ -- The National Institute for Health and Care Excellence (NICE) has recently issued approval via Interventional Procedure Guidance IPG557 for endovenous mechanochemical ablation for the treatment of varicose veins in the United Kingdom. The NICE guidelines ...
13-07-2016FDA Approves First And Only Single Monthly Injection For A PCSK9 Inhibitor
THOUSAND OAKS, Calif., July 11, 2016 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved the Repatha® (evolocumab) Pushtronex™ system (on-body infusor with prefilled cartridge), a new, monthly single-dose administration option.1 The P...
12-07-2016Sunshine Heart Announces Clinical Update and Product Development Strategy
EDEN PRAIRIE, Minn., July 11, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced today an update to its clinical strategy that could benefit an underserved population of patients with Class III heart failure and other related conditions.After months of collecting data and researchi...
11-07-2016Enrollment for PLIANT study completed
Patients with iLIac Aneurysm undergoing endovascular stenting with a New generation of low profile E-liac STent Graft System.PLIANT is an observational prospective, non-randomised, multicentre single-arm study to evaluate clinical and technical success as well as safety and feasibility of the E-liac...
11-07-2016Sunshine Heart Announces Clinical Update and Product Development Strategy
EDEN PRAIRIE, Minn., July 11, 2016 (GLOBE NEWSWIRE) — Sunshine Heart, Inc. (NASDAQ:SSH) announced today an update to its clinical strategy that could benefit an underserved population of patients with Class III heart failure and other related conditions.After months of collecting data and research...
11-07-2016Major amputation over utilised globally for critical limb ischaemia
Due to an absence of standardised protocols, major amputation is being over utilised worldwide as a treatment for critical limb ischaemia, according to Mary Yost, president and senior analyst at The Sage Group LLC, who gave a presentation at the 2016 New Cardiovascular Horizons annual meeting (1–3...
08-07-2016Essential Medical Inc. Announces FDA Approval to Begin a U.S. Clinical Trial for the MANTA™ Large Bore Vascular Closure Device
MALVERN, Pennsylvania, July 8, 2016 /PRNewswire/ --Essential Medical, Inc., a privately held medical device company addressing the rapidly growing large bore vascular closure market, announced today that it has received Investigational Device Exemption (IDE) approval from the FDA to begin the U.S. c...
08-07-2016Varithena Earns FDA Approval for 30 Day Post-Activation Shelf Life
WEST CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--BTG plc (LSE:BTG), the specialist healthcare company, announced that the U.S. Food and Drug Administration has approved an extension of the post-activation shelf life of Varithena (polidocanol injectable foam) 1% to thirty days from seven.“It highlights our...
07-07-2016Cardiovascular Systems Submits Diamondback 360® Coronary Orbital Atherectomy System Micro Crown for Approval in Japan
ST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today announced that it has submitted an application to Japan’s Pharmaceuticals andMedical Devices Agency (PMDA) for approval of its Diamondback 360® Coronary Orbital Atherectomy System (OAS) Micro Crown to trea...
07-07-2016
IRVINE, Calif., July 06, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that it had expanded the European launch of its revolutionary new Altura® Endovascular...
06-07-2016
SOUTH JORDAN, Utah, July 06, 2016 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has acquired DFINE, Inc. headquartered in San Jose, Ca...
06-07-2016
IRVINE, Calif., June 30, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that on June 28, 2016, the first commercial use of its new IntelliFlex™ Low Profile (...
30-06-2016
Frank J Criado, MD, FACS, FSVMA most pertinent and practically useful study on surgeons’ ability to estimate operative blood loss (EBL) was presented at the recent Annual Meeting of the Central Surgical Association in Montreal last April 2016. The study was designed and predicated on the well-esta...
30-06-2016Proven Performance and Results with Valiant™ Captivia™
Ver noticia...
29-06-2016
DUBLIN - June 28, 2016 - Medtronic plc (NYSE:MDT) today announced availability of its Beacon Heart Failure Management Service in the United States. This new service from Medtronic Care Management Services (MCMS) combines data from Medtronic implantable cardioverter defibrillator (ICD) or cardiac res...
28-06-2016
BENGALURU (June 27): Medtronic Plc said it would buy HeartWare International Inc for about US$1.1 billion, bulking up its portfolio of devices for treating heart diseases and pushing deeper into the market for less-invasive surgical products.HeartWare shares rose as much as 92% to US$57.58 in mornin...
27-06-2016Next-generation of HeartFlow launched
REDWOOD CITY, Calif.--(BUSINESS WIRE)--HeartFlow, Inc., a personalized medical technology company seeking to transform the way cardiovascular disease is diagnosed and treated, announced today that it is launching its next generation of the HeartFlow® FFRct Analysis. The result of years of developme...
23-06-2016
FREMONT, Calif. and ST. LOUIS, June 20, 2016 /PRNewswire/ -- VENITI, Inc., the leader in the advancement of treatment for venous disease, announced today that physicians have treated over 1,000 patients with the VICI VENOUS STENT. The product received CE marking in October 2013 and was first implant...
21-06-2016CorMatrix® Cardiovascular, Inc. Treats First Patients with New Tyke® Product for Neonates and Infants
Extracellular Matrix (ECM®) Now an Alternative for Congenital Heart Defect Repairs in Smaller Structures(Roswell, GA – June 21, 2016) – CorMatrix Cardiovascular, Inc., a leading developer of biomaterials and medical devices, today announced the treatment of the first patients using its CorMatri...
21-06-2016
SIOUX FALLS, SD (PRWEB) JUNE 21, 2016Sanford Vascular Innovations, a division of Sanford Health working on technology to improve vascular surgery and endovascular care, has been approved by the FDA to study a new device to treat complex aneurysms occurring in the descending aorta.The device, the Uni...
21-06-2016
IRVINE, Calif., June 20, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that it has received CE Mark approval for its IntelliFlex™ Low Profile (LP) Delivery ...
20-06-2016
IRVINE, Calif., June 16, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced plans to conduct a 1,000 patient global registry to evaluate its new Altura® Endograft...
16-06-2016
SUNNYVALE, Calif., June 15, 2016 /PRNewswire/ -- Silk Road Medical, Inc., a company dedicated to preventing the devastating burden of stroke through surgical innovation, announced that the 2016 Vascular Annual Meeting of the Society for Vascular Surgery (SVS) held June 8-11 in National Harbor, MD fe...
15-06-2016
TUSTIN, Calif., June 15, 2016 /PRNewswire/ -- MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation, today announced that Terumo Corporation has entered into an agreement to purchase Sequent Medical, Inc, a privately-held firm based in Aliso Viejo, CA with European operations based in ...
15-06-2016
The publication of the Mimics Study article; the enrollment of the 200th patient in the MIMICS-2 IDE Study; the 1st live case transmission from a US MIMICS-2 investigational site, and the start of its MIMICS-3D RegistryJune 13, 2016 - Veryan Medical has announced that results from the Mimics randomi...
13-06-2016
IRVINE, Calif., June 09, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today positive clinical data from the Italian Research Nellix Endoprosthesis (“IRENE”) study at the 2016 Society of Vascular Surgery (...
09-06-2016
IRVINE, Calif., June 08, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced the following commercial update of the new Altura® Endovascular Stent Graft System.Alt...
08-06-2016
DUBLIN and HOUSTON - June 8, 2016 - Medtronic plc (NYSE: MDT) and the University of Texas Health Science Center at Houston (UTHealth) today announced the first patient enrolled in a clinical study assessing the Medtronic Valiant(TM) Evo Thoracic Stent Graft System for the minimally invasive repair o...
08-06-2016
IRVINE, Calif., June 06, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that theAustralian Therapeutic Goods Administration (TGA) has approved the Aorfix™ En...
06-06-2016EU Reaches Deal on New Medical Device Regulations
The European Parliament and European Council recently jointly announced an agreement regarding new rules on medical devices and in vitro diagnostic medical devices. The process that lead to the agreement began in 2012. According to the press release, the goal of these new regulations is to:mak[e] su...
06-06-2016St. Jude Medical CardioMEMS HF System is Now Guideline Directed Therapy for Heart Failure Patients in Europe
ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that its CardioMEMS™ HF System was added to the European Society of Cardiology (ESC) guidelines as a directed therapy management and monitoring tool for heart failure patients. The...
06-06-2016CELA cumple 20 años
....
03-06-2016
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced receipt of CE Mark for the GORE® EXCLUDER® Conformable AAA Device, a product designed for the treatment of abdominal aortic aneurysms (AAA) in patients with challenging anatomies. This device is the latest addi...
03-06-2016CARDIONOVUM Announces Enrollment Completion of RAPID Trial
BONN, GERMANY, June 01, 2016 /24-7PressRelease/ -- CARDIONOVUM GmbH, a medical technology company developing and commercializing innovative medical devices such as drug-coated balloons and drug-eluting stents for the treatment of coronary and peripheral artery disease, today announced the completion...
01-06-2016Second Interim Analysis on ILLUMENATE Global Study Presented on Spectranetics’ Stellarex drug-coated balloon at NCVH
COLORADO SPRINGS, Colo., June 01, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation(NASDAQ:SPNC) today announced that Dr. Prakash Krishnan of Mount Sinai Medical Center, New York, NY presented the second interim analysis of 12-month data from the ILLUMENATE Global Study at the New Cardiovascula...
01-06-2016
Seen and heard at Charing Cross 2016 in London – April 26-29Frank J Criado, MD, FACS, FSVMThe headline on the front page of the CX Daily News of Wednesday April 27 summed up nicely what we saw and heard in the Upper (main) Auditorium the first day (April 26): “Good day for drug-coated balloons, ...
31-05-2016
WASHINGTON D.C., US: BTG plc (LSE: BTG), an international specialist healthcare company, has today announced the publication of new data at the 21st Annual Meeting of ISPOR (International Society for Pharmacoeconomics and Outcomes Research), highlighting that treatment of hepatocellular carcinoma (H...
26-05-2016OrbusNeich Expands Portfolio to Treat Peripheral Disease
HONG KONG, May 24, 2016 /PRNewswire/ --The innovator of COMBO?,the world's first dual therapy stent, introduces catheters for lower limb and AV fistula intervention OrbusNeich, a global company specializing in the provision of life-changing vascular solutions, has expanded its portfolio to include p...
24-05-2016HeartFlow hemodynamic data may help predict coronary plaque rupture potential
PARIS--(BUSINESS WIRE)--First-in-human data presented at EuroPCR 2016 demonstrate that hemodynamic data from HeartFlow, Inc., may help predict which coronary plaques have the potential to rupture. The results were part of a study designed to determine whether use of HeartFlow technology could predic...
19-05-2016iVascular wins CE Mark for Luminor 18 DCB
Spanish vascular device company iVascular S.L.U. said today it won CE Mark approval in the European Union for its Luminor 18 drug eluting balloon designed for lower limb angioplasty.The Luminor 18 is 0.018 guidewire compatible and has an extra low profile, and joins the company’s Luminor 14 and Lu...
18-05-2016Alvimedica TNT session at EuroPCR 2016
ALVIMEDICA TNT session “PCI in diabetic patients: turning challenges into today’s solution”Wednesday May 18th 2016 – Alvimedica Medical Technologies, a leading European company in interventional cardiology, sponsored a TNT session which includes a LIVE case during Euro PCR 2016 titled “PCI...
18-05-2016
IRVINE, Calif., May 17, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced the 30-day clinical results on 57 patients that were implanted with the Altura® Endogra...
17-05-2016GNT Pharma Receives IND Approval for Phase II Clinical Trial for Stroke Patients with Endovascular Treatment with First in Class Multi-Target Neuroprotection Drug Neu2000
OSAN, SOUTH KOREA--(Korea Newswire) May 17, 2016 -- GNT Pharma (“GNTP”) announced that the Korea Ministry of Food and Drug Safety has approved the company's Investigational New Drug (IND) application to initiate a Phase II clinical study of Neu2000 in ischemic stroke patients receiving endovascu...
17-05-2016
IRVINE, Calif., May 16, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has completed patient enrollment in the LIFE study, a multi-center post-market registry designed to evaluate the Ovation ®Abd...
16-05-2016BTG acquires Galil Medical for $110m
The company has developed cryoablation systems and needles for treating cancer at its Israeli laboratories.Cancer treatment company Galil Medical has been acquired by UK healthcare company BTG plc for $110 million. Galil Medical, which has its development operations in Yokneam near Haifa, has develo...
06-05-2016Better interventional radiology staffing needed to meet demand
FAIRFAX, Va. (May 5, 2016)—The Society of Interventional Radiology published 11 new recommendations to ensure that interventional radiology suites are adequately staffed to meet the growing demand for services. These first-ever, evidence-based interventional radiology staffing guidelines were publ...
05-05-2016Positive 12-month TOBA-BTK results presented at SCAI 2016
Data Presented at the Society for Cardiac Angiography and Interventions 2016 Annual Meeting Demonstrate Sustained Vessel Patency and Low Re-Intervention Rates with the Tack Endovascular System™May 04, 2016 05:00 PM Eastern Daylight TimeWAYNE, Pa.--(BUSINESS WIRE)--Intact Vascular, Inc., a develope...
04-05-2016First Patients in Central Pennsylvania Received New Aortic Valve Reconstruction Procedures at PinnacleHealth
HARRISBURG, Pa., May 3, 2016 /PRNewswire/ -- Three PinnacleHealth patients recently underwent a new procedure for aortic valve reconstruction using the patients' own heart tissue (pericardium) to create the new valves. It was first available in centralPennsylvania at PinnacleHealth and is currently ...
04-05-2016
Cook Medical has initiated a global, voluntary recall of all catheters with Beacon® Tip technology. This recall includes all lots of catheters with the Beacon Tip technology. The catheters were recalled on April 15, 2016 due to complaints of tip splitting and/or fracture. The U.S. Food and Drug Adm...
02-05-2016
....
29-04-2016
....
29-04-2016Programa Final del SITE 2016
...
29-04-2016Medtronic Demonstrates Commitment to EVAR in Comparison Study of ENGAGE Global Registry and Landmark EVAR 1 Trial
Clinical Integrity on Display through Longest Term Data of 1,200 Endurant AAA Stent Graft PatientsDUBLIN AND LONDON - April 27, 2016 - Medtronic plc (NYSE:MDT) today reported on the ENGAGE global registry of experiences with the Endurant® AAA stent graft system from Medtronic with a reference to th...
28-04-2016
ABBOTT PARK, Ill. and ST. PAUL, Minn., April 28, 2016 /PRNewswire/ -- Abbott (NYSE: ABT) and St. Jude Medical, Inc. announced today a definitive agreement for Abbott to acquire St. Jude Medical, creating a premier medical device leader with top positions in high-growth cardiovascular markets, includ...
28-04-2016Hansen pursues neurological indication for Magellan robot-assisted surgery device
Hansen Medical (NSDQ:HNSN) said today it filed a 510(k) application with the FDA for an expanded neurological indication for its Magellan robotic surgical system.If the Mountain View, Calif.-based company wins approval, the Magellan system will be fully indicated for applications in peripheral vascu...
26-04-2016AV Medical Announces Successful Completion of 30 Patient Study with its Innovative Angioplasty Balloon Catheter, Chameleon
TEL AVIV, Israel --(BUSINESS WIRE)AV Medical Technologies Ltd. announced today the culmination of a 30 patient study that evaluated the proprietary design of the Chameleon™ angioplasty balloon catheter. The study was conducted by Dr. Anthony Verstandig, Director of Interventional Radiology at Shaa...
21-04-2016GORE® EXCLUDER® Iliac Branch Endoprosthesis Gains Health Canada Approval
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced the Health Canada approval of the GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE), making it the most recent off-the-shelf aortic branch device approved in Canada for the endovascular treatment of common ilia...
21-04-2016Auris Surgical Robotics Agrees to Acquire Hansen Medical
SAN CARLOS, CA and MOUNTAIN VIEW, CA--(Marketwired - Apr 20, 2016) - Auris Surgical Robotics, Inc. and Hansen Medical, Inc. (NASDAQ:HNSN) today announced that they have signed a definitive merger agreement under which Auris will acquire Hansen Medical for $4.00 per share in cash, or a total equity v...
20-04-2016
IRVINE, Calif., April 14, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that it completed its first Altura® Endovascular Stent Graft Live Case Physician Training Work...
15-04-2016Psoriasis severity linked to rising risk of abdominal aortic aneurysms
Usman Khalid, M.D.Ph.D. fellow, Department of Cardiology Herlev and Gentofte HospitalDenmarkAmerican Heart Association Rapid Access Journal ReporApril 14, 2016 Categories: Heart NewsStudy HighlightsPsoriasis sufferers may have an increased risk for abdominal aortic aneurysms.The more severe the psor...
14-04-2016
The nominees and opening of voting for 2016-2017 Pioneers in Performance Awards for Latin America has been announced at the Congreso Internacional Cirugia Endovascular 2016 (CICE) Symposium (13–16 April, São Paulo, Brazil).Each year, distinguished physicians are honoured with the Pioneers in Perf...
14-04-2016
SUNNYVALE, Calif., April 13, 2016 /PRNewswire/ -- Silk Road Medical, Inc., a company dedicated to preventing the devastating burden of stroke through surgical innovation, announced that the United States Food and Drug Administration (US FDA) has granted 510(k) clearance for its next generation ENROU...
13-04-2016
IRVINE, Calif., April 11, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today achievement of CE (Conformite Europeenne) Mark of the next-generation Nellix Endovascular Aneurysm Sealing System ("Nellix EVAS Syst...
11-04-2016
BONN, March 30, 2016 -- CARDIONOVUM GmbH, a medical technology company developing and commercializing innovative medical devices such as drug-coated balloons and drug-eluting stents for the treatment of coronary and peripheral artery disease, announced today the enrollment of the first patient in t...
08-04-2016Admedus expands distribution agreement with Coroneo
Admedus Ltd (ASX:AHZ) has expanded its exclusive distribution partnership with Canada's CORONEO to sell its Extra-Aortic Annuloplasty Ring and related products in Australia and New Zealand.This builds on original agreement to distribute CORONEO products in UK and Germany.The ring is implanted into p...
08-04-2016Abiomed Impella® Therapy Receives FDA Approval for Cardiogenic Shock After Heart Attack or Heart Surgery
Entire Family of Impella Left Side Heart Pumps FDA Approved To Enable Heart RecoveryDANVERS, Mass., April 07, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that it has received U.S. Food and Drug Administration (F...
07-04-2016St Jude Medical launches Trifecta surgical valve in Europe
The new Trifecta™ Valve with Glide™ Technology provides enhanced valve delivery designed to improve implantation during both minimally invasive and conventional valve replacement proceduresST. PAUL, Minn.--(BUSINESS WIRE)-- St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, toda...
07-04-2016Cryoablation Shows Promise in Reducing Phantom Limb Pain
April 6, 2016 -- A new interventional radiology technique is showing promise in relieving chronic pain at the site of amputated limbs, according to research presented at this week's Society of Interventional Radiology (SIR) meeting.Called phantom limb pain, the condition is known to plague military ...
06-04-2016Eximo Medical, an Accelmed portfolio Company, Announces the Successful Completion of a Multi-Center First-In-Human Trial in Europe with a Hybrid Catheter for Treating Complex Lesions in Peripheral Blood Vessels
Eximo Medical, a medical device company that is developing a laser system and unique catheters for the treatment of peripheral artery disease (PAD), has successfully completed a multicenter clinical trial for the purpose of obtaining CE approval for marketing in Europe. The results of the trial indi...
06-04-2016It is now confirmed: CAS risks and challenges are all upfront, but the long-term stroke prevention benefit that is very bit as good as that of CEA
Frank J Criado, MD, FACS, FSVMThe “noise” and controversy about CAS and which one is better CAS or CEA continues unabated… although things are finally beginning to change and move forward with many noted experts predicting that carotid stenting will evolve into an intervention that is equal to...
05-04-2016Lombard Medical Provides Update on New Altura® Endovascular Stent Graft Launch
IRVINE, Calif., April 04, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced an update on the commercial launch of the new Altura® Endovascular Stent Graft. Since the com...
04-04-2016First Patients Enrolled in Medtronic Trial in Low-Risk Aortic Stenosis Patients
DUBLIN - March 31, 2016 - Medtronic plc announced that the first patients were enrolled in the expanded indication trial for the CoreValve Evolut R System, the first and only next-generation recapturable, self-expanding transcatheter aortic valve replacement (TAVR) system commercially available in t...
01-04-2016Penumbra to Launch LanternTM Microcatheter, Present Final Results of Multicenter Prism Trial on Indigo® System at SIR 2016
ALAMEDA, Calif.--(BUSINESS WIRE)--Penumbra, Inc., a global interventional therapies company, today announced the launch of its Lantern™ microcatheter at the upcoming Society for Interventional Radiology 2016 meeting (SIR 2016) to be held at the Vancouver Convention Center, April 2-7th. Lantern is ...
01-04-2016
WALTHAM, MA - March 29, 2016 – Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular robotics, announced today that the U.S. Food and Drug Administration has cleared the CorPath® System for use in peripheral vascular interventions. This is the third clearanc...
29-03-2016ZOLL Receives Approval to Market Intravascular Temperature Management Technology for Sudden Cardiac Arrest in Japan
CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today that its Japanese subsidiary, Asahi Kasei ZOLL Medical Corp. (AZM), has obtained approval from Japan’s Pharmaceuticals and ...
28-03-2016
COLORADO SPRINGS, Colo., March 24, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today announced that Udo Scheiner has been named Senior Vice President, International Operations, effective March 23rd, 2016. In this role, Mr. Scheiner will report directly to Scott Drake, Presid...
24-03-2016
INGELHEIM, Germany - Wednesday, March 23rd 2016 [ME NewsWire] First patient enrolled in RE-COVERY DVT/PE™ Involving 14,000 patients worldwide, the study will collect real-world data on reducing the risk of DVT and PE with Pradaxa®1(BUSINESS WIRE)-- Boehringer Ingelheim today announces the ...
23-03-2016El Hospital General de Valencia repara la válvula mitral cardiaca sin necesidad de cirugía
El Hospital General Universitario de Valencia repara la válvula mitral cardiaca sin necesidad de cirugía. A través de una mínima incisión en la vena femoral, desde la ingle, se llega hasta el corazón donde se introduce un pequeño dispositivo en forma de clip o grapa que se engancha en los vel...
22-03-2016
Today, the U.S. Food and Drug Administration announced a proposal to ban most powdered gloves in the United States. While use of these gloves is decreasing, they pose an unreasonable and substantial risk of illness or injury to health care providers, patients and other individuals who are exposed to...
21-03-2016
El dispositivo GORE® EXCLUDER® alcanza un hito significativoEl dispositivo probado para la reparación de aneurismas endovasculares (endovascular aneurysm repair, EVAR) alcanza los 250 000 pacientes en todo el mundo.FLAGSTAFF, Arizona -- W. L. Gore & Associates, Inc. (Gore) anunció hoy que más d...
18-03-2016
Nuevo dispositivo de investigación de Gore diseñado para tratar aneurismas aórticos que involucran ramas vasculares visceralesFLAGSTAFF, Arizona- W. L. Gore & Associates, Inc. (Gore) anunció hoy el primer implante, en Estados Unidos, de la Endoprótesis Torácico Abdominal GORE® EXCLUDER® en u...
18-03-2016
BURLINGTON, Mass., March 18, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it has acquired the ProCol Vascular Bioprosthesis product line from Hancock Jaffe Laboratories, Inc. for $665,000 plus a three yea...
18-03-2016Canon Inc. to make Toshiba Medical Systems Corporation a subsidiary
TOKYO, Japan, March 17, 2016—Canon Inc. ('Canon'; Headquarters: Tokyo, Japan; Chairman, President and CEO: Fujio Mitarai) announced today that it has concluded a share transfer agreement with Toshiba Corporation ('Toshiba'; Headquarters: Tokyo, Japan; President and CEO: Masashi Muromachi) concerni...
17-03-2016Abbott Vascular Recalls MitraClip Clip Delivery System Due to Issue with Delivery System Deployment Process
The FDA has identified this as a Class I recall, the most serious type of recall. Use of this device may cause serious injuries or death.Recalled Product:MitraClip Clip Delivery System Lot Numbers:50811U1, 50811U2, 50812U1, 50813U1, 50814U1, 50826U1, 50826U2, 50827U1, 50908U1, 50908U2, 50909U1, 5091...
16-03-2016
SUNNYVALE, Calif., March 15, 2016 /PRNewswire/ -- Silk Road Medical, Inc., a company dedicated to preventing the devastating burden of stroke through surgical innovation, announced CE Mark approval for its next generation ENROUTE Transcarotid Neuroprotection System (NPS). The ENROUTE NPS remains th...
15-03-2016Cardiólogos del Instituto de Investigación del Hospital Clínico desarrollan una técnica para predecir eventos mayores tras sufrir un infarto
El Grupo de Investigación de Cardiopatía Isquémica del Instituto de Investigación Sanitaria del Hospital Clínico INCLIVA y su servicio de Cardiología han desarrollado una técnica para predecir eventos mayores tras sufrir un infarto mediante resonancia magnética cardiaca. La investigación se...
14-03-2016AngioDynamics and Merz North America Establish Multi-Year Relationship to Market Asclera for Vein Patients
ALBANY, N.Y., March 10, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that they have signed an agreement with Merz North America, U.S. ...
10-03-2016
IRVINE, Calif., March 08, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that the first two patients with abdominal aortic aneurysms (“AAAs”) in Japan have been treated with the Nellix® EndoVascular A...
08-03-2016Women less likely to receive basic life support for cardiac arrest from public
Sophia Antipolis, 8 March 2016: Women are less likely to receive basic life support for cardiac arrest from members of the public then men, the European Society of Cardiology announced today on International Women’s Day.“There is a misconception that women don’t have heart problems so they don...
08-03-2016Corvia Medical Receives IDE Approval For REDUCE LAP-HF I Clinical Study & Announces Agreement With Strategic Partner For Exclusive Option To Purchase Company
TEWKSBURY, Mass., March 7, 2016 /PRNewswire/ -- Corvia Medical, Inc., a privately-held medical device company that developed a first-in-class transcatheter structural heart device to treat heart failure, today announced that it has received Investigational Device Exemption (IDE) approval from the FD...
07-03-2016Ethicon Announces Agreement To Acquire NeuWave Medical, Inc.
CINCINNATI, March 7, 2016 /PRNewswire-USNewswire/ -- Ethicon, a medical device company of the Johnson & Johnson family of companies, today announced a definitive agreement to acquire NeuWave Medical, Inc., a privately held medical device company that manufactures and markets minimally invasive soft ...
07-03-2016
SOMERVILLE, N.J., March 5, 2016 /PRNewswire/ -- Ethicon* today announced new data from a global cardiovascular (CV) Phase III clinical trial of the EVARREST® Fibrin Sealant Patch. Seventy five percent of patients treated during aortic reconstruction surgery with EVARREST® achieved hemostasis on th...
05-03-2016GORE® EXCLUDER® Iliac Branch Endoprosthesis Gains FDA Approval
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--At the Houston Aortic Symposium today, W. L. Gore & Associates, Inc. (Gore) announced the Food and Drug Administration (FDA) approval of the GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE), making it the first off-the-shelf aortic branch device approved in the ...
03-03-2016Cook Medical marks 20 years of success in Limerick
Limerick, Ireland – In 2016 Cook Medical will celebrate 20 years of operations in the National Technology Park where it has grown from a primary team of less than a dozen people to a staff of over 800, who are designing and delivering life-changing devices every day.The medical device company prov...
03-03-2016El Hospital Clínico de Valencia incorpora una nueva sala de hemodinámica
El Hospital Clínico Universitario de Valencia ha puesto en marcha recientemente una nueva sala de hemodinámica que permitirá incrementar las pruebas de cardiología intervencionista, tales como angioplastia coronaria (pruebas que se realizan para abrir las arterias del corazón que se han estrech...
02-03-2016FDA Approves Edwards' Sapien XT for Pulmonary Valve Replacement
The agency has considerably expanded the indications of Edwards Lifesciences’ Sapient XT transcatheter valve, which was granted FDA approval for use in valve-in-valve transcatheter aortic valve replacement (TAVR) procedure.Nancy CrottiFDA’s approval of the XT TAVI valve will allow for minimally ...
02-03-2016
Frank J Criado, MD, FACS, FSVMAccording to the updated guidelines concerning treatment of patients with venous thromboembolism (American College of Chest Physicians’ 10th edition of “Antithrombotic Therapy for VTE Disease”, Chest. 2015. doi: 10.1016/j.chest.2015.11.026), routine use of compres...
01-03-2016Gore Launches New 7.5 cm Length GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates (Gore) today announced the availability of a new 7.5 centimeter length of the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface. Gore developed this size in response to physician needs for certain clinical situations. The GORE V...
01-03-2016Disponible programa preliminar del SITE Update Barcelona 2016
....
29-02-2016New Generation BeGraft. Bentley - BeGraft Peripheral (Innovations for life)
....
29-02-2016IN.PACT Admiral Drug-Coated Balloon by Medtronic
....
29-02-2016GORE Excluder - Proven now and Positioned for the Future
....
29-02-2016
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA) today announced that Paul J. Gagne, MD, Chief of Vascular Surgery at Norwalk Hospital in Norwalk, CT, has presented clinical trial data that demonstrates the benefits of its intravascular ultrasound (IVUS) technology compared to con...
26-02-2016E-liac – More than 700 patients successful treated worldwide
Since the worldwide market launch in 2014 more than 700 patients have been successfully treated with the E-liac stent graft. The innovative iliac side branch stent graft system is indicated for endovascular treatment of aorto-iliac aneurysm as well as for isolated iliac aneurysm to preserve blood fl...
25-02-2016
Based on its core competences and technologies JOTEC provides physicians with custom-made endovascular products. This allows treatment of vessel anatomies which cannot be treated by existing standard products. The E-xtra DESIGN ENGINEERING department offers the possibility of patient specific therap...
25-02-2016
In January 2016 JOTEC has launched a new E-ventus BX balloon expandable peripheral stent graft system indicated for interventional therapy of renal and iliac arteries in cases such as ruptures, dissections and aneurysms. To meet the highest demands of interventional therapies the cobalt-chromium ste...
25-02-2016
IRVINE, Calif., Feb. 24, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that the first commercial procedure in Germany using the revolutionary new Altura® Endovascular...
24-02-2016Angioplastia carotidea similar a cirugía en pacientes asintomáticos
Título original: Randomized Trial of stent versus Surgery for Asymptomatic Carotid Stenosis. Kenneth Rosenfield. N Engl J Med. 2016 Feb 17. [Epub ahead of print]Gentileza del Dr. Carlos Fava.El accidente cerebro vascular (ACV) es una de las principales causas de muerte e incapacidad en el mundo y h...
24-02-2016
....
22-02-2016Boston Scientific Receives CE Mark For Eluvia™ Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial
MARLBOROUGH, Mass., Feb. 22, 2016 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced that the Eluvia™ Drug-Eluting Vascular Stent System has received CE Mark and is commencing commercialization immediately in the European Union and other countries where CE Mark is recognized. The Eluvi...
22-02-2016Nipro Medical Corporation launches the Cronus™ HP 0.035" OTW PTA Balloon Catheter in the United States
BRIDGEWATER, N.J., Feb. 19, 2016 /PRNewswire/ -- Nipro North America, a division of Nipro Medical Corporation, announced the launch of the Cronus HP high-pressure, 0.035" over-the-wire (OTW) percutaneous transluminal angioplasty (PTA) balloon catheter.Cronus HP is indicated for percutaneous translum...
19-02-2016
WAYNE, Pa.--(BUSINESS WIRE)--Feb. 19, 2015-- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical devices for critical care and surgery, announced the launch of the triple-lumen ARROW® PICC with Chlorag+ard® Technology. This completes the Company’s portfolio of PICCs with the u...
19-02-2016ArtVentive Medical Group, Inc. Announces Enrollment in OCCLUDE Post-Market Study of EOS™ Endoluminal Occlusion System
CARLSBAD, Calif.--(BUSINESS WIRE)--ArtVentive Medical Group, Inc. (OTCBB: AVTD) announced today enrollment in the ongoing ArtVentive EOS™ Endoluminal Occlusion System, OCCLUDE post-market surveillance study.“The ArtVentive EOS™ device enhances our ability to treat challenging embolization case...
16-02-2016
Proven device for endovascular aneurysm repair (EVAR) reaches 250,000 patients worldwideFLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced that more than 250,000 patients have been treated* with the GORE® EXCLUDER® AAA Endoprosthesis. The GORE EXCLUDER Device h...
16-02-2016
FOR IMMEDIATE RELEASE: February 10, 2016Cook Incorporated750 Daniels Way, P.O. Box 489Bloomington, Indiana 47402812.339.2235www.cookmedical.comArterial Pressure Monitoring CatheterOn January 6, 2016, Cook Medical initiated a voluntary recall of 360 specific lots of Single Lumen Central Venous Cathet...
10-02-2016
DUBLIN and SIOUX FALLS, S.D. - February 9, 2016 - Medtronic plc (NYSE:MDT), a global leader in medical technology, services and solutions and Sanford Health, one of the nation's largest health care systems, today announced the first patient enrolled in a clinical study using the Medtronic Valiant® ...
09-02-2016TVA Medical Receives Additional Reimbursement In Germany For The everlinQ™ endoAVF System
AUSTIN, Texas, Feb. 5, 2016 /PRNewswire/ -- TVA Medical, Inc., a medical device company developing innovative therapies for end-stage renal disease (ESRD), today announced that its everlinQTM endoAVF System has received NUB (German Neue Untersuchungs und Behandlungsmethoden) Status 1 approval across...
05-02-2016
IRVINE, Calif., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that the first commercial procedure using the revolutionary new Altura® Endovascular Stent Graf...
04-02-2016CryoLife Announces Sale of HeRO Graft to Merit Medical Systems
ATLANTA, Feb. 4, 2016 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that it sold its HeRO Graft product line to Merit Medical Systems, Inc. (NASDAQ: MMSI) for $18.5 million in cash.J. Patrick Mackin, Cha...
04-02-2016Merit Medical Acquires the HeRO®Graft From CryoLife, Inc.
SOUTH JORDAN, Utah, Feb. 04, 2016 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, today announced that i...
04-02-2016Maquet Medical Systems USA, A Getinge Group Company Announces Partnership with BIOTRONIK to Distribute Endovascular Medical Devices in United States
WAYNE, N.J., Feb. 3, 2016 /PRNewswire/ -- Maquet Medical Systems USA, a Getinge Group Company announced today that it has entered into a partnership with BIOTRONIK, a Berlin, Germany-based manufacturer of cardiovascular and endovascular medical devices, to distribute BIOTRONIK's peripheral vascular ...
03-02-2016
IRVINE, Calif., Feb. 03, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has successfully completed the previously announced merger with TriVascular Technologies, Inc.John McDermott, Chairman and Ch...
03-02-2016Summit CELA 2016 Montevideo - Uruguay
....
02-02-2016First Intervention with the Self-Apposing Drug-Eluting Stent for Lower Limbs broadcasted live at LINC international congress
Friday, January 29, 2016Two procedures successfully performed at Leipzig University hospitalPRINCETON, N.J. and PARIS., STENTYS a medical technology company commercializing the world's first and only Self-Apposing® coronary stent, today announces that the first interventions using its self-expandin...
29-01-2016Novel Hemodialysis Access System Demonstrates High Suitability For Dialysis In Clinical Trial
LEIPZIG, Germany, Jan. 28, 2016 /PRNewswire/ -- TVA Medical, Inc., announced primary endpoint data from a prospective, multicenter clinical study evaluating the everlinQ™ endoAVF System. This novel medical technology creates an arteriovenous (AV) fistula for hemodialysis access in people with end-...
28-01-2016
IRVINE, Calif., Jan. 27, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that on January 27, 2016 its new Altura® Endograft System successfully treated a patient with a...
27-01-2016
Smaller Diameters Gain CE Approval for Enhanced Treatment of Below-the-Knee Arterial Disease BUELACH, Switzerland, January 26, 2016 – BIOTRONIK, a leader in cardio- and endovascular medical technology, announced today that it has received CE mark approval for smaller diameters of its Passeo-18 Lu...
26-01-2016Roxwood Medical Expands Its Microcross Catheter Platform With The Addition Of The Micro14es (Extra Support) Catheter
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Roxwood Medical, Inc. announced today the expansion of its successful MicroCross™ Catheter platform with the addition of the Micro14es (extra support) catheter. Micro14es is an extension of the Micro14 catheter, specifically designed for complex peripheral an...
26-01-2016JenaValve Technology Appoints Pieter Van den Steen As Chief Commercial Officer, General Manager
IRVINE, Calif.--(BUSINESS WIRE)--JenaValve Technology, Inc., a next-generation heart-valve technology company, committed to providing state-of-the-art transcatheter aortic valve replacement (TAVR) technologies to cardiology professionals and to the broadest spectrum of patients with aortic valve dis...
22-01-2016Clinical Trial of Novel Infusion Device for Below the Knee Angioplasty Begins in Germany
January 21, 2016 -- Emeryville, California -- Mercator MedSystems, Inc., has announced their first patient enrollment from Bad Krozingen, Germany, in the company's LIMBO-PTA clinical trial. This trial combines localized drug delivery using the company's proprietary Bullfrog® Micro-Infusion Device o...
21-01-2016Rapid Medical Announces First Stroke Patient Treated With TIGERTRIEVER
YOKNEAM, Israel, January 19, 2016 /PRNewswire/ --Rapid Medical, a company focused on the development of neurovascular interventional devices, announced today that the first patient has been treated with its CE marked TIGERTRIEVER revascularization device. The TIGERTRIEVER uses Rapid Medical's unique...
19-01-2016
....
18-01-2016
RALEIGH, N.C., Jan. 14, 2016 /PRNewswire/ -- Contego Medical today announced the European commercialization of the Paladin® Carotid Post-Dilation Balloon, the first and only angioplasty balloon with Integrated Embolic Protection™ (IEP) Technology for patients undergoing carotid stenting procedure...
14-01-2016
Contego Medical anuncia la comercialización europea del globo postdilatación de carótida Paladin® con tecnología Integrated Embolic Protection™La presentación tendrá lugar en el Leipzig Interventional Course (LINC) del 26 al 29 de enero en Leipzig, Germany.RALEIGH, Carolina del Norte, 14 d...
14-01-2016
IRVINE, Calif., Jan. 12, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced preliminary revenue for its fourth quarter and full year 2015 as well as several key co...
13-01-2016InnAVasc, Inc. Hires Joseph Knight, PhD, MBA
DURHAM, N.C.--(BUSINESS WIRE)--InnAVasc, Inc., a medical device company that designs and develops products for vascular and hemodialysis access, today announced that Joseph A. Knight, PhD, MBA, has been appointed President.“We are pleased to announce Joe’s appointment as President,” said Jeffr...
13-01-2016
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced the first implant in the United States of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in a clinical study for the treatment of aortic aneurysms involving the visceral branch vessels. The procedur...
12-01-2016
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX), a leading global provider of medical devices for critical care and surgery, has acquired privately held Nostix, LLC, a Boulder, Colorado developer of innovative tip confirmation systems that are used to increase the accuracy of vascular ...
11-01-2016
DUBLIN - January 11, 2016 - Medtronic plc (NYSE:MDT), a global leader in medical technology, services and solutions, today announced that the IN.PACT® Admiral® drug eluting balloon (DEB) (also known as the IN.PACT Admiral drug-coated balloon (DCB) in non-European markets) has received CE (Conformi...
11-01-2016
ALAMEDA, Calif.--(BUSINESS WIRE)--Penumbra, Inc., a global interventional therapies company, today announced the U.S. launch of its new POD® Packing Coil, designed to be used as a complementary device with Penumbra’s Ruby® and POD (Penumbra Occlusion Device) embolization products. This latest la...
06-01-2016Vascular Dynamics’ MobiusHD™ System Receives CE Mark for the Treatment of Resistant Hypertension
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Vascular Dynamics, Inc., a private medical device company developing novel solutions for the treatment of hypertension, today announced receipt of CE Mark approval for its MobiusHD™ System, a minimally invasive system for the treatment of resistant hypertens...
06-01-2016Argon Medical Devices Acquires Three Technologies from Rex Medical
PLANO, Texas, Jan. 5, 2016 /PRNewswire/ -- Argon Medical Devices, Inc. announced the completed acquisition of three vascular products from Rex Medical, LLC. The OptionELITE™ Retrievable Vena Cava Filter, CLEANER™ Rotational Thrombectomy System, and UltraStream™ Chronic Hemodialysis Catheter ar...
05-01-2016QT Vascular Announces Clinical Outcomes of Its Chocolate Heart Drug Coated Coronary Balloon
SINGAPORE, Jan. 5, 2016 /PRNewswire/ -- QT Vascular Ltd., together with its subsidiaries (the "Company" or "QT Vascular", and together with its subsidiaries, the "Group"), a global company engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive t...
05-01-2016
Frank J Criado, MD, FACS, FSVMIn a recent study (published online Aug 26, 2015), attending surgeons who work through the wee hours of the night do not have measurably different short-term outcomes for elective surgical operations performed the next day. The primary composite outcome of death, readmi...
28-12-2015Galil Medical Tender Offer to Acquire Perseon Corporation Expires
ARDEN HILLS, Minn. and SALT LAKE CITY, Dec. 22, 2015 /PRNewswire/ -- Galil Medical Ltd. ("Galil"), a global leader in delivering innovative cryotherapy ablation solutions, today announced the expiration of the previously announced tender offer by Galil's indirect wholly owned subsidiary Galil Merger...
22-12-2015
American Heart Association Rapid Access Journal ReportDecember 22, 2015 Categories: Heart NewsStudy Highlights:Middle-aged adults who scored well on the American Heart Association’s Life’ Simple 7 checklist were less likely to develop heart failure.Managing blood pressure, controlling cholestero...
22-12-2015Proxy Biomedical announces facility expansion
Galway, Ireland, December 21st, 2015 – Proxy Biomedical Ltd., a leading global innovator in the design, development and manufacturing of biomaterial based product solutions for medical implants, today announced a substantial facility expansion. Over the last twelve months, the company launched a s...
21-12-2015
ZURICH, December 17, 2015 /PRNewswire/ --In 2015: positive results from first two clinical trials, stronger leadership team and corporate recognitions Xeltis has completed a €3 million extension to its series B financing, bringing the total round to €30 million. Xeltis is the first-ever medical...
17-12-2015Sanford Health, University of South Dakota Collaborate to Develop New Drug-coated Balloons
SIOUX FALLS, S.D. (PRWEB) DECEMBER 16, 2015Sanford Health and the University of South Dakota are collaborating to develop more effective drug-coated balloons to treat peripheral artery disease. The two new devices, which can more precisely deliver drugs to specific arteries, are based on intellectua...
16-12-2015
16 December 2015 (Flagstaff, Arizona)108 patient trial to add evidence for treatment of in-stent restenosis using the GORE® VIABAHN® EndoprosthesisW. L. Gore & Associates (Gore) announces that the first patients are now enrolled in the Gore RELINE MAX Clinical Study, a post-approval study to conti...
16-12-2015Patient enrollment begins for PRESERVE, a large study of retrievable IVC filters
CHICAGO, Dec. 16, 2015 /PRNewswire-USNewswire/ -- As of mid-December, researchers have activated the first 10 medical sites and enrolled the first nine patients in a study that will determine the safety and effectiveness of inferior vena cava filters, small, cage-like devices implanted to prevent li...
16-12-2015
DALLAS, December 16, 2015 – One of every three deaths in the U.S. in 2013 were from heart disease, stroke and other cardiovascular diseases, while heart disease and stroke were the No. 1 and No. 2 killers worldwide, according to American Heart Association’s 2016 Heart Disease and Stroke Statisti...
16-12-2015
WAYNE, N.J., Dec. 15, 2015 /PRNewswire/ -- Maquet Medical Systems USA announced today an exclusive U.S. distribution agreement with ReFlow Medical, Inc., a company focused on developing technologies for accessing and treating cardiovascular disease, to distribute their complete line of catheters. Th...
15-12-2015
LONDON, December 14, 2015 /PRNewswire/ --BTG plc (LSE: BTG), a global specialist healthcare company, today announced it has received 510k clearance from the US Food and Drug Administration (FDA) for LC Bead LUMI™, the first commercially available radiopaque embolic bead for the embolization of hyp...
14-12-2015
REDWOOD CITY, Calif., December 14, 2015 — Roxwood Medical Inc. reported today that more than 500 patients have been successfully treated as part of the initial limited release of its MicroCross™ Catheter, the latest addition to Roxwood Medical’s expanding product line. The MicroCross Catheter ...
14-12-2015
Medtronic announced Monday a new facility in Galway, Ireland that will manufacture the company's IN.PAC Admiral drug-coated balloon (DCB) for the treatment of peripheral artery disease. Tony Semedo, president of Medtronic's Aortic & Peripheral Vascular business, remarked "our global market leadershi...
14-12-2015
IRVINE, Calif., Dec. 10, 2015 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that the AFX® Endovascular AAA System for the treatment of abdominal aortic aneurysms has received Shonin approval from the Japanese...
10-12-2015
DECEMBER 10TH, 2015Bloomington, Ind. – Just weeks after 2015 country approval of Cook Medical’s Zenith Alpha™ Abdominal Endovascular Graft, the University of Western London Health Sciences Centre in London, Ontario treated the first patient with the device as part of Cook’s Canada commercial...
10-12-2015
MARLBOROUGH, Mass., Dec. 9, 2015 /PRNewswire/ -- Boston Scientific (NYSE: BSX) has voluntarily recalled the Chariot™ Guiding Sheath globally. These devices are intended for the introduction of interventional devices during peripheral vascular procedures, and were recalled onNovember 19th due to th...
09-12-2015Edwards Lifesciences Outlines Sharpened Growth Strategy at Investor Conference
IRVINE, Calif., Dec. 9-- Edwards Lifesciences Corporation (NYSE: EW), a global leader in products and technologies to treat advanced cardiovascular disease, today is hosting its 2003 Investor Conference at its corporate headquarters in Irvine, Calif., during which management will provide greater vis...
09-12-2015
CARLSBAD, Calif.--(BUSINESS WIRE)--ArtVentive Medical Group, Inc. (OTC Bulletin Board AVTD) announced today that the Company conducted its first animal study of its next generation of the ArtVentive Endoluminal Occlusion System (EOS™ Gen II). The EOS™ is designed for use in the peripheral vascul...
04-12-2015Surefire Medical Closes $15M Series C Financing for direct-to-tumor delivery systems
Surefire Medical is developing direct-to-tumor drug delivery systems that are are designed to be used in minimally invasive interventional procedures. The company has announced a successful $15 million Series C financing led by Tullis Health Investors. The financing will go toward the global launch ...
02-12-2015European medical technology industry adopts new code of ethical business practice
Brussels, 2 December 2015 – Members of the European Diagnostics Manufacturers Association (EDMA) and of the European Medical Technology Industry (Eucomed), both members of MedTech Europe, have approved a new Code of Ethical Business Practice at their General Assemblies held on 2 December in Brusse...
02-12-2015Endovascular TV en colaboración con la primera edición del "Coronary and Structural Course"
endovascular.tv fue una de las novedades del 'Coronary and Structural Course' CSC 2015 celebrado del 18 a 20 de Noviembre en Barcelona.CSC en colaboración con Endovascular.TV contó con un estudio de TV situado en el vestíbulo del Hotel Crowne Plaza de Barcelona, hotel sede del congreso.En el plat...
30-11-2015
MARLBOROUGH, Mass., Nov. 30, 2015 /PRNewswire/ -- Boston Scientific (NYSE: BSX) has received United States (U.S.) Food and Drug Administration (FDA) approval and CE Mark for the AngioJet™ ZelanteDVT™ thrombectomy catheter to treat deep vein thrombosis (DVT) in large-diameter upper and lower limb...
30-11-2015
IRVINE, Calif., Nov. 30, 2015 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), presented efficacy and safety data from the three-year follow up of the U.S. PYTHAGORAS pre-marketing a...
30-11-2015
....
29-11-2015
October 26, 2015 03:00 PM Eastern Daylight TimeTEL AVIV, Israel--(BUSINESS WIRE)--AV Medical Technologies Ltd. announced today that it has received U.S. Food and Drug Administration (FDA) clearance for the Chameleon™ angioplasty balloon catheter. With its Proximal Injection Port (PIP™) technolog...
26-11-2015
MINNEAPOLIS, Nov. 24, 2015 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for a new and enhanced version of the R350 guidewire, an extra-long guidewire designed for use in complex interventio...
24-11-2015
Treatment Combining Passeo-18 Lux Drug-Coated Balloon with Pulsar-18 Stent Led to Excellent Patency and SafetyNEW YORK, US, and BUELACH, Switzerland, November 20, 2015 –BIOTRONIK, a leading manufacturer of cardio- and endovascular medical technology, has presented the 24-month results from the DEB...
20-11-2015
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced in conjunction with its 40th anniversary, it has sold 40 million devices worldwide. The milestones come as the company showcases its latest innovations and achievements for the vascular community at the 2015 VEIT...
18-11-2015
Endologix (NSDQ:ELGX) and TriVascular Technologies (NSDQ:TRIV) yesterday said that the waiting period set by U.S. anti-trust laws for their $211 million merger ended early, setting the stage for the deal to close during the 1st quarter next year.The companies said the U.S. Federal Trade Commission a...
18-11-2015
Awards Program Honors Medical Specialists Advancing Therapy and Improving Patient and Clinical Performance Through Active CollaborationNovember 18, 2015 08:00 AM Eastern Standard TimeFLAGSTAFF, Ariz. & NEW YORK--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced the nominees and o...
18-11-2015
DUBLIN and NEW YORK CITY- November 17, 2015 - Selected for nearly one of every two endovascular abdominal aortic aneurysm (AAA) repairs globally, the Endurant® AAA stent graft system from Medtronic plc (NYSE: MDT) continues to maintain durable and consistent outcomes at four years in real world set...
17-11-2015
Estos hitos son un testimonio de su legado de 40 años de diseñar dispositivos para mejorar los resultados del pacienteNovember 17, 2015 08:00 AM Eastern Standard TimeFLAGSTAFF, Arizona--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) anunció hoy, conjuntamente con su 40° aniversario, que h...
17-11-2015
IRVINE, Calif., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced the successful outcome of the first-in-man clinical EVAR case using its new low profile...
12-11-2015
Wholly-Owned Facility Fully Equipped to Develop, Test and Deliver Existing and Next-Generation Valve TechnologiesNovember 11, 2015 11:00 AM Eastern Standard TimeIRVINE, Calif.--(BUSINESS WIRE)--JenaValve Technology, Inc., a developer, manufacturer and marketer of next-generation transcatheter aortic...
11-11-2015
MARLBOROUGH, Mass., Nov. 10, 2015 /PRNewswire/ -- Boston Scientific (NYSE: BSX) has entered into a definitive agreement to acquire the interventional radiology portfolio of CeloNova Biosciences, a San Antonio-based developer of endovascular and interventional cardiology technologies. The structured ...
10-11-2015
ZURICH, Switzerland--(BUSINESS WIRE)--Xeltis has successfully completed its second feasibility trial in just over three months, showing positive results in patients a year after surgery for its bioabsorbable cardiovascular device technology. Xeltis is the first-ever medical device company developing...
10-11-2015
DUBLIN - November 9, 2015 - Medtronic plc (NYSE: MDT) today announced U.S. availability of the VenaSeal(TM) closure system, the first and only non-tumescent, non-thermal, non-sclerosant procedure approved for the treatment of symptomatic venous reflux in the U.S. The VenaSeal closure system was appr...
09-11-2015Women cardiologists do different work, make less money than men
DURHAM, N.C. -- Despite efforts to increase gender diversity in cardiology, major differences in job characteristics and pay persist between men and women who treat heart patients, according to a Duke Medicine-led study presented at the annual American Heart Association meeting.The researchers found...
09-11-2015
ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the publication of new, prospective data in The Lancet journal further supporting the long-term effectiveness of theCardioMEMS™ HF System at reducing heart failure (HF) hospitaliza...
09-11-2015
November 5, 2015Data from ARISE II Will Be Submitted to FDA in support of Market Clearance for EmboTrap in the U.S.Galway, Ireland — 5 November, 2015 — Neuravi, a company dedicated to improving clinical outcomes for stroke patients, announced today that the Tennessee Interventional and Imaging A...
05-11-2015TherOx Receives FDA IDE Approval for Study of Next-Generation Supersaturated Oxygen Therapy for AMI
Important Milestone Toward Bringing SSO2 Therapy to the U.S. MarketNovember 05, 2015 09:00 AM Eastern Standard TimeIRVINE, Calif.--(BUSINESS WIRE)--TherOx, Inc., a privately held medical device company focused on improved treatment of Acute Myocardial Infarction (AMI), announced it has received U.S....
05-11-2015Come and join us for the SITE@LINC session during LINC 2016 in Leipzig, Germany
....
04-11-2015
First Clinical Case Performed at Hopital Europeen Georges Pompidou (HEGP-APHP)MOUNTAIN VIEW, CA--(Marketwired - Nov 4, 2015) - Hansen Medical, Inc. (NASDAQ: HNSN), announced today the completion of the world's first clinical procedure using the Magellan™ Robotic Microcatheter Driver as part of the...
04-11-2015
...
03-11-2015Nuevas Guías TACS: Un suplemento enfocado hacia la patología infrapoplítea
...
03-11-2015
...
03-11-2015Bard Presto - Dispositivo de Inflado
...
03-11-2015
...
03-11-2015
VIVA Physician Sponsored Study to Determine the Benefits of Debulking Plaque and Maximizing Luminal Gain Prior to Drug Coated Balloon TherapyDUBLIN and LAS VEGAS - Nov. 2, 2015 - Medtronic plc (NYSE: MDT) announced today the initiation of the REALITY Study (DiRectional AthErectomy + Drug-coAted BaLl...
02-11-2015
VIVA Physician Sponsored Study to Determine the Benefits of Debulking Plaque and Maximizing Luminal Gain Prior to Drug Coated Balloon TherapyDUBLIN and LAS VEGAS - Nov. 2, 2015 - Medtronic plc (NYSE: MDT) announced today the initiation of the REALITY Study (DiRectional AthErectomy + Drug-coAted BaLl...
02-11-2015
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII), announced that the first two patients have been enrolled in its OPTIMIZE, peripheral Orbital Atherectomy System (OAS) study. Taking place in Europe, OPTIMIZE will evaluate the acute and long-term clinical outcomes of...
29-10-2015
ARDEN HILLS, Minn. and SALT LAKE CITY, Oct. 27, 2015 (GLOBE NEWSWIRE) -- Galil Medical, a global leader in delivering innovative cryotherapy ablation solutions, and Perseon Corporation (NASDAQ:PRSN) (NASDAQ:PRSNW) ('Perseon' or 'The Company'), a leading provider of medical systems that utilize energ...
27-10-2015
Frank J Criado, MD, FACS, FSVMMatti Lane (from Helsinki University Hospital) presented a most interesting recent study at the annual meeting of the European Society for Vascular Surgery (ESVS) held in Porto, Portugal in September 2015. The retrospective multi-center clinical study concluded that hyp...
26-10-2015
IRVINE, Calif., and SANTA ROSA, Calif., Oct. 26, 2015 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX) and TriVascular Technologies, Inc.(Nasdaq:TRIV) announced today that they have entered into a definitive merger agreement under which Endologix and TriVascular will combine in a stock and cash tra...
26-10-2015Pryor Medical Devices Receives 510(k) Clearance For Distribution Of ER-REBOA Catheter
San Antonio, TX –- Pryor Medical Devices (The REBOA Company), today announced it has received FDA 510(k) clearance for the sale and distribution of its ER-REBOA catheter. REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta) is a minimally invasive technique used by the Trauma, Critica...
26-10-2015Atención primaria y cardiología, un paso más cerca gracias a ACER-C-AP
Dra. Almudena CastroDr. Domingo MarzalDr. Juan Carlos ObayaEl proyecto ACER-C-AP nace de la necesidad de integrar y mejorar la coordinación asistencial del paciente coronario crónico entre cardiología y atención primaria (AP).La clave para asegurar la continuidad tras una hospitalización por un...
23-10-2015Vascular Flow Technologies launches Spiral Flow™ PV Bypass Graft registry in Germany
Dundee, UK, 22 October, 2015 – Vascular Flow Technologies, the medical device company using proprietary Spiral Laminar Flow™ (SLF™) technology to replicate natural blood flow for enhanced patient outcomes, today announces the launch of its Spiral Flow™ PV Bypass Graft registry at the 31st an...
22-10-2015Paciente crítico cardiovascular: hacia una atención integral de todo el proceso
El manejo del paciente agudo y crítico cardiovascular ha experimentado un cambio drástico de paradigma en las últimas dos décadas, pasando de una actitud de vigilancia a otra de intervención y uso precoz de técnicas invasivas y de soporte. Esto ha llevado al Comité de Cuidados Agudos y Críti...
22-10-2015
SUNNYVALE, Calif., Oct. 20, 2015 /PRNewswire/ -- Silk Road Medical, Inc., a company dedicated to alleviating the devastating burden of stroke through surgical innovation, today announced it has received up to $57 million in equity and debt funding from new and existing investors. CRG, a premier heal...
20-10-2015
Ingelheim, Germany, 19. October 2015 – Boehringer Ingelheim GmbH announced the U.S. Food and Drug Administration (FDA) granted approval of Praxbind® (idarucizumab).4 Praxbind® is indicated for patients treated with Pradaxa® (dabigatran etexilate), when reversal of the anticoagulant effects of d...
19-10-2015Bolton Medical Announces the First Patient Treated with the New TREO® Abdominal Stent-Graft System
SUNRISE, Fla., Oct. 16, 2015 /PRNewswire/ -- Bolton Medical, a subsidiary of the WerfenLife Company, announced the first commercial implant of the TREO Abdominal Stent-Graft System by Theodosios Bisdas, MD and Professor Giovanni Torsello, MD, Director of the Center for Vascular and Endovascular Surg...
16-10-2015
Presented at TCT and Published in JACC, Two-Year Outcomes Reinforce IN.PACT Admiral's Durability, Consistency and Safety as a Best-in-Class Treatment Option for PADDUBLIN and SAN FRANCSICO - October 14, 2015 - Medtronic plc (NYSE: MDT) announced today that new two-year clinical data from the pivotal...
14-10-2015
REDWOOD CITY, Calif., Oct. 14, 2015 (GLOBE NEWSWIRE) -- Avinger, Inc., (NASDAQ:AVGR) a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial disease (PAD) and pioneer of the Lumivascular approach to treating vascular disease, today announced that...
14-10-2015
SAN FRANCISCO, Oct. 13, 2015 (GLOBE NEWSWIRE) -- Avinger, Inc., (NASDAQ:AVGR) a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial disease (PAD) and pioneer of the lumivascular approach to treating vascular disease, today announced interim six...
13-10-2015
MURRAY HILL, N.J.--(BUSINESS WIRE)--C. R. Bard, Inc. (NYSE:BCR) announced today the presentation of the 12-month results from the Lutonix® Global Real-World Registry at the Transcatheter Cardiovascular Therapeutics (TCT) 2015 meeting. These results come just months after publication in the New Engl...
12-10-2015CorVascular and Vasamed Enter Into Collaboration and Distribution Agreement for Peripheral Vascular Diagnostic Systems
MINNEAPOLIS, Oct. 12, 2015 /PRNewswire/ -- CorVascular Diagnostics, LLC, a Minneapolis-based medical technology company that designs and distributes advanced peripheral vascular diagnostic solutions, announced today it has entered into a collaboration and distribution agreement with Vasamed Incorpor...
12-10-2015
HAIFA, Israel, October 7, 2015 /PRNewswire/ --INSIGHTEC, the leader in MR guided Focused Ultrasound (MRgFUS) therapy announces today that the United States Food and Drug Administration (FDA) has approved its next generation Exablate system to treat symptomatic uterine fibroids and changed the labeli...
07-10-2015
SUNNYVALE, Calif., Oct. 6, 2015 /PRNewswire/ -- Silk Road Medical, Inc. announced the first U.S. commercial case using the ENROUTE Transcarotid Stent System was successfully performed at Kaiser Permanente Moanalua Medical Center in Honolulu, HI, by Vascular Surgeon Peter A. Schneider, M.D. The ENRO...
06-10-2015
Meeting Highlights New Two-Year Data on IN.PACT Admiral DCB, First Report of Real-World TVT Registry with CoreValve System, First One-Year Data on Recapturable Evolut R, and Initial Results on First Implants of Drug-Filled StentDUBLIN - October 6, 2015 - Medtronic plc (NYSE: MDT) today announced a p...
06-10-2015
SINGAPORE, Oct. 5, 2015 /PRNewswire/ -- QT Vascular Ltd., together with its subsidiaries (the 'Company' or 'QT Vascular', and together with its subsidiaries, the 'Group'), a global company engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive t...
05-10-2015Cardinal Health Completes Acquisition Of Cordis
ACQUIRES WORLDWIDE LEADER IN CARDIOLOGY AND ENDOVASCULAR DEVICESDUBLIN, Ohio, Oct. 4, 2015 /PRNewswire/ -- Cardinal Health today announced that it has completed the acquisition of Johnson & Johnson's Cordis business, a global leader in cardiology and endovascular devices, for $1.944 billion. Plannin...
04-10-2015
GALWAY, Ireland--(BUSINESS WIRE)--Neuravi, a company dedicated to improving clinical outcomes for stroke patients, today announced commercial availability of the company’s EmboTrap® Revascularization Device for the treatment of acute ischemic stroke in Europe. The device will be marketed through ...
01-10-2015
Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced the completion of the first robot-assisted Prostatic Artery Embolization (PAE) procedure in the United Kingdom with the Magellan™ Robotic System. Interventional Radiologist Dr. Mohammad Hamady perform...
29-09-2015
CARLSBAD, Calif.--(BUSINESS WIRE)-- ArtVentive Medical Group, Inc. (OTC Bulletin Board AVTD) announced today that it has received U.S. Food and Drug Administration (FDA) clearance for its 11mm Endoluminal Occlusion System (EOS™). Designed for use in the peripheral vasculature, the ArtVentive EOS...
29-09-2015
DUBLIN - September 28, 2015 - Medtronic plc (NYSE:MDT) today announced it has acquired Lazarus Effect, a Campbell, Calif.-based and privately-held medical device company focused on acute ischemic stroke products that facilitate the capture and removal of clots. The acquisition is another example of...
28-09-2015
MAJESTIC Trial Data Support Strong Safety Profile with Low Target Lesion Revascularization RateSep 28, 2015MARLBOROUGH, Mass., Sept. 28, 2015 /PRNewswire/ -- New 12-month clinical trial outcomes assessing the safety and performance of the Boston Scientific (NYSE: BSX) Eluvia™ Drug-Eluting Vascular...
28-09-2015
Bloomington, Ind. — Dr. Kimihiko Kichikawa, Department of Radiology at Nara Medical University in Japan, reported two-year results of the Zilver® PTX® post-market surveillance (PMS) study on September 27, 2015, in Lisbon, Portugal. Dr. Kichikawa presented initial target data on lesion revascular...
28-09-2015
BOSTON, MA – September 28, 2015 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS), neurovascular devices and thrombus management technologies, announced today the full market launch of the CGuardTM Embolic Prevention System fo...
28-09-2015
WESTMINSTER, Colo., Sept. 25, 2015 /PRNewswire/ -- Surefire Medical, Inc. today announced the launch of the company's new Precision targeted delivery infusion system for direct-to-tumor embolization procedures. The new technology will be displayed at the Cardiovascular and Interventional Radiologica...
25-09-2015Bolton Medical Receives CE Mark for TREO® Abdominal Stent-Graft System
SUNRISE, Fla., Sept. 24, 2015 /PRNewswire/ -- Bolton Medical, a subsidiary of the WerfenLife Company, received CE Mark for the TREO® Abdominal Stent-Graft System used to treat abdominal aortic aneurysms (AAAs). TREO is the latest advancement in endovascular aneurysm repair (EVAR), embodying the bes...
24-09-2015
REDWOOD CITY, Calif., Sept. 23, 2015 (GLOBE NEWSWIRE) -- Avinger, Inc., (NASDAQ:AVGR) a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial disease (PAD) and pioneer of the lumivascular approach to treating vascular disease, announced today tha...
23-09-2015
St. Jude Medical (NYSE:STJ) said today that it won CE Mark approval in the European Union 2 new, larger sizes of its Portico replacement heart valve.Little Canada, Minn.-based St. Jude said the approval covers the 27mm and 29mm sizes of the Portico transcatheter aortic valve implant. The 23mm Portic...
21-09-2015
Frank J Criado, MD, FACS, FSVM The important technical issue surrounding safety of pre and post-ballooning during CAS was examined in a recent paper published in JVS by Obeid et al. (J Vasc Surg 2015;62:616-623). The objective of the study was to analyze the effect of pre-ballooning (before stent p...
18-09-2015
The Arc Support Catheter is the Most Navigable 6F Tapered Support Catheter Available, Providing Enhanced Delivery of the Solitaire(TM) Stent RetrieverDUBLIN -September 17, 2015 - Medtronic plc (NYSE: MDT) today announced the U.S. launch of the Arc(TM) support catheter, the most navigable, 6F tapered...
17-09-2015
Bloomington, Ind. ─ Cook Medical has received premarket approval from the U.S. Food and Drug Administration (FDA) for its lower-profile Zenith Alpha™ Thoracic Endovascular Graft. Zenith Alpha Thoracic is indicated for the endovascular treatment of patients with isolated lesions of the descending...
17-09-2015Ventrix Initiates Clinical Trial of VentriGel™
SAN DIEGO, Sept. 17, 2015 /PRNewswire/ -- Ventrix, Inc., today announced that it has initiated a Phase 1 trial of VentriGel™, an off-the-shelf, biomaterial scaffold designed to facilitate the repair of cardiac tissue following myocardial infarction (MI), commonly known as a heart attack. The open-...
17-09-2015
ALAMEDA, Calif.--(BUSINESS WIRE)--Penumbra, Inc., today announced the pricing of its initial public offering of 4,000,000 shares of its common stock at a price to the public of $30.00 per share. The offering is scheduled to close on September 23, 2015, subject to customary closing conditions. The un...
17-09-2015Panel Releases Guide for Appropriate Use of PICCs
Clinicians can now refer to a new tool, the Michigan Appropriateness Guide for Intravenous Catheters (MAGIC), to help determine when and how to use peripherally inserted central catheters (PICCs) and related venous access devices. The guide is published as a supplement to the Annals of Internal Medi...
15-09-2015Harpoon Medical Enrolls Ten Patients in Early Feasibility Study with 100% Procedural Success
BALTIMORE, Sept. 15, 2015 /PRNewswire/ -- Harpoon Medical, a medical device company focused on minimally-invasive, beating-heart, mitral valve repair, announced today that ten patients with severe degenerative mitral valve disease are now enrolled in its ongoing Early Feasibility Study at two clinic...
15-09-2015
Amsterdam, Eindhoven – Royal Philips (NYSE: PHG, AEX: PHIA) and Catharina Hospital(Eindhoven, The Netherlands) today signed an agreement for the installation of Philips’ advanced medical technologies in Catharina Hospital’s new cardiovascular center, which is currently under construction and d...
14-09-2015First patient enrolled in CeloNova’s e-COBRA clinical registry
French Registry Evaluating the COBRA PzF™ Coronary Stent System in Patients with Heart DiseaseSeptember 14, 2015 02:00 AM Eastern Daylight TimeSAN ANTONIO--(BUSINESS WIRE)--CeloNova BioSciences, Inc. (CN) has announced that it enrolled the first patient in its multicenter e-COBRA clinical study in...
14-09-2015Incoming St. Jude Medical President and CEO Mike Rousseau Announces Executive Leadership Team
Leadership structure leverages strength of St. Jude Medical executive management teamST. PAUL, Minn.--(BUSINESS WIRE)-- St. Jude Medical, Inc. (NYSE:STJ) today announced the new executive leadership team that incoming President and Chief Executive Officer (CEO) Michael T. Rousseau has chosen to lead...
14-09-2015Cost-Utility Analysis Projects CARILLON Mitral Contour System as a Cost Effective Treatment Option for Functional Mitral Regurgitation
KIRKLAND, Wash.--(BUSINESS WIRE)--The CARILLON® Mitral Contour System® is projected to be a cost-effective treatment option when compared to a typical regimen of optimal medical treatment (OMT), the present standard of care for functional mitral regurgitation (FMR). This finding has been establish...
10-09-2015
Daniel J. Starks to Become Executive Chairman, Effective January 1, 2016Michael T. Rousseau to Succeed Starks as President and Chief Executive OFFICERST. PAUL, Minn.--(BUSINESS WIRE)-- St. Jude Medical, Inc. NYSE:STJ) today announced that its Board of Directors has implemented a leadership transitio...
09-09-2015
September 9th, 2015 – Terumo Corporation (Headquarters: Shibuya-ku, Tokyo, Japan; President: Yutaro Shintaku) and Quirem Medical B.V., a commercial stage Dutch medical technology company that focuses on radioembolization, today announced that Terumo has made an equity investments in Quirem Medical...
09-09-2015Starnes' Physician-Sponsored IDE Study Gains FDA Approval to Add More AAA Devices & Introduce Planning Tool
Leading Vascular Surgeon Expands IDE Study That Could Significantly Reduce the Number of AAA Patients Requiring Open SurgerySeptember 09, 2015 11:00 AM Eastern Daylight TimeBELLEVUE, Wash.--(BUSINESS WIRE)--Benjamin W. Starnes, MD, Chief of Vascular Surgery at Harborview Medical Center and one of th...
09-09-2015
IRVINE, Calif., Sept. 9, 2015 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), announced today that a new peer reviewed article e-published in August 2015 in the Journal of Vascular ...
09-09-2015
AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved BRILINTA® (ticagrelor) tablets at a new 60mg dose to be used in patients with a history of heart attack beyond the first year. With this expanded indication, BRILINTA is now approved to reduce the rate of cardio...
03-09-2015
Lombard Estimates 5% Market Share AchievedIrvine, CA – September 1, 2015 – Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that within a year of the Aorfix™ regulatory approval in ...
01-09-2015
LONDON, Sept. 1, 2015 /PRNewswire/ -- Abbott (NYSE: ABT) announced today positive one-year clinical results from ABSORB Japan, a multi-center, randomized trial comparing the safety and effectiveness of Abbott's fully dissolving Absorb™ heart stent to XIENCE ®, Abbott's market-leading, permanent d...
01-09-2015Save the date: 13th May 2016 next SITE update in Barcelona
...
28-08-2015Mensaje del presidente y vicepresidente de CELA
El presidente de CELA (Dr. Alejandro Fabiani) y el vicepresidente (Dr. Ignacio Escotto) mandaron un mensaje sobre la nueva etapa que se inicia en CELA durante la celebración del congreso SITE - CELA que se llevo a cabo en Barcelona el pasado mes de junio. ...
28-08-2015
The U.S. Food and Drug Administration today approved Repatha (evolocumab) injection for some patients who are unable to get their low-density lipoprotein (LDL)cholesterol under control with current treatment options.Repatha, the second drug approved in a new class of drugs known as PCSK9inhibitors, ...
27-08-2015UK’s NICE recommends once-daily LIXIANA (edoxaban) for the treatment and prevention of recurrent deep vein thrombosis and pulmonary embolism in adults
Tokyo, Japan (August 26, 2015) - The National Institute for Health and Care Excellence (NICE), the medicines cost-effectiveness body for England and Wales, has today recommended a new treatment to help patients suffering from blood clots in the legs and lungs.1Daiichi Sankyo Company, Limited (hereaf...
26-08-2015
Frank J Criado, MD, FACS, FSVMIn a recent and important population-based study (Thromb Res 2015;136:250-260) Macedo et al. from the U.K. have shown that only a minority of patients with atrial fibrillation (AF) or venous thromboembolism (VTE) achieved optimal anticoagulation control while on warfari...
25-08-2015
DUBLIN - August 25, 2015 - In support of the company's therapy innovation strategy, Medtronic plc (NYSE: MDT) today announced that it has signed a definitive agreement to acquire Twelve, Inc. ("Twelve"), a privately-held medical device company based in Redwood City, Calif., focused on the developmen...
25-08-2015TriVascular Announces First Patient Enrolled in the LUCY Study
SANTA ROSA, Calif., Aug. 24, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (NASDAQ:TRIV), manufacturer of the Ovation® Abdominal Stent Graft platform, announced today the first patient enrolled and treated in the LUCY Study (TriVascular Evaluation of FemaLes who are Underrepresented Candi...
24-08-2015Real World ETNA Registries of New Once-Daily LIXIANA▼® (edoxaban) Start in Europe
MUNICH, August 24, 2015 /PRNewswire/ --FOR UK MEDIA ONLY.Daiichi Sankyo announces enrollment of first patient in ETNA-AF-Europe and the commencement of ETNA-VTE-Europe, two regional registries to collect robust information on how once-daily edoxaban is being used in real world settings ETNA is a Da...
24-08-2015Acute Pulmonary Embolism Trial (SEATTLE II) Published in the JACC: Cardiovascular Interventions
BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation, a BTG International group company (BTG plc (LSE:BTG)), announced the publication of results of the SEATTLE II trial in the JACC: Cardiovascular Interventions. The study concluded that treatment with ultrasound-facilitated catheter-directed low-dose ...
24-08-2015Colibri Heart Valve Strengthens Patent Portfolio with Receipt of 12th Transcatheter Heart Valve (THV) Patent
Colibri Heart Valve Strengthens Patent Portfolio with Receipt of 12th Transcatheter Heart Valve (THV) PatentBROOMFIELD, CO – August 24, 2015 – Colibri Heart Valve LLC, a privately held emerging medical device company, has received an Issue Notification from the U.S. Patent and Trademark Office r...
24-08-2015Heart attack patients without obstructive coronary artery disease at high risk of residual angina
Patients without obstructive coronary artery disease (CAD) are just as at risk of angina as those with obstructive CAD, according to new research published today in the European Heart Journal - Quality of Care and Clinical Outcomes.According to researchers in America, patients are at a substantial r...
20-08-2015Cyberonics and Sorin Provide Merger Update
HOUSTON and MILAN, Aug. 20, 2015 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX, "Cyberonics") and Sorin S.p.A. (MTA; Reuters Code: SORN.MI, "Sorin") today announced an update on various matters relating to their pending business combination (the "Transaction").The companies announced that the regis...
20-08-2015
U.S. Launch Underway for Therapy Designed to Treat Peripheral Artery DiseaseAug 19, 2015MARLBOROUGH, Mass., Aug. 19, 2015 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received Food and Drug Administration (FDA) approval for the Innova™ Vascular Self-Expanding Stent System, an adva...
19-08-2015
Updating national screening policies could help detect a deadly form of aneurysm in older men; saving lives and resources, according to research presented in the Journal of the American Heart Association.Abdominal aortic aneurysm is a potentially lethal ballooning of the aorta, the body’s largest ...
19-08-2015Post-exercise ABI expands clinical, prognostic information
(HealthDay)—For individuals with normal and abnormal resting ankle-brachial index (ABI), post-exercise ABI expands clinical and prognostic information, according to a study published in the Aug. 17 issue of JACC: Cardiovascular Interventions.Tarek A. Hammad, M.D., from the Cleveland Clinic, and co...
18-08-2015Corindus Vascular Robotics and Unfors RaySafe Partner to Protect Against Physician and Staff Radiation Exposure in the Cath Lab
CorPath® System, RaySafe i2 product alignment identifies real-time radiation exposure for better dose protection during robotic-assisted proceduresWaltham, MA and Everett, WA – August 18, 2015 – Corindus Vascular Robotics, Inc.[NYSE MKT: CVRS], a leading developer of precision vascular robotics...
18-08-2015
DANVERS, Mass., Aug. 17, 2015 (GLOBE NEWSWIRE) --Abiomed, Inc. (Nasdaq: ABMD), a leading provider of breakthrough heart support technologies, announced today that it has submitted U.S Food & Drug Administration (FDA) pre-market approval (PMA) supplemental submissions requesting to expand Impella® 2...
17-08-2015El Hospital Reina Sofía realiza anualmente unos 2.000 procedimientos de Radiología Vascular e Intervencio-nista Periférica
Se trata de técnicas complejas que requieren de una alta espe-cialización por parte de los radiólogos y permiten solucionar tanto problemas médicos como quirúrgicosCórdoba, España - 14 de Agosto 2015El Hospital Universitario Reina Sofía interviene anualmente a alre-dedor de 2.000 pacientes m...
14-08-2015Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease
WALTHAM, Mass., Aug. 13, 2015 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular diseases, today announced top-line results from its Phase 1 study of investigational vo...
13-08-2015
REDWOOD CITY, Calif., Aug 12, 2015 (GLOBE NEWSWIRE via COMTEX) --Avinger, Inc., AVGR, -0.85% a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial disease (PAD) and pioneer of the lumivascular approach to treating vascular disease, announced it...
12-08-2015Japan Grants Safety Clearance to Pluristem’s PLX-PAD Cells for Use in Clinical Trials
Safety clearance is another step towards the start of Phase II CLI trial via Japan’s accelerated approval pathway HAIFA, ISRAEL, August 12, 2015 --Pluristem Therapeutics Inc. (NasdaqCM: PSTI) TASE: PSTI), a leading developer of placenta-based cell therapy products, today announced that Japan’s ...
12-08-2015Testosterone supplementation does not result in progression of atherosclerosis
Among older men with low testosterone levels, testosterone administration for 3 years compared with placebo did not result in a significant difference in the rates of change in atherosclerosis (thickening and hardening of artery walls), nor was it associated with improved overall sexual function or ...
11-08-2015Mount Sinai Heart Launches Clinical Trial to Test if Coronary Stent Patients Can Avoid Taking Aspirin
TWILIGHT’s Global Principal Investigator Roxana Mehran, MD, Director of the Office of Interventional Cardiovascular Research and Clinical Trials of Mount Sinai HeartNew, large international clinical trial TWILIGHT to test the safety and effectiveness of treating coronary stent patients with the an...
11-08-2015
ALBANY, N.Y., Aug. 6, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announce the enrollment of the first patient into the Registry of AngioVac Pr...
06-08-2015
BOSTON, Aug. 5, 2015 /PRNewswire/ -- InspireMD, Inc. (NYSE MKT: NSPR) a leader in stent embolic prevention systems ("EPS") and thrombus management technologies, today announced that it has entered into a partnership with Penumbra, Inc. to distribute its carotid CGuard™ EPS through their direct com...
05-08-2015
New System Provides an Easy to Use, Accurate and Controlled, One-Handed Stent Delivery System When Treating Patients with Peripheral Arterial DiseaseDUBLIN - August 5, 2015 - Medtronic plc (NYSE: MDT) today announced the launch of its Entrust(TM) delivery system in the United States. The new Entrust...
05-08-2015
SOUTH JORDAN, Utah, Aug. 04, 2015 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, today announced that i...
04-08-2015
Next Generation Aortic Body Delivery System Approval Continues Strong Cadence of New Product IntroductionsSANTA ROSA, Calif., Aug. 4, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (NASDAQ:TRIV) announced today that the U.S. Food and Drug Administration (FDA) approved the Ovation iX Abdomin...
04-08-2015Gynesonics’ Investigational Sonata System Receives New AMA CPT Code for Uterine Fibroids Treatment
Redwood City, CA – August 4, 2015 - Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that the American Medical Association (AMA) Current Procedure Terminology (CPT) Editorial Panel has establishe...
04-08-2015
Decision Will Provide Patients with Additional Access to New Medical Device with Potential to Improve Standard of Care for Peripheral Arterial Disease in Vessels Above the KneeDUBLIN -- August 3, 2015 -- Medtronic plc (NYSE: MDT) announced today that the U.S. Centers for Medicare and Medicaid Servic...
03-08-2015Nitinol Devices & Components Acquires Interface Catheter Solutions to Create Confluent Medical Technologies
FREMONT, Calif.--(BUSINESS WIRE)--Nitinol Devices & Components, Inc. (“NDC”), announced today it has successfully completed the acquisition of Interface Catheter Solutions (“Interface”). Reflecting the combination’s expanded strategic breadth, NDC and Interface will create Confluent Medica...
03-08-2015
MINNEAPOLIS, Minnesota -- Vascular Solutions, Inc. (Nasdaq: VASC) today announced that it has expanded the PolarCath peripheral dilatation system product line with the launch of 11 versions of 0.035” guidewire-compatible balloon catheters in collaboration with NuCryo Vascular LLC, the manufacturer...
03-08-2015
SANTA ROSA, Calif., Aug. 3, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (NASDAQ:TRIV), manufacturer of the Ovation Abdominal Stent Graft platform, announced today two major clinical milestones: surpassing 100 patients enrolled in the Least Invasive Fast-Track EVAR (LIFE) study and comple...
03-08-2015
On July 2, 2015, Cook Medical initiated a lot-specific voluntary recall of 2,239 lots of Beacon Tip Angiographic Catheters. Globally, 95,167 devices are subject to this recall. The products include specific versions and lot numbers of the Torcon NB® Advantage Beacon® Tip Catheters (Catalog Prefix ...
03-08-2015Latest Update to TASC II (Inter-Society Consensus for the Management of Peripheral Arterial Disease) Is Published in the Journal of Endovascular Therapy
Los Angeles, CA (August 3, 2015). The Journal of Endovascular Therapy (JEVT), official publication of the INTERNATIONAL SOCIETY OF ENDOVASCULAR SPECIALISTS (ISES), announces that is it today publishing the latest update of the Inter-Society Consensus for the Management of Peripheral Arterial Disease...
03-08-2015
Decision comes after two-year effort to improve the alignment of payment with cost of treatment for abdominal aortic aneurysmsAugust 03, 2015 08:00 AM Eastern Daylight TimeFLAGSTAFF, Ariz. — W. L. Gore & Associates, Inc. (Gore) applauds the recent reclassification of endovascular abdominal aneurys...
03-08-2015Disponible nueva revista de técnicas endovasculares
Volumen XVIII - Número 2 (Mayo - Agosto 2015)...
01-08-2015
Acquisition Expands Lombard Product Portfolio with Simple, Safe and EfficientUltra-Low Profile Endovascular Stent GraftCE Mark in Place – European Launch Scheduled for JanuaryIrvine, CA – July 30, 2015 – Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular ane...
30-07-2015
“An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)...
30-07-2015EMBA Medical™ Limited Awarded CE Certificate for Hourglass™ Peripheral Embolization Plug
DUBLIN--(BUSINESS WIRE)--EMBA Medical™ Limited announced today that the company has received CE certification for its revolutionary peripheral embolization device. The device, known as the Hourglass™ Peripheral Embolization Plug, was awarded a CE certificate on July 10, 2015, enabling the compan...
29-07-2015
COLORADO SPRINGS, Colo., July 29, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today announced it has completed enrollment of 300 subjects in the ILLUMENATE Pivotal clinical study, a prospective, randomized controlled, multicenter study designed to assess the clinical perform...
29-07-2015
July 29, 2015 08:00 AM Eastern Daylight TimeREHOVOT, Israel--(BUSINESS WIRE)--Eximo Medical has completed its Series A funding round of $1.6M. Accelmed, a leading medical device Investment Fund, led the round, with the participation of the Alfred Mann Institute at the Technion (AMIT), the Technion R...
29-07-2015Un equipo médico de premio
Barcelona,Grandes profesionales luchan a diario contra los recortes que sufre la sanidad en España. Un ejemplo son los especialistas del Hospital de Sant Pau, un grupo referente en el estudio de las bases genéticas de enfermedades vasculares.SEGUIR CON LA NOTICIAFuente: Dicen...Diario deportivo y ...
28-07-2015
Frank J Criado, MD, FACS, FSVMMore than 40% of VTE (venous thromboembolism) patients with transient risk factors receive anticoagulation therapy for 1 year or longer, and this is at least four times longer than the period recommended in current guidelines as observed by the authors of a recent large...
28-07-2015Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms
SAN FRANCISCO, July 28, 2015 /PRNewswire/ -- Codman Neuro*, part of DePuy Synthes Companies of Johnson & Johnson, has introduced a new platform of embolic coils for the treatment of brain aneurysms, supported by an enhanced detachment system designed to improve microcatheter stability and provide an...
28-07-2015
MALVERN, Pennsylvania, July 27, 2015 /PRNewswire/ --Essential Medical, Inc., a privately held medical device company focused on transforming the large bore vascular closure market, announced today that it has successfully commenced EU clinical studies using its MANTA Large Bore Vascular Closure devi...
27-07-2015Metactive Awarded Phase I SBIR Grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health
OLATHE, Kan.--(BUSINESS WIRE)--Metactive Medical Inc. (Metactive), an early-stage company focused on developing embolization devices for the treatment of peripheral vascular and neurovascular diseases, announced today that it has received a $224,000 Phase I SBIR grant from the National Heart, Lung, ...
21-07-2015Médicos colaboradores de la ACtV, premiados en el European Venous Forum de San Petersburgo
Un equipo de médicos colaboradores de la Asociación Cuida tus Venas ha sido galardonado con el Premio a la Mejor Presentación Científica en el 16th European Venous Forum, celebrado en San Petersburgo. Este foro es uno de los principales eventos científicos internacionales relacionados con la i...
20-07-2015A Bipartisan Victory for Medical Research in Congress
With exquisite timing, House Republicans last week stepped into a public-relations debacle. The House was working to pass an appropriations bill for the Department of the Interior, but the longstanding bipartisan process on spending bills has been shattered, meaning that there would be no Democratic...
16-07-2015
PARK CITY—July 15, 2015—Distal Access™ announced that it sold rights to its SPINR platform for peripheral vascular, coronary vascular, and endoscopic use to Merit Medical System’s NRI Limited, Dublin, Ireland.The SPINR High-Performance Guidewire Controller™ is an award-winning system with ...
15-07-2015
The National Institute for Health and Care Excellence (NICE) has recommended a new treatment to help patients suffering from blood clots in the legs and lungs.[1]NICE has issued a Final Appraisal Determination (FAD) for Lixiana (edoxaban) for the treatment and prevention of recurrent deep vein throm...
13-07-2015
The Food and Drug Administration (FDA) is announcing a public Workshop “Acute Ischemic Stroke Medical Devices Trials.”The purpose of this workshop is to obtain public input and feedback on scientific, clinical, and regulatory considerations associated with acute ischemic stroke medical devices. ...
09-07-2015
The new NICE Quality Standard on Atrial Fibrillation (AF) states that adults with AF should be prescribed suitable anticoagulation instead of aspirin for the prevention of stroke1. This is good news for patients as the new standard will drive measurable quality improvements in the treatment and mana...
09-07-2015
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (NASDAQ:CSII) (CSI), today announced that it has received FDA clearance for its new ViperWire Advance® Peripheral Guide Wire with Flex Tip for their Peripheral Orbital Atherectomy Systems (OAS). The new guide wire provides physicians wi...
06-07-2015CMS and AMA Announce Efforts to Help Providers Get Ready For ICD-10
CMS and AMA Announce Efforts to Help Providers Get Ready For ICD-10With less than three months remaining until the nation switches from ICD-9 to ICD-10 coding for medical diagnoses and inpatient hospital procedures, The Centers for Medicare & Medicaid Services (CMS) and the American Medical Associat...
06-07-2015The Vygon Group buys Perouse Medical
The acquisition will strengthen Vygon’s commercial foothold in France and abroad, and develop a new area of expertise in the cardiovascular market Ecouen, France, July 6, 2015 – Vygon, the specialist single-use medical devices group, announces today the acquisition of Perouse Medical, a French c...
06-07-2015
DUBLIN -- July 2, 2015 -- Medtronic plc (NYSE: MDT) today announced the twelve-month results of the VeClose pivotal study, which demonstrated the safety and effectiveness of the VenaSeal(TM) closure system for the treatment of incompetent greater saphenous veins with a 96.8 percent closure rate. Th...
02-07-2015
The CMS plans to soften but keep the controversial "two-midnight" rulegoverning short hospital stays in spite of aggressive calls from providers and policy experts to abandon the policy. In a proposed payment rule posted Wednesday, the Obama administration said it plans to allow physicians to exerci...
02-07-2015Anunciado el próximo SITE update 2016
01-07-2015
News vii from Salutaria ...
01-07-2015Endovascular TV entrevistó a médicos durante el SITE CELA Barcelona 2015
La plataforma de endovascular.tv realizó varias entrevistas a distintos y reconocidos médicos durante la celebración del SITE CELA 2015, realizado con éxito en Barcelona. Durante el evento se focalizaron las preguntas entorno a la divulgación a pacientes sobre patologías cardiovasculares.El ed...
30-06-2015
Dr. Frank CriadoIn a provocative recent article published in the Wall Street Journal ('How to Stop Hospitals from Killing Us'), Dr. Marty Makary (a surgeon at Johns Hopkins in Baltimore) brought to our attention the huge and largely unresolved problem of hospital errors and unnecessary medications a...
29-06-2015Nombramiento presidente y vicepresidente de CELA
En el pasado congreso SITE CELA 2015 celebrado en el Palau de Congressos de Catalunya de Barcelona, se eligió al Dr. Alejandro Fabiani como nueve presidente de CELA (Cirujanos Endovasculares de Latino América) y se nombró al Dr. Ignacio Escotto como vicepresidente. ...
27-06-2015Palex Medical SA lanza al mercado el nuevo balón de Valvuloplastia Aórtica V8
...
27-06-2015
...
27-06-2015
...
27-06-2015LifeStream and Ultraverse 035
...
27-06-2015
Unlocks niche in endovascular care with $150M market opportunity; Enables physicians to deliver precision, power, safety for hemodialysis fistula or graftCOLORADO SPRINGS, Colo., June 24, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced it has received U.S. Food a...
24-06-2015Ya están disponibles los abstracts del Congreso SITE CELA 2015
Ya están disponibles los abstracts del Congreso SITE CELA 2015Volumen XVIII - Número 1...
24-06-2015
CMS Decision Provides Supplemental Reimbursement to U.S. Hospitals for New Medical Device with Potential to Improve Outcomes for Patients Undergoing a Percutaneous Transthoracic Lung BiopsyBRAINTREE, MA, June 22, 2015 /CNW/ - Surgical Specialties Corporation (Surgical Specialties), a leading provide...
22-06-2015
Five-Year Results from U.S. IDE Study Presented at Society for Vascular Surgery MeetingCHICAGO - June 20, 2015 - Selected for nearly one of every two endovascular abdominal aortic aneurysm (AAA) repairs globally, the Endurant AAA stent graft system from Medtronic plc (NYSE: MDT) maintained durable, ...
20-06-2015
Aptus Endosystems' Helical Anchor Technology Complements Medtronic's Aortic Stent Platform for the Treatment of Complex Aortic DiseaseDUBLIN-- June 19, 2015 -- Medtronic plc (NYSE:MDT) today announced it has acquired the assets of Aptus Endosystems, Inc., a Sunnyvale, Calif. based, privately held m...
19-06-2015
SANTA ROSA, Calif., June 15, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV) announced today that the U.S. Food and Drug Administration (FDA) has approved the Ovation iX Iliac Stent Graft for the Ovation Prime® Abdominal Stent Graft System, together with manufacturing enhancem...
15-06-2015
June 11, 2015 — (Statement from Medtronic) — In February, U.S. Centers for Medicare and Medicaid Services (CMS) announced it approved a transitional pass-through payment for the company's IN.PACT Admiral drug-coated balloon (DCB) under the Medicare hospital outpatient prospective payment system...
11-06-2015Cordis Corporation Expands Cordis Crossing Portfolio With New Support, Re-entry Catheters
June 10, 2015 — Cordis Corp. announced the launch of the new Elitecross support catheter in the United States and Outback Elite re-entry catheter in the United States, Europe and Japan. This expands the Cordis Crossing Portfolio for treatment of chronic total occlusions (CTO), a suite of specialty...
10-06-2015
C.R. Bard ($BCR) announced that the federal Centers for Medicare & Medicaid Services further improved reimbursement for its recently launched Lutonix drug-coated balloon for peripheral artery disease in the femoropopliteal arteries (located near the knee).'After further review, CMS determined that c...
10-06-2015
DUBLIN -- June 10, 2015 -- Medtronic plc (NYSE: MDT) announced today the launch of the Fortrex(TM) over-the-wire (OTW) percutaneous transluminal angioplasty (PTA) balloon catheter. The Fortrex PTA balloon catheter utilizes a high pressure balloon to break up the blockages and open the vessels to hel...
10-06-2015
Investigator-Initiated Registry Reveals 4 French Interventions Are Effective and Safe Even for Long, Occluded Femoropopliteal Lesions BUELACH, Switzerland, June 9, 2015—BIOTRONIK, a leading manufacturer of cardio- and endovascular medical devices, announced the publication of promising clinical re...
09-06-2015GraftWorx Wins Mid-Atlantic Bio Angels 1st Pitch Life Science Competition
NEW YORK, June 9, 2015 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that GraftWorx (http://www.graftworx.com) was chosen as 'Best in Show' at MABA's 1st Pitch Life Science event, which took place at the New York Genomics Center on June 3, 2015. Graftworx is a medical device com...
09-06-2015
MOUNTAIN VIEW, CA -- (Marketwired) -- 06/03/15 -- Hansen Medical®, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced the completion of the world's first robotically-assisted radioembolization procedures for cancer treatment. The procedures, utilizing the Magellan Rob...
03-06-2015As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question
Group aims to encourage physicians and patient conversations by identifying five tests or procedures to question, highlighting potentially unnecessary-sometimes harmful- care in vascular surgery.OTTAWA, June 2, 2015 The Canadian Society for Vascular Surgery (CSVS) today released a list of specific t...
02-06-2015NuVascular Technologies Launches Suite Of Hemodialysis Devices
New product pipeline uses patented nanotechnology to help those suffering from end-stage renal diseaseAshland, Mass., June 2, 2015 – A new line of medical devices has the potential to save the lives of millions of hemodialysis patients and billions of dollars worth of secondary medical treatments,...
02-06-2015
Frank J Criado, MD, FACS, FSVMResearchers argue in a recent important article (Johansson M, et al, BMJ 2015;350) whether AAA screening makes any sense as it could result in harm to some patients. It is well established that abdominal aneurysms occur mostly in men over 65 years of age and are more co...
29-05-2015
...
29-05-2015
...
29-05-2015
...
29-05-2015Johnson & Johnson Announces Acceptance of Binding Offer From Cardinal Health To Acquire Cordis
NEW BRUNSWICK, N.J., May 28, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced the acceptance of theMarch 1, 2015 binding offer from Cardinal Health to acquire its Cordis business for an approximate value of $2 billion. The offer was accepted after consultations with relevant works ...
28-05-2015
SUNNYVALE, Calif., May 28, 2015 /PRNewswire/ -- Silk Road Medical, Inc., a pioneer in the development of transcarotid therapies for intra and extracranial vascular diseases, announces the appointment of Andrew (Andy) Davis to the position of Executive Vice President of Global Sales. In this new role...
28-05-2015
ALAMEDA, Calif.--(BUSINESS WIRE)--Penumbra, Inc., a global interventional therapies company and innovator in intra-arterial stroke therapy, today announced that the company’s ACE64 aspiration thrombectomy system received 510(k) marketing clearance from the U.S. Food and Drug Administration for the...
27-05-2015
BOSTON, May 22, 2015 /PRNewswire/ -- InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in stent embolic protection systems ("EPS"), today announced that its CGuardTM Embolic Prevention System reported positive results in PARADIGM, lead by principle investigator Prof. Piotr Mu...
22-05-2015
DUBLIN - May 21, 2015 - Medtronic plc (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Sanford Bernstein 31st Annual Strategic Decisions Conference on Friday, May 29, 2015, in New York.Omar Ishrak, chairman and chief executive officer of Medtron...
21-05-2015
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) and Academic Medical Center (AMC) in Amsterdam, the Netherlands, today announced their collaboration in a European multi-center clinical study to investigate a new diagnostic technique targeting immediate assessment of the results o...
21-05-2015
PARIS -- May 20, 2015 -- Presented for the first time today at EuroPCR during the 'Hot line' session on 'Peripheral interventions,' new clinical data from two different studies show that the IN.PACT Admiral drug-coated balloon from Medtronic plc (NYSE: MDT) successfully treated long lesions in the s...
20-05-2015
...
20-05-2015
IRVINE, Calif., May 19, 2015 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (Nasdaq: EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAA), today announced that the first procedures were successfully performed in Japan using the Company's uniqu...
19-05-2015
SUNNYVALE, Calif., May 19, 2015 /PRNewswire/ -- Silk Road Medical, Inc., a pioneer in the development of transcarotid therapies for intra and extracranial vascular diseases, announces the company has received Premarket Approval (PMA) from the United States Food & Drug Administration (FDA) for the EN...
19-05-2015
PARIS, May 19, 2015 /PRNewswire/ -- Abbott announced today that it has received CE Mark for the latest advancement of its Absorb stent system, called Absorb GT1™, which combines the world's first fully dissolving stent with a next-generation delivery catheter to help doctors treat people with hear...
19-05-2015Nitiloop Announces FDA 510(k) Clearance for its NovaCross™ Microcatheter for Support of Guidewire Access to Discrete Regions of the Coronary and Peripheral Vasculature
HERZLIYA, Israel--(BUSINESS WIRE)--Nitiloop, a medical device company dedicated to the development of cardiovascular microcatheters for complex lesions and Chronic Total Occlusions (CTO) received FDA clearance for its first product, NovaCross, which is intended to be used in conjunction with a guide...
18-05-2015
WAYNE, Pa.--(BUSINESS WIRE)--Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that it has raised $38.9 million in a Series B venture capital financing. The funds will be used to accelerate the development and FDA approval of...
14-05-2015
MOUNTAIN VIEW, CA -- (Marketwired) -- 05/14/15 -- Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced the completion of the world's first clinical procedure with the Magellan™ 10Fr Robotic Catheter. Interventional radiologist Dr. Gerard Goh performed t...
14-05-2015
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates (Gore) today announced the GORE® EXCLUDER® Iliac Branch Endoprosthesis, the first complete, fully engineered system (Gore designed iliac branch and internal iliac components) intended for endovascular treatment of common iliac artery aneur...
12-05-2015Sequent Medical Announces Presentation of Compelling Long-Term Clinical Data and Commercial Release of its Next Generation WEB Product
ALISO VIEJO, Calif., May 12, 2015 /PRNewswire/ -- Sequent Medical, Inc. announced today the presentation of prospective long-term clinical data for the WEB™ Aneurysm Embolization System at the recent Societe Francaise de Neuroradiologie ('SFNR') meeting inParis, France. Twelve-month data were rep...
12-05-2015
BOSTON & LAKE OSWEGO, Ore.--(BUSINESS WIRE)--BIOTRONIK, a leading manufacturer of cardiovascular medical technology, today announced an agreement to be the U.S. distributor of CFI Medical’s Zero-Gravity™ weightless radiation protection system. To date, more than 275 Zero-Gravity systems have bee...
11-05-2015
WESTMINSTER, Colo.--(BUSINESS WIRE)--Surefire Medical, Inc. today announced that the company’s new Precision targeted delivery infusion system, for direct-to-tumor embolization procedures, has received the CE Mark from European regulators. Surefire infusion systems are today used primarily in trea...
08-05-2015
ST. PAUL, Minn. & SAN DIEGO--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), featured two-year data from its ORBIT II study of the company’s Diamondback 360® Coronary Orbital Atherectomy System (OAS), the only U.S. Food and Drug Administration (FDA) approved Atherectomy Techno...
07-05-2015ORSIF Documentary Featuring Noted Heart Surgeon Dr. Edward Diethrich Tells Personal Story of Serious Health Risks from Occupational Exposure to Radiation in Fluoroscopy Labs
WALTHAM, Mass., May 6, 2015 /PRNewswire/ -- The Organization for Occupational Safety in Interventional Fluoroscopy (ORSIF) today announced the release of a new documentary film to focus widespread attention on the impact that chronic, low-level exposure to ionizing radiation has on physicians that p...
06-05-2015
Frank J Criado, MD, FACS, FSVMAs published in the Journal of Vascular Surgery by Nelson et al. in 2014, the first multicenter randomized controlled trial on PEVAR (Percutaneous EVAR) was designed and conducted to evaluate the safety and effectiveness of the percutaneous approach technique with use o...
05-05-2015
MALVERN, Pa., May 4, 2015 /PRNewswire/ -- Essential Medical, Inc., a privately held medical device company, announced today that it has successfully completed additional clinical studies using its MANTA 14F Large Bore Vascular Closure device, a revolutionary vascular closure device designed to seal ...
04-05-2015XVI International Symposium of Angiology and Vascular Surgery
Programa oficial...
30-04-2015
DUBLIN - April 30, 2015 - Medtronic plc (NYSE: MDT) today announced the start of a clinical study using Medtronic technologies to determine whether paroxysmal and persistent atrial fibrillation (AF) can be treated with a combination of two ablation procedures targeting different anatomical location...
30-04-2015
IRVINE, Calif., April 29, 2015 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today the presentation of updated clinical data from the Company's EVAS FORWARD - Global Registry, a post-market study that prospectively ...
29-04-2014
Analysis of ENGAGE Registry Patients Presented at Charing Cross International SymposiumLONDON -- April 29, 2015 -- For endovascular repair of abdominal aortic aneurysms, the Endurant(TM) AAA stent graft system from Medtronic plc (NYSE: MDT) delivered consistently strong results in patients with shor...
29-04-2015
FLAGSTAFF, Ariz. & LONDON--(BUSINESS WIRE)--W. L. Gore & Associates (Gore) today announcedthat Michel Makaroun, MD, co-director of the University of Pittsburgh MedicalCenter (UPMC) Heart and Vascular Institute and the chair and professor ofsurgery in the division of vascular surgery, enrolled the fi...
28-04-2015
Principal Investigators Perform First Implant of Investigational Medical Device Designed to Expand Applicability of Minimally Invasive Alternative to Open Surgical RepairDUBLIN -- April 27, 2015 -- Medtronic plc (NYSE: MDT) recently began a clinical study to evaluate the safety and effectiveness of ...
27-04-2015Codman Enterprise 2 Intracranial Vascular Reconstruction Device Launched in Europe
Solothurn, Switzerland – April 27, 2015 -- Codman Neuro* has launched the CODMAN ENTERPRISE® 2 Vascular Reconstruction Device in Europe. The CODMAN ENTERPRISE 2 System is the latest generation of the company’s self-expanding stent and delivery system used to treat wide-necked intracranial aneur...
27-04-2015
IRVINE, Calif., April 22, 2015 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on Endovascular Aneurysm Repair ( EVAR ) of abdominal aortic aneurysms (AAAs), today announced the enrollment and treatment of the first patient in the ARCHYTAS global registry. A...
22-04-2015
DUBLIN -- April 21, 2015 -- Medtronic plc (NYSE: MDT) today announced the start of a new feasibility study to evaluate the safety and effectiveness of the Valiant Mona LSA branch thoracic stent graft system, an investigational medical device designed to enable a completely endovascular solution for ...
21-04-2015Médicos y deportistas debaten sobre la prevención de la trombosis en el deporte
La asociación Cuida tus Venas (ACtV) y la plataforma iWOPI (www.iwopi.org) organizaron el pasado 14 de abril en el Hospital de Sant Pau una reunión en la cual se analizó la relación entre trombosis y el deporte, se presentó el reto de participación ciudadana “La vida corre por tus venas, cu...
20-04-2015
SUNNYVALE, Calif., April 17, 2015 /PRNewswire/ -- Silk Road Medical, Inc. announced the first U.S. commercial procedure using the ENROUTE Transcarotid Neuroprotection System (NPS) was successfully performed at Mills-Peninsula Medical Center in Burlingame, CA by Vascular Surgeon John E. Rosenman, M.D...
17-04-2015
MARLBOROUGH, Mass., April 16, 2015 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is taking a new approach to evaluate the performance of the Vessix™ Renal Denervation System, initiating a study with a novel design to isolate the effects of the therapy in patients with high blood pressu...
16-04-2015
DUBLIN, Ireland and SIOUX FALLS, S.D. -- April 14, 2015 -- The global leader in medical technology for endovascular aortic repair (EVAR), Medtronic plc (NYSE: MDT) today announced that it plans to develop a stent graft system for less invasive treatment of thoracoabdominal aortic aneurysms under an ...
14-04-2015Médicos y deportistas debatirán sobre la prevención de la trombosis en el deporte
* La Asociación Cuida tus Venas (ACtV) y la plataforma iWOPI organizan el próximo 14 de abril en el Hospital de Sant Pau un encuentro para analizar la relación entre trombosis y deporte.* El debate contará con la participación del médico del F.C. Barcelona y del CAR, Franchek Drobnic; y de dep...
09-04-2015
Third-Generation System Treats All Plaque Morphologies Including Severe Calcium, While Streamlining Procedural EfficiencyDUBLIN -- April 9, 2015 -- Medtronic plc (NYSE: MDT) enhances its leading directional atherectomy portfolio with the U.S. launch of the HawkOne(TM) directional atherectomy system....
09-04-2015
Many nursing home residents who underwent lower extremity revascularization died, did not walk or had functional decline following the procedure, which is commonly used to treat leg pain caused by peripheral arterial disease, wounds that will not heal or worsening gangrene, according to an article p...
06-04-2015
Terumo announces that on March 16th 2015 it received CE approval for:· HydroPearl – A new Terumo microsphere for more predictable bland embolisation · LifePearl – A new Terumo drug-elutable microsphere for chemo-embolisationTerumo developed these products in-house so that it can continue to pr...
02-04-2015
DUBLIN - April 1, 2015 - Medtronic plc (NYSE:MDT) today announced the initiation of the SPYRAL HTN Global Clinical Trial Program, a unique, phased clinical program studying renal denervation in uncontrolled hypertension. This announcement follows investigational device exemption (IDE) approval by th...
01-04-2015
Three-Year Data from DURABILITY II Study Published inCatheterization and Cardiovascular Intervention JournalDUBLIN -- April 1, 2015 -- The EverFlex(TM) self-expanding peripheral stent system from Medtronic plc (NYSE: MDT) has proven to provide sustained patency in the treatment of long, complex ...
01-04-2015Hatch Medical Brokers Sale of Novotek AAA Stent-graft Patent Portfolio
ATLANTA--(BUSINESS WIRE)--Hatch Medical, L.L.C., a medical device incubator and technology brokerage firm, announced today that it has successfully brokered the sale of Novotek Innovation Ltd.’s novel intellectual property portfolio for endovascular repair of abdominal aortic aneurysms (AAA). The ...
01-04-2015
Frank J Criado MDIt is universally accepted that lower-extremity revascularization can save limbs and prevent amputation in peripheral arterial disease. However, it is generally unknown that in some regions of the U.S., the amount and intensity of vascular care is inversely related to the amputation...
30-03-2015Médicos, deportistas y empresas se reunen para prevenir e investigar la trombosis y las varices
Barcelona, 6 de marzo de 2014Médicos y deportistas han presentado hoy en el Hospital de la Santa Creu y Sant Pau de Barcelona la campaña 'La vida corre por tus venas ¡Cuídalas!' cuyo objetivo es concienciar sobre la importancia de la trombosis y la Insuficiencia Venosa Crónica y recaudar fondos...
26-03-2015House Passes SGR Repeal Bill; Action Moves to the Senate
WASHINGTON -- The House of Representatives voted 392-37 Thursday to permanently repeal the sustainable growth rate (SGR) formula for Medicare physician reimbursement, putting the bill's fate in the hands of the Senate.The vote came after years of negotiations to get rid of the much-maligned formula,...
26-03-2015Vascular Solutions Announces the Launch of the PolarCath Peripheral Dilatation System
MINNEAPOLIS, Minnesota -- Vascular Solutions, Inc. recently announced the launch of the PolarCath peripheral dilatation system for use in dilating stenoses in the peripheral vasculature (iliac, femoral, popliteal, infrapopliteal, renal, and subclavian arteries) and for the treatment of obstructive l...
25-03-2015
AUSTIN, Texas, March 25, 2015 /PRNewswire/ -- TVA Medical, Inc., today announced promising results from a clinical study evaluating a novel hemodialysis access technique that has the potential to revolutionize vascular access for patients with chronic kidney disease without the use of traditional op...
25-03-2015
...
18-03-2015
...
18-03-2015
DUBLIN -- March 18, 2015 -- Medtronic plc (NYSE: MDT) today announced that its Protégé(TM) GPS(TM) self-expanding peripheral stent system has received approval from the U.S. Food and Drug Administration (FDA) for the treatment of stenotic lesions of the common and external iliac arteries. The news...
18-03-2015
In the first-line treatment of non-resectable metastatic colorectal cancer: SIRFLOX study does not show a statistically significant improvement in overall Progression-Free Survival.SIRFLOX study does show a statistically significant improvement in Progression-Free Survival in the liver.Data to be su...
17-03-2015
MINNEAPOLIS, March 16, 2015 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it has commenced sales of the PolarCath peripheral dilatation system in the United States in collaboration with NuCryo Vascular LLC, the manufacturer of the product.As previously announced, Va...
16-03-2015
IRVINE, Calif., March 13, 2015 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that it has received approval for the AorFlex™ delivery system from the Japanese Min...
13-03-2015
ATLANTA, March 12, 2015 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, today provided an update on its ongoing litigation with C.R. Bard, Inc. and certain of its subsidiaries regarding PerClot. The U.S. Dist...
12-03-2015
Company Reaches Key Milestone for Pantheris(TM) Image-Guided Atherectomy DeviceREDWOOD CITY, Calif., March 12, 2015 (GLOBE NEWSWIRE) -- Avinger, Inc., (Nasdaq:AVGR) a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial disease (PAD) and pioneer...
12-03-2015Vascular Flow Technologies Signs Deal With Vascutek to Strengthen Presence in Europe
Dundee, UK, 4 March, 2015 – Vascular Flow Technologies, the medical device company using proprietary Spiral Laminar Flow (SLF) technology to replicate natural blood flow for enhanced patient outcomes, has appointed Vascutek as an exclusive regional distributor in France, Germany, Austria and Switz...
04-03-2015Aneurysm screening should be revisited, say experts
Aneurysm screening for men over 65 should be revisited as it is unknown whether the benefits outweigh the harms, argue researchers in The BMJ this week.This article is part of a series on overdiagnosis looking at the risks and harms to patients of expanding definitions of disease and increasing use ...
04-03-2015
ATLANTA, March 3, 2015 /PRNewswire-USNewswire/ -- Men with benign prostatic hyperplasia (BPH), a condition in which the prostate is enlarged but not cancerous, have a new, breakthrough treatment option that is less invasive and has fewer complications than other minimally invasive treatments, such a...
03-03-2015
ATLANTA, March 3, 2015 /PRNewswire-USNewswire/ -- 3-D printing could become a powerful tool in customizing interventional radiology treatments to individual patient needs, with clinicians having the ability to construct devices to a specific size and shape. That's according to a study being presente...
03-03-2015
CARLSBAD, Calif.–(BUSINESS WIRE)– ArtVentive Medical Group, Inc. (OTC Bulletin Board: AVTD) announced today the first use of its Endoluminal Occlusion System (EOS™) in the United States at The Johns Hopkins Hospital in Baltimore, MD, where Dr.’s Kelvin Hong and Anobel Tamrazi performed a spl...
03-03-2015
BUELACH, Switzerland, March 3, 2015 – BIOTRONIK announced today that results of its BIOLUX P-I clinical study have been published in the Journal of Endovascular Therapy.BIOLUX P-I was a prospective, international, multi-center, first-in-human, randomized, controlled trial that enrolled 60 patients...
03-03-2015
Guest blog post for Interventional Oncology 360 by Ryan M. Hickey, MD, interventional radiologist and assistant professor in radiology at Northwestern University, Chicago, ILIn the United States, colorectal cancer is the third most common cause of cancer death. This is an aggressive disease and abou...
03-03-2015
- Significantly advances Cardinal Health's offering of interventional cardiology and endovascular solutions for integrated health systems and their patients- Creates immediate global scale and scope- Fiscal 2017, first full post-close year, accretion is expected to be greater than $0.20 in non-GAAP ...
02-03-2015
ATLANTA--Patients suffering from chronic plantar fasciitis now have a new weapon against this debilitating foot ailment, according to research presented at the Society of Interventional Radiology's Annual Scientific Meeting. Researchers utilized ultrasound imaging and specific ultrasonic energy to p...
02-03-2015
MARLBOROUGH, Mass., March 2, 2015 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Endo International plc (NASDAQ: ENDP) (TSX: ENL) to acquire the American Medical Systems urology portfolio, which includes the Men's Health...
02-03-2015Nerve Treatment Via Nose Promising for Migraines
SUNDAY, March 1, 2015 (HealthDay News) -- A procedure that delivers the anesthetic lidocaine (Xylocaine) directly to nerves in the back of the nasal cavity appears to offer significant relief to migraine sufferers, preliminary research indicates.Early findings suggest that a single outpatient treatm...
01-03-2015
El Hospital de la Santa Creu i Sant Pau y la Asociación Cuida tus Venas se complacen en invitarle al acto de presentación de la campaña “La vida corre por tus venas ¡cuídalas!” que tendá lugar el viernes 06 de marzo de 2015 a las 9.30 h, en la Sala Francesc Cambó del Recinto Modernista de...
27-02-2015
ALAMEDA, Calif.--(BUSINESS WIRE)--Penumbra, Inc., a specialty interventional therapies company, today announced that its newest vascular embolization device, POD™, will debut at the Society of Interventional Radiology 2015 meeting in Atlanta, Georgia. In addition, results of two clinical trials fe...
26-02-2015
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) reports that more than 2,500 patients have been enrolled in the Gore Global Registry for Endovascular Aortic Treatment (GREAT). The registry is part of Gore’s dedication to post-market surveillance and monitoring long-term dev...
25-02-2015
LEXINGTON, Mass.--(BUSINESS WIRE)--CBSET, a not-for-profit preclinical research institute dedicated to biomedical research, education, and advancement of medical technologies, announced today that its scientists have defined the optimal tissue debulking protocol for treating in-stent restenosis (ISR...
25-02-2015Quirón Sagrado Corazón hace la primera intervención privada de aneurisma cerebral con stent derivador de flujo
El servicio de radiología vascular e intervencionista de Quirón Sagrado Corazón, dirigido por el doctor Antonio Mayol Deja, ha realizado la primera intervención de aneurisma intracerebral con stent derivador de flujo de la sanidad privada sevillana. Según explica el doctor Mayol en un comunicad...
25-02-2015
VenaSeal Closure System, a Next-Generation Chronic Venous Insufficiency Procedure with Demonstrated Safety and EffectivenessDUBLIN - Feb. 24, 2015 - Medtronic plc today announced U.S. Food and Drug Administration approval for VenaSeal(TM) closure system, a minimally invasive procedure that uses ...
24-02-2015Enrollment Begins for Pivotal Trial of BiO2 Medical's Angel Catheter and IVC Filter
SAN ANTONIO, Feb. 19, 2015 /PRNewswire/ -- Enrollment for The Angel Catheter® Clinical Trial has begun with three patients successfully enrolled. Site Initiation Visits are underway with a goal to include up to 30 U.S. sites in this multicenter, prospective, single arm clinical investigation of the...
19-02-2015
CMS Decision Provides Supplemental Reimbursement to U.S. Hospitals for New Medical Device with Potential to Improve Standard of Care for Peripheral Arterial Disease in Upper Leg DUBLIN –– Feb. 19, 2015 –– Medtronic plc announced today that the U.S. Centers for Medicare and Medicaid Services ...
19-02-2015
62 patients enrolled in US investigational device exemption clinical study to assess first complete, low-profile system for managing common iliac artery aneurysms or aorto-iliac aneurysmsFLAGSTAFF, Ariz.—February 17, 2015—W. L. Gore & Associates (Gore) today announced that it has completed prima...
17-02-2015
MARLBOROUGH, Mass., Feb. 17, 2015 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the settlement of the breach of merger agreement lawsuit brought by Johnson & Johnson against Guidant Corporation, stemming from Boston Scientific's acquisition of Guidant. In the lawsuit file...
17-02-2015
Amsterdam, the Netherlands and San Diego, CA, US – Royal Philips (NYSE: PHG; AEX: PHIA) today announced that it has completed the acquisition of Volcano Corporation (NASDAQ: VOLC). Volcano’s financial results will be consolidated as part of Philips’ image-guided therapy business group as of Fe...
17-02-2015The American Heart Association - American Stroke Association and Medtronic Collaborate to Reduce Recurrent Strokes
A Leading Cause of Disability and Death, Many Strokes Have No Known CauseDUBLIN and NASHVILLE, TENN. - Feb. 13, 2015 - The American Heart Association/American Stroke Association (AHA/ASA) and Medtronic plc (NYSE: MDT), today announced a collaboration to reduce the rate of recurrent strokes in the U....
13-02-2015
DUBLIN - February 12, 2015 - Medtronic announced today that a previously communicated global voluntary recall to address an issue with certain lots of its Trellis-6(TM) and Trellis-8(TM) peripheral infusion systems has now been classified as a Class 1 Recall by the U.S. Food and Drug Administration....
12-02-2015
ESCAPE and EXTEND-IA Show Improved Neurological Outcomes with Addition of Stent ThrombectomyDUBLIN - February 11, 2015 - Research presented today at the International Stroke Conference (ISC) in Nashville, Tenn. and published online in The New England Journal of Medicine (NEJM) found that the additio...
11-02-2015
American Stroke Association Meeting Report Abstract 112February 11, 2015 Categories: Scientific Conferences & Meetings, Stroke NewsStudy Highlights: Among some patients, a new device called a HydroCoil® inserted into ruptured blood vessels in the brain significantly improved healing of the aneurys...
11-02-2015
SUNNYVALE, Calif., Feb. 10, 2015 /PRNewswire/ -- Silk Road Medical, Inc., a pioneer in the development of transcarotid therapies for intra and extracranial vascular diseases, announces the company has received Food & Drug Administration (FDA) 510(k) clearance for its ENROUTE Transcarotid Neuroprotec...
10-02-2015
DUBLIN - Feb. 10, 2015 - The ClosureFast(TM) endovenous radiofrequency ablation catheter from Medtronic plc (NYSE: MDT) is safe and effective for the treatment of chronic venous insufficiency (CVI) over five years, according to data published in the February 2015 issue of British Journal of Surgery....
10-02-2015
Feb 9, 2015MARLBOROUGH, Mass., and MURRAY HILL, N.J., Feb. 9, 2015 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) and C. R. Bard, Inc. (NYSE: BCR) ("Bard") today announced that Boston Scientific will distribute the Lutonix® 035 Drug Coated Balloon Percutaneous Transluminal Angioplasty Ca...
09-02-2015Atlanta’s Emory HealthCare and WellStar Health System Discuss Merger
WellStar Kennestone HospitalIn the turbulent business of health care, bigger is often better.Nowhere is that more evident than in the stunning announcement Monday that Emory University and WellStar Health System are talking about merging their medical assets in metro Atlanta.If a deal is consummated...
09-02-2015
PARK CITY, Utah--(BUSINESS WIRE)--Distal Access™ announced the FDA cleared the SPINR High-Performance Guidewire Controller™ for use in the coronary and peripheral vasculature.“The SPINR is a cost-effective ‘first-use’ device to improve guidewire performance. Users connect a SPINR to 0.014...
05-02-2015
IRVINE, Calif., Feb. 5, 2015 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that the U.S. Food and Drug Administration (FDA) has approved Aorfix™Plus. The approva...
05-02-2015
Minimally-Invasive Flow Diversion Device for Unruptured Brain Aneurysms Designed for More Exact and Controlled Placement1DUBLIN - February 5, 2015 - Medtronic plc (NYSE:MDT), a global leader in medical technology, services and solutions, announced today that it has received U.S. Food and Drug Admini...
05-02-2015FDA Commissioner Margaret A. Hamburg Stepping Down
Dear FDA Colleagues:It has been a privilege to serve as your FDA Commissioner for almost six years. So it is with very mixed emotions that I write today to inform you that I plan to step down as FDA Commissioner at the end of March 2015. As you can imagine, this decision was not easy. My tenure lead...
05-02-2015
Longer and Lower Profile Options Now Available in Canada to Treat More Patient AnatomiesW. L. Gore & Associates, Inc. (Gore) today announced that it has received approval from Health Canada for two innovations of the GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface. The newly approved...
04-02-2015
First Uses of New Medical Device Following FDA Approval Take Place at Hospitals NationwideDUBLIN - Feb. 4, 2015 - U.S. hospitals this week began using a new medical device from Medtronic plc (NYSE: MDT) called the IN.PACT Admiral drug-coated balloon (DCB) to treat patients with peripheral arterial d...
04-02-2015ISET 2015: Computer Program Helps Doctors Gauge Blood Flow During Aneurysm Treatment
HOLLYWOOD, Fla.--(BUSINESS WIRE)--A new computer program allows doctors to assess blood flow as they are using flow-diverter devices to treat life-threatening aneurysms, suggests a preliminary study being presented at the 27th annual International Symposium on Endovascular Therapy (ISET).“Until no...
03-02-2015
Durante los días del 27 al 30 de Enero, miembros de CELA, SITE y endovascular.tv se reunieron en el prestigioso congreso de Leipzig, LINC 2015....
30-01-2015Biosensors enters into distribution agreement with veryan for Biomimics 3D stent
28 January 2015 – Biosensors International Group has announced a distribution agreement with Veryan Medical Ltd. for BioMimics 3D™, a nitinol stent with unique three-dimensional helical geometry designed for use in the superficial femoral artery. The agreement covers certain international market...
28-01-2015
PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS (Paris:STNT) (FR0010949404 — STNT), a medical technology company commercializing the world's first and only Self-Apposing® coronary stent, today announced that its unique Drug-Eluting and Self-Expanding stent was evaluated in 70 patients suffering...
28-01-2015
Data Presented at the Leipzig Interventional Course 2015 Demonstrate Significant Improvement in Dissection Repair with the Tack Endovascular System™Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that positive twelve-mont...
27-01-2015
COLORADO SPRINGS, Colo., Jan. 27, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced it has completed the acquisition of Covidien's Stellarex™ drug coated balloon angioplasty (DCB) platform. The transaction closed after the acquisition of Covidien by Medtronic.The...
27-01-2015Surgeon, Dr. Jeffrey H. Lawson, to Present on Bioengineering and the Potential to Create New Blood Vessels at the International Symposium for Endovascular Therapy
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Jeffrey H. Lawson, M.D., Ph.D., Vice Chair for Research, Professor of Surgery and Pathology at Duke University Medical Center (Durham, N.C.), Director of the Vascular Research Laboratory, Director of Clinical Trials for the Department of Surgery and cli...
27-01-2015
BOSTON, Jan. 27, 2015 /PRNewswire/ -- InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced that it received CE mark approval for its new CGuard RX rapid exchange system for its MicroNet™ covered carotid stent technology. ...
27-01-2015
IRVINE, Calif., Jan. 27, 2015 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced the initiation of the ARCHYTAS global registry. The ARCHYTAS registry is a prospective ...
27-01-2015Better, Smarter, Healthier: In historic announcement, HHS sets clear goals and timeline for shifting Medicare reimbursements from volume to value
In a meeting with nearly two dozen leaders representing consumers, insurers, providers, and business leaders, Health and Human Services Secretary Sylvia M. Burwell today announced measurable goals and a timeline to move the Medicare program, and the health care system at large, toward paying provide...
26-01-2015
MINNEAPOLIS AND DUBLIN, Ireland - January 26, 2015 - Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced that the Irish High Court has sanctioned the Covidien scheme of arrangement pursuant to which Medtronic will acquire Covidien under a new holding company incorporated in Irel...
26-01-2015
U.S. Food and Drug Administration Commissioner Margaret A. Hamburg, M.D., today appointed Robert Califf, M.D., a recognized global leader in cardiology, clinical research, and medical economics, as FDA Deputy Commissioner for Medical Products and Tobacco. In this position, Dr. Califf will provide e...
26-01-2015
MOUNTAIN VIEW, CA -- (Marketwired) -- 01/22/15 -- Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced the completion of the world's first intravascular robot-assisted retrieval of an Inferior Vena Cava (IVC) Filter. Dr. Alan Lumsden, Vascular Surgeon and D...
22-01-2015Transcatheter Technologies to Expand Product Pipeline with Tumbao EndoVascular Aortic Repair (EVAR) System
Platform technology allows for unprecedented precision-controlled expansion and anchoring of self-expanding Nitinol stentsREGENSBURG, Germany, Jan. 20, 2015 — Transcatheter Technologies GmbH, an emerging medical device company that has developed a full range of transcatheter valve implantation sys...
20-01-2015
Dundee, UK - 20 January, 2015 – Vascular Flow Technologies, the medical device company using proprietary Spiral Laminar Flow™ (SLF™) technology to replicate natural blood flow for enhanced patient outcomes, today announced the start of a randomised controlled clinical trial at St. Georges Hosp...
20-01-2015Were Interventionalists “Too Quick” to Adopt Renal Denervation? Yes!
According to the results of a new survey (Biba MedTech Insights), the majority of interventionalists believe that the European community was “too quick” to start using renal denervation before the efficacy of the procedure was established. One hundred twelve interventionalists were polled across...
20-01-2015
AUSTIN, Texas, Jan. 19, 2015 /PRNewswire/ -- TVA Medical, Inc., today announced it has won the 2014 Innovations in Cardiovascular Interventions (ICI) Best Start-Up Innovation Award. The company received the top international honor for its everlinQTM System, a catheter-based technology designed to cr...
19-01-2015New Varicose Vein Registry Launched
Chicago IL/Milwaukee WI – 13 January 2015: The American Venous Forum (AVF) and the Society for Vascular Surgery Patient Safety Organization (SVS PSO) have collaborated to launch a new Varicose Vein Registry® (VVR) for the Vascular Quality Initiative (VQI). Participants will have access to user-cu...
19-01-2015
SAN ANTONIO--(BUSINESS WIRE)--CeloNova BioSciences, Inc., today announced that it has received an expanded indication (CE Mark) in Europe for its EMBOZENETM embolic microspheres to include the treatment of benign prostatic hyperplasia (BPH).“The symptoms of benign prostatic hyperplasia can cause s...
14-01-2015
WAYNE, Pa.--(BUSINESS WIRE)--Jan. 13, 2015-- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, announced that a recent peer-reviewed article about the ARROW VPS®Vascular Positioning System showed the technology can reduce improper positio...
13-01-2015
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has announced a new agreement with HealthTrust covering PICC (peripherally inserted central catheter) and tip location devices. HealthTrust serves nearly 1,350 ...
13-01-2015
ST. LOUIS, Jan. 11, 2015 /PRNewswire/ -- Veniti, Inc. is pleased to announce the first use of the VENITI VICI VENOUS STENT System in Germany. The System is used to treat venous outflow obstruction in the lower extremities. The procedures were performed by Michael Lichtenberg, M.D., FESC, Head of Int...
11-01-2015
SIR launches new brand, reinforcing specialty’s commitment to develop breakthrough treatments, enhance medical practice and improve standard of patient care through image-guided therapiesFAIRFAX, Va.— The Society of Interventional Radiology (SIR) unveiled a new brand for the society and its rese...
09-01-2015
2014 Global AorfixTM Revenue More than Doubled Year-over-YearIrvine, CA – January 8, 2015 – Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair of abdominal aortic aneurysms (AAAs) and manufacturer of the AorfixTM endovascular stent graft, today...
08-01-2015Covidien’s Stellarex™ Drug-Coated Angioplasty Balloon Receives CE Mark to Treat Peripheral Arterial Disease Patients
Stellarex™ DCB featuring EnduraCoat™ technology designed to restore blood flow and prevent formation of new blockagesDUBLIN, Ireland--(BUSINESS WIRE)--Jan. 8, 2015-- Covidien plc (NYSE:COV) today announced it has received CE Mark approval for its Stellarex™ drug-coated angioplasty balloon (DCB...
08-01-2015
Results Complement Ongoing Phase 1 Clinical StudyWALTHAM, Mass., Jan. 8, 2015 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and vascular diseases, today announced publicatio...
08-01-2015
Innovative Treatment Allows for the Safe Disruption of Superficial and Deep Calcium within the Vascular ObstructionFREMONT, Calif.--(BUSINESS WIRE)--Shockwave Medical, a pioneer in the treatment of advanced peripheral and coronary vascular disease, today announced CE Mark regulatory approval for the...
07-01-2015Chinese FDA approves Straub Endovascular System
Wangs (Switzerland), January 7th, 2015 – Straub Medical AG announced today that the Chinese FDA has approved the Straub Endovascular System with its Rotarex®S and Aspirex®S rotational catheter families. These endovascular rotational catheters restore blood flow in occluded blood vessels by remov...
07-01-2015
Pivotal Study Shows New Medical Device Provides Exceptional Clinical Outcomes and Reduces Need for Costly Repeat ProceduresMINNEAPOLIS -- Jan. 5, 2015 -- Medtronic, Inc. (NYSE: MDT) announced today that the U.S. Food and Drug Administration (FDA) has approved the company's IN.PACT Admiral drug-coate...
05-01-2015
To improve functionality and build on lessons learned, registration, data submission, and review and dispute functions within the Open Payments system will be unavailable beginning January 1 through late January, 2015, due to system enhancements and preparations for the 2014 program year. It is impo...
05-01-2015Nueva revista Técnicas Endovasculares Volumen XVII - Número 3 (Septiembre-Diciembre 2014)
Ya está disponible en www.endovascular.es el último número de la Revista Técnicas Endovasculares:Volumen XVII - Número 3 (Septiembre-Diciembre 2014)La Revista Técnicas Endovasculares y el portal endovascular.es son órganos oficiales de expresión de la Sociedad CELA, Cirujanos Endovasculares ...
02-01-2015
CELA 2015 from Salutaria ...
02-01-2015XIV REUNIÓN GALAICO DURIENSE. Ourense, 20-21 Febrero 2015 - Programa preliminar
Xiv reunion galaico duriense preliminario from Salutaria ...
02-01-2015BARD Ultraverse 035 PTA Dilatation Catheter
Ultraverse035 from Salutaria ...
02-01-2015
Xiv reunion galaico duriense dosier patrocinios from Salutaria ...
02-01-2015JOTEC lanza la nueva endoprótesis E-tegra
La empresa alemana Jotec, ha lanzado su nuevo sistema de endoprótesis E-tegra. Jotec proporciona un diseño totalmente nuevo del sistema de endoprótesis A.A.A. que incluso permite tratar anatomías vasculares complicadas, lo que amplia el tratamiento endovascular de los aneurismas aórticos abdomi...
24-12-2014
Results of IN.PACT SFA Trial Published in CirculationMINNEAPOLIS -- Dec. 22, 2014 -- The results of a landmark study published this month in Circulation, the world's leading cardiovascular journal, indicate that a novel medical device from Medtronic, Inc. (NYSE: MDT) called the IN.PACT Admiral drug-...
22-12-2014Roxwood Medical Announces FDA 510(k) Clearance and US Commercial Launch of Its CenterCross Catheter
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Roxwood Medical Inc. announced today FDA clearance for the US commercialization of itsCenterCross Catheter for use in the coronary and peripheral vasculature. The CenterCross Catheter expands Roxwood Medical’s product offerings that already includes the FDA-c...
19-12-2014
Company Signs Exclusive Distribution Agreement With AB Medica s.p.a.; First Magellan(TM) Robotic System Installation Completed in Middle East RegionMOUNTAIN VIEW, CA -- (Marketwired) -- 12/19/14 -- Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced key re...
19-12-2014
− Vascular Solutions will distribute two models of the ZigiWire guidewire system, a novel support wire system designed for gaining vascular access in both simple and challenging peripheral interventions− ZigiWire is developed and manufactured by VadisWire Corp. − Vascular Solutions expects U.S...
19-12-2014
On December 19, 2014, CMS added approximately 68,000 payment records – valued at more than $200 million – to the Open Payments data set. With this new data, Open Payments now reports information on $3.7 billion in payments and transfers of value to up to 546,000 individual physicians and up to 1...
19-12-2014A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke
Intravenous alteplase administered within 4.5 hours after symptom onset is the only reperfusion therapy with proven efficacy in patients with acute ischemic stroke.1 However, well-recognized limitations of this therapy include the narrow therapeutic time window and contraindications such as recent s...
17-12-2014Philips to acquire Volcano to expand global leadership position in image-guided therapy market
- Philips to acquire Volcano for USD 18.00 per share; total transaction value of USD 1.2 billion (approx. EUR 1 billion), inclusive of Volcano's cash and debt- Agreement to acquire Volcano, a global leader in catheter-based imaging and measurement solutions for cardiovascular applications, advances ...
17-12-2014ReFlow Medical Corporation Announces FDA 510(k) Clearance And Initial US Clinical Use Of The SpeX™ Shapeable Support Catheter
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--ReFlow Medical, Inc. (ReFlow) today announced FDA clearance for US commercialization of their SpeX™ Shapeable Support Catheter for use in the peripheral vasculature as well as the first US clinical cases with the device. The initial US cases were performed by...
17-12-2014Cigarette smoking rates among adults at an all-time low in the United States, but total triumph remains elusive
Frank J Criado, MD, FACS, FSVM The Nov. 28 issue of the CDC’s Morbidity and Mortality Weekly Report (MMWR 2014;63:1108-12) documents that the rate of cigarette smoking among adults in the United States dropped from 20.9% in 2005 to 17.8% in 2013 - the lowest it has been since the CDC began recordi...
17-12-2014La Marató de TV3 dedicada este año a investigar sobre enfermedades cardíacas supera los 8 millones de euros
El programa, además de recaudar fondos para investigar las enfermedades cardíacas, pretende divulgar información sobre este tipo de dolencias, que provocan la muerte de una de cada cuatro personas en Cataluña y son la primera causa de ingreso hospitalario.Durante La Marató de este año, persona...
15-12-2014
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced that the GORE® VIABAHN® Endoprosthesishas received CE Mark approval to improve blood flow in symptomatic obstruction of peripheral veins, excluding the venae cavae and pulmonary veins.“The GORE VIABAHN Endopr...
10-12-2014
SOUTH JORDAN, Utah, Dec. 10, 2014 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has received 510(k) clearance for three products: the ...
10-12-2014
Latest Results from Two Clinical Studies Show Strong Mid-Term Performance of Leading Medical Device for Endovascular Repair of Abdominal Aortic AneurysmsMINNEAPOLIS -- Dec. 9, 2014 -- For endovascular repair of abdominal aortic aneurysms, the Endurant AAA stent graft system from Medtronic, Inc. (NYS...
09-12-2014
- Line of 17 models of the VSI Radial™ introducer sheath targets vascular access needs in the rapidly-growing radial artery catheterization market- Developed and manufactured by LePu Medical of Beijing, China, building on the successful initial collaboration for the Vasc™ Band radial hemostat- V...
08-12-2014Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS-FXI Rx for the Prevention of Venous Thrombosis in Patients Undergoing Total Knee Replacement Surgery
Seven-fold lower incidence of VTE in patients treated with ISIS-FXI Rx compared with enoxaparinData published in New England Journal of Medicine and featured at the American Society of Hematology annual meetingIsis to host a webcast at 9:00 a.m. ET on Monday, December 8, 2014CARLSBAD, Calif., Dec. 7...
07-12-2014
December 04, 2014 03:33 PM Eastern Standard TimeCARLSBAD, Calif.--(BUSINESS WIRE)--ArtVentive Medical Group, Inc. (OTC Bulletin Board AVTD) announced today that it has received U.S. Food and Drug Administration (FDA) clearance for the Endoluminal Occlusion System (EOSTM). Designed for use in the per...
04-12-2014
Cardionovum GmbH announced today that it has initiated a 150-patient clinical study of its novel paclitaxel-releasing high-pressure shunt balloon dilatation catheter APERTO®. The study aims to sustain the highly promising and significant first clinical evidence for APERTO.Regardless of whether it i...
04-12-2014
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has announced it has been awarded an agreement with Premier, Inc., a leading healthcare improvement company, for its ARROW® Dialysis Access portfolio.“We loo...
02-12-2014
ANDOVER, Mass. and CHICAGO, Nov. 30, 2014 /PRNewswire/ -- Royal Philips (NYSE: PHG, AEX: PHIA) today introduced theDoseWise Portal, a comprehensive radiation dose management software solution aimed at managing radiation exposure risk to patients and their caregivers. Announced at the 100th annual me...
01-12-2014
ST. LOUIS, Dec. 1, 2014 /PRNewswire/ -- VENITI, Inc., a company dedicated to advancing the treatment of venous disease, announced that it has enrolled the first United States patients in the VIRTUS trial of the VENITI VICI™ Venous Stent System. The four procedures were performed at two sites, incl...
01-12-2014Neovasc Announces Treatment of First Patient in TIARA-I Clinical Trial
VANCOUVER, Dec. 1, 2014 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced that the first patient has been enrolled in the European arm of its TIARA-I Early Feasibility Trial, a multinational, multicenter trial being conducted at centers in the US, Eur...
01-12-2014IMRIS completes SYMBIS Surgical System human factors study
18 US neurosurgeons from 9 leading institutions validate robot usability for final 510(k) submission deliverableMINNEAPOLIS, MN, December 1, 2014 – IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ('IMRIS' or the “Company”) today announced that the Company has successfully completed the human factors study ...
01-12-2014Participación con stand de SITE-CELA y Endovascular TV en el VEITH Symposium de Nueva York 2014
Durante los días del 18 al 22 de Noviembre 2014 se celebró en Nueva York el congreso anual VEITH Symposium, uno de los congresos más importantes del mundo sobre cirugía vascular y endovascular. El congreso en su 41 edición contó con un stand del congreso SITE-CELA 2015 y la plataforma Endovasc...
30-11-2014Medtronic presents Endurant IIs AAA Stent Graft System
Three-piece system leverages proven design of leading Endurant II Abdominal Stent GraftOffers a shorter ipsilateral leg for more flexible targeted limb placementFeatures equal leg diameters to allow limbs to be used on either sideUtilises existing delivery system allowing accurate placement and cont...
30-11-2014Programa final SITE-CELA 2015, 24 al 27 de Junio - Barcelona
El SITEupdate-CELA se celebrará en Barcelona del 24 al 27 de Junio 2015 en el Palau de Congressos de Catalunya.WEB OFICIAL: http://www.sitesymposium.org/A continuación se muestra el programa final: Programa final from Salutaria ...
30-11-2014Reunión comisión directiva CELA en el congreso VEITH Symposium de Nueva York 2014
Estimados colegas,Como es habitual, la Comisión Directiva de CELA, aprovechó el tiempo del Congreso de Frank Veith en NYC, para llevar a cabo una de sus Reuniones. En realidad, fueron varias reuniones las que se realizaron durante este evento.En primer lugar el jueves 20 de noviembre, se reunieron...
30-11-2014
Could this be at last the light at the end of the long tunnel for renal artery stenting?As announced by the Society for Cardiovascular Angiography and Interventions (SCAI) last May, a new meta-analysis found that renal artery stenting significantly reduces the risk of serious health problems when co...
28-11-2014
MINNEAPOLIS AND DUBLIN, Ireland - Nov. 26, 2014 - Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced the receipt of U.S. Federal Trade Commission (FTC) clearance of Medtronic's proposed acquisition of Covidien. "This regulatory clearance represents an important milestone in bri...
26-11-2014
- Catheter-delivered gelatin pledgets targeting treatment of hypervascular tumors and arteriovenous malformations (AVMs) available for immediate U.S. launch- Pre-formed, ready-to-deliver pledgets eliminate the need for physicians to cut and manufacture their own embolization pledgets- ...
25-11-2014
Fortrex™ PTA Balloon Facilitates Arteriovenous Access in Patients Receiving Hemodialysis for Chronic Kidney DiseaseDUBLIN, Ireland--(BUSINESS WIRE)--Nov. 24, 2014-- Covidien plc (NYSE: COV) today announced U.S. Food and Drug Administration510(k) clearance for its Fortrex™ over-the-wire (OTW) per...
24-11-2014Bracco Diagnostics Inc. Creates First and Only U.S. FDA-Approved Multi-Dose Compliant Contrast Medium as Breakthrough Solution for Point-of-Care Use in the CT Suite
MONROE TOWNSHIP, N.J.--(BUSINESS WIRE)--Bracco Diagnostics Inc. (BDI), the U.S. subsidiary of Bracco Imaging S.p.A. - a global leading company in the diagnostic imaging business - today announced the availability of its innovative ISOVUE® (iopamidol injection) Imaging Bulk Package* (IBP), the first...
24-11-2014
--Positive Outcomes in Abdominal Aortic Aneurysm Patients with Challenging Anatomies Reinforce Clinical Value of Aorfix – Irvine, CA and London, UK – November 20, 2014 – Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal a...
20-11-2014
IRVINE, Calif., Nov. 20, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today the presentation of initial clinical data from the Company's EVAS FORWARD - Global Registry, a post-market study that prospectively e...
20-11-2014
PLANO, Texas, Nov. 19, 2014 /PRNewswire/ -- Argon Medical Devices, Inc. announced today that the company has received clearance from the US Food and Drug Administration to begin marketing the CLEANER XT™ and CLEANER 15™ Rotational Thrombectomy Systems for mechanical declotting and controlled and...
19-11-2014VEITHsymposium: Gore Joins Vascular and Endovascular Leaders in Recognizing the 2014 Pioneers in Performance for North America
Leading Practitioners and Researchers from North America Commended for Commitment to Advancing Vascular and Endovascular TherapyFLAGSTAFF, Ariz.--W. L. Gore & Associates (Gore) joined with leaders across the vascular and endovascular community in honoring four North American physicians as Pioneers i...
19-11-2014
IRVINE, Calif., Nov. 18, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has completed patient enrollment in the EVAS FORWARD-IDE clinical trial, the Company's U.S. pivotal clinical trial designed t...
18-11-2014
La empresa Palex Medical SA anuncia el lanzamiento al mercado de la nueva generación de cierres radiales SealOne® (Perouse Medical). El dispositivo de compresión radial SealOne® se utiliza para comprimir el sitio de la punción después de realizar todos los procedimientos de acceso radial míni...
17-11-2014
MALVERN, Pennsylvania, November 17, 2014 /PRNewswire/ --Essential Medical, Inc., a privately held medical device company, announced today that it has successfully completed First in Man studies for its MANTA Large Bore Vascular Closure device, a revolutionary vascular closure device designed to seal...
17-11-2014ZOLL Announces Acquisition of Philips InnerCool Temperature Management
Expands ZOLL’s Temperature Management PortfolioNovember 17, 2014—CHELMSFORD, MASS.— ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that it has signed an agreement to purchase substantially all of the assets of Philips’ InnerCool™...
17-11-2014Baja la mortalidad en el mes posterior a sufrir un ictus o un aneurisma
- Los hospitales de Sant Joan de Reus, y Sant Pau, de Barcelona, son los que han hecho más ingresos innecesarios- Salut penalizará a los centro públicos que hacen hospitalizaciones no necesariasAcceder a fuente de la noticia...
14-11-2014La Fe acoge una carrera en beneficio de la investigación en malformaciones vasculares
El Hospital Universitari i Politècnic La Fe recibirá mañana a varios atletas que han participado en una iniciativa basada en recorrer los más de 400 quilómetros que separan Madrid de Valencia, para promover la investigación en malformaciones vasculares del sistema nervioso central. La iniciati...
14-11-2014Asahi Intecc Receives CE Mark for New Neurovascular Guide Wires
Nagoya, Japan (November 14) – ASAHI INTECC has received CE certification of Neurovascular Guide Wires ASAHI CHIKAI 008, ASAHI CHIKAI black, and ASAHI CHIKAI black 18 and is initiating sales in Europe.The above wires join the currently marketed ASAHI CHIKAI and ASAHI CHIKAI 10 in incorporating ASAH...
14-11-2014
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced that Pierre Galvagni Silveira, MD, PhD, from the Federal University of Santa Catarina in Florianopolis, Brazil, enrolled the first two patients in the Gore Thoracoabdominal Aortic Aneurysm Clinical Study. This in...
13-11-2014
DUBLIN, Ireland--(BUSINESS WIRE)--Nov. 13, 2014-- Covidien plc (NYSE:COV) today announced the six-month results of the VeClose pivotal study, which demonstrated the safety and effectiveness of the VenaSeal™ closure system* in patients with chronic venous insufficiency (CVI) having symptomatic refl...
13-11-2014
George J. Arnaoutakis et al. (from Johns Hopkins in Baltimore, MD) just published an important study in the January 2014 issue of the Journal of Vascular Surgery (J Vasc Surg 2014;59:45–51). As summarized in the article, the investigators conducted a review of the 2005 to 2011 ACS-NSQIP database t...
13-11-2014
New Bifurcated Component Leverages Proven Design of Predicate Device and Expands Anatomical Customization Options for Endovascular Repair of Abdominal Aortic AneurysmsMINNEAPOLIS -- Nov. 12, 2014 -- The global leader in medical technology for endovascular aortic repair (EVAR), Medtronic, Inc. (NYSE:...
12-11-2014Large-scale study on vein filter use launches
Joint press release from Society for Vascular Surgery (SVS) and Society of Interventional Radiology (SIR) on behalf of the IVC Filter Study Group Foundation: Seven filter manufacturers set to participate in multicenter Predicting the Safety and Effectiveness of Inferior Vena Cava Filters (PRESERVE) ...
12-11-2014Barrow Neurosurgeons Implant the World's First Scaffold into a Patient's Spinal Cord
PHOENIX, Nov. 11, 2014 /PRNewswire/ -- Performed last month, the surgery involves inserting a bioresorbable scaffolding implant to act as a bridge across the gap of the injured section of the cord in an attempt to help the spinal cord heal. This first case is part of a pilot study to measure the cli...
11-11-2014El Peset retransmite en directo una operación compleja de aneurisma de aorta
El Hospital Universitario Doctor Peset ha sido elegido para retransmitir mañana en directo una cirugía endovascular compleja para el tratamiento de un aneurisma de aorta abdominal. Esta retransmisión forma parte del programa del IV Simposium Internacional de Cirugía Endovascular, que se celebra ...
05-11-2014
LAS VEGAS--(BUSINESS WIRE)--Nov. 5, 2014-- Covidien plc (NYSE: COV) today announced nine-month results of the DURABILITY Iliac study and addition of the iliac indication for its EverFlex™ stent at the Vascular Interventional Advances (VIVA) 2014 conference. The nine-month results confirm the safet...
05-11-2014
MINNEAPOLIS, Nov. 4, 2014 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it has entered into an agreement with NuCryo Vascular LLC under which Vascular Solutions will serve as exclusive distributor of the PolarCath Peripheral Dilatation System in the United States.Va...
04-11-2014
Results suggest long-term benefits for peripheral artery disease patients treated with directional atherectomy followed by a drug-coated balloonLAS VEGAS--(BUSINESS WIRE)--Nov. 4, 2014-- Covidien plc (NYSE: COV) today announced 12-month results of the DEFINITIVE AR study, the first randomized study ...
04-11-2014
Consistent Outcomes Despite Common and Challenging Comorbidity Reinforce Overall Findings of IN.PACT SFA TrialLAS VEGAS -- Nov. 4, 2014 -- For the treatment of peripheral artery disease in leg arteries above the knee, the IN.PACT Admiral drug-coated balloon from Medtronic, Inc. (NYSE: MDT) provided ...
04-11-2014
The HawkOne™ System strengthens Covidien’s directional atherectomy platform with a versatile solution for the treatment of peripheral arterial diseaseDUBLIN, Ireland, Nov 04, 2014 (BUSINESS WIRE) -- Covidien plc COV, -0.42% today announced U.S. Food and Drug Administration 510(k) clearance for t...
04-11-2014
Device Now Approved for Use to Seal Femoral Arterial and Femoral Venous Access SitesDUBLIN, Ohio, Nov. 4, 2014 — Cardinal Health today announced that its MynxGrip Vascular Closure Device recently received Food and Drug Administration approval for use to close femoral veins. The MynxGrip device is ...
04-11-2014
NOVEMBER 4, 2014 - WAYNE, Pa.-- (BUSINESS WIRE)--Intact Vascular, a medical device company and developer of products for minimally invasive peripheral vascular procedures, today announced its completion of the TOBA-BTK Study, Tack Optimized Balloon Angioplasty - Below the Knee Study.This multi-cente...
04-11-2014
Las Vegas, Nev., November 4, 2014 — Five-year results from the largest and longest-running clinical trial of a drug-eluting stent for treating peripheral arterial disease (PAD) confirmed long-term patency for patients treated with Zilver PTX.The results were presented today by Michael Dake, M.D., ...
04-11-2014
Las Vegas, 4th November 2014 – Two-year data from the Mimics study, presented at today’s Late- Breaking Clinical Trials session at the VIVA Symposium, have confirmed that BioMimics 3DTM provides a significant improvement in long-term primary patency compared to a straight nitinol control stent i...
04-11-20143D Virtual Implantation Demonstrated that 19-Year-Old Female Could be Successfully Bridged to Transplant with the SynCardia Total Artificial Heart
Case series in The Journal of Heart and Lung Transplantation discusses how 3D imaging software helps make more patients eligible for the life-saving SynCardia Heart implant even if they don’t meet minimum fit criteria. With SynCardia Heart support, this patient was successfully bridged to a donor ...
04-11-2014Trusted Performance by Gore Excluder AAA Endoprosthesis
Trusted performance from Salutaria ...
03-11-2014
ST. PAUL, Minn.--(BUSINESS WIRE)--Nov. 3, 2014-- Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today announced that it has received CE (Conformité Européenne) Mark for its Stealth 360º Orbital Atherectomy System (OAS). Stealth 360º is a percutaneous OAS that is indicated to treat patients w...
03-11-2014
MOUNTAIN VIEW, CA, Nov 03, 2014 (Marketwired via COMTEX) -- Hansen Medical, Inc. HNSN, +4.55% a global leader in intravascular robotics, today announced the Company's Magellan(TM) 6Fr Robotic Catheter has received European Conformity (CE) Marking for use in the peripheral vasculature. Achieving this...
03-11-2014
Expands Spectranetics' portfolio of solutions to treat complex vascular conditions in projected $700 million drug coated balloon segmentCOLORADO SPRINGS, Colo., and DUBLIN, Ireland, Nov. 2, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) and Covidien plc (NYSE:COV) today announc...
02-11-2014LIVE STREAMING realizado con éxito desde el Hospital Plató de Barcelona
El pasado 24 de Octubre se realizó con éxito la grabación en LIVE STREAMING del Taller/Workshop sobre las técnicas de tratamiento de las varices, con motivo de la celebración del 51 Congreso Internacional de la Sociedad Europea de Flebectomía en Barcelona. Se pudieron grabar 4 operaciones, tod...
31-10-2014
Success of the Passeo-18 Lux Drug-Releasing Balloon in Treating Peripheral Artery Disease to Be Assessed in Real-World PopulationBUELACH, Switzerland, October 30, 2014 – BIOTRONIK, a leading manufacturer of cardio- and endovascular devices, announced the first implantation in the BIOLUX P-III All-...
30-10-2014RenovoCath™ RC120 Receives FDA 510(k) Clearance
Menlo Park, CA (October 30, 2014) – RenovoRx, a leading developer of innovative solutions for targeted delivery of fluids to selected sites in the vascular system, today announced the company has received FDA 510(k) clearance of its flagship product, the RenovoCath RC120 catheter.The RenovoCath RC...
30-10-2014
Sophia Antipolis, 29 October 2014. The European Society of Cardiology (ESC) announced today that its annual congress will be held in Barcelona in 2017 and Munich in 2018. ESC Congress is the largest cardiology meeting in the world and hosts more than 30 000 cardiovascular medical professionals duri...
29-10-2014
MINNEAPOLIS - October 28, 2014 - Medtronic, Inc. (NYSE: MDT) today announced it has initiated the PERIGON (PERIcardial SurGical AOrtic Valve ReplacemeNt) Pivotal Trial, a global, prospective clinical trial evaluating an investigational surgical aortic heart valve made from bovine pericardial (cow he...
28-10-2014
MALVERN, Pa., Oct. 27, 2014 /PRNewswire/ -- Essential Medical, Inc., a privately held medical device company, announced today that it has received CE mark approval for X-Seal™, a new vascular closure device with superior handling and closure features. X-Seal closes femoral arterial punctures made ...
27-10-2014
SANTA ROSA, Calif., Oct. 27, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV) announced today the first patient enrollment in the LIFE Study, a multi-center post-market registry. The first LIFE Study patient was treated by Wayne K. Nelson, MD at Bend Memorial Clinic and St. Char...
27-10-2014Bolton Medical initiates Regeneration: The International Clinical Trial for Relay PRO and Relay NBS PRO Aortic Stent-Grafts
BARCELONA, SPAIN - (Oct. 27th, 2014) - Bolton Medical, a medical device manufacturer that specializes in endovascular treatments for aortic pathologies, announced today it has performed its first in-human implantation of its Relay PRO device. The Relay PRO Thoracic Stent- Graft System will enhance t...
27-10-2014FDA 510(k) Clearance and Initial US Clinical Use of the Wingman35 Crossing Catheter
ReFlow Medical, Inc. (ReFlow) today announced FDA clearance for US commercialization of their Wingman35 Crossing Catheter for use in the peripheral vasculature as well as the first US clinical cases with the device. The initial US cases were performed by Dr. John R. Laird at the UC Davis Vascular Ce...
23-10-2014
Distinct Alternative to Surgery, Radiological Approaches and Power Morcellation, for the Treatment of Symptomatic Uterine FibroidsREDWOOD CITY, CA – October 22, 2014 – Gynesonics, Inc., a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uter...
22-10-2014
MOUNTAIN VIEW, CA -- (Marketwired) -- 10/21/14 -- Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced the completion of the first robot-assisted Uterine Fibroid Embolization (UFE) in the United States. Sandeep Rao, MD, Interventional Radiologist, performed...
21-10-2014Más mujeres que hombres enfrentan ataques cerebrales
En el Día Mundial del Ataque Cerebral, American Heart Association/American Stroke Association urgen a todos a aprender las señales de un ataque cerebral.(Dallas) 20 de octubre 2014 - La modelo y actriz Claudia Mason está ayudando a American Heart Association/American Stroke Association a crear co...
20-10-2014
--Cases Led by Prof. Andrew Holden, Globally-Recognized Expert on Endovascular Treatments--Irvine, CA and London, UK – October 16, 2014 – Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today anno...
16-10-2014
Customized Sealing Technology Enables Faster Procedure Times, Preserves the Aortic Neck and Provides an Optimized Seal Tailored to Each Patient's Specific AnatomySANTA ROSA, Calif., Oct. 15, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV) announced today that the U.S. Food and ...
15-10-2014
FDA Issues Final Medical Device Recalls Guidance Explains How to Distinguish Enhancements from Recalls...
15-10-2014US Appeals Court Upholds Florida’s Record Release Law in Medical Liability Suits
A federal appeals court has upheld a state law that requires plaintiffs to release their relevant protected health information before proceeding with allegations of medical liability.In Murphy v. Dulay, the appeals court overturned a lower court ruling that said a Florida law requiring the release o...
15-10-2014Cardiatis Targets Crawford V Thoracoabdominal Aortic Aneurysms with Cardiatis C5 Second Generation Multilayer Flow Modulating Endograft
NAMUR, Belgium--(BUSINESS WIRE)--Cardiatis S.A., developer and marketer of innovative minimally invasive treatments for thoracoabdominal aortic aneurysms, announced today plans of targeting Crawford Extent V lesions with its second generation aortic multilayer flow diversion device, the Cardiatis C5...
14-10-2014
MURRAY HILL, N.J.--(BUSINESS WIRE)--Oct. 10, 2014-- C. R. Bard, Inc. (NYSE: BCR) today announced the U.S. Food and Drug Administration (FDA) approval of the Lutonix® 035 Drug Coated Balloon (DCB) Catheter for percutaneous transluminal angioplasty (PTA), after pre-dilatation, for the treatment of de...
10-10-2014BIOTRONIK to Offer New Treatment Options in France with Release of Orsiro Drug-Eluting Stent
PARIS, France, October 10, 2014—BIOTRONIK, a leading manufacturer of cardiovascular medical technology, today announced the market release ofOrsiro, the industry’s first hybrid Drug-Eluting Stent (DES) combining an active BIOlute coating and a passive proBIO coating. The release comes after a su...
10-10-2014FDA approves first drug-coated angioplasty balloon catheter to treat vascular disease
The U.S.Food and Drug Administration today approved the Lutonix 035 Drug CoatedBalloon Percutaneous Transluminal Angioplasty Catheter (Lutonix DCB). This isthe first drug-coated balloon used to re-open arteries in the thigh(superficial femoral arteries) and knee (popliteal arteries) when narrowed or...
10-10-2014
MINNEAPOLIS -- October 10, 2014 -- Medtronic (NYSE: MDT) today announced the executive team who will lead the combined organization following the close of its proposed acquisition of Covidien. The new company will be comprised of four major business groups and four geographic regions led by a new E...
10-10-2014XV Simposio de Angiologia e Cirugia Vascular- 17 e 18 de Outubro - Porto, Palácio Hotel
Programa xv simpósio de angiologia e cirurgia vascular 17 e 18 de outubro - porto palácio hotel from Salutaria ...
09-10-2014Neovasc Receives FDA Conditional Approval to Initiate TIARA-I Trial in US: A Multinational, Multicenter Early Feasibility Trial of the Tiara™ Transcatheter Mitral Valve
VANCOUVER, Oct. 9, 2014 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced that it has received conditional Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to initiate the U.S. arm of its TIARA-I Early F...
09-10-2014Claret treats first patient in pivotal US trial of Sentinel cerebral protection system
US-based Claret Medical has completed treatment of the first patient in its multicentre pivotal SENTINEL trial of the Sentinel cerebral protection system (CPS).A total of 284 patients at about 15 centres in the US, will be enrolled in the prospective, randomised, controlled, blinded SENTINEL trial, ...
08-10-2014Results of the ANCHOR prospective, multicenter registry of EndoAnchors for type Ia endoleaks and endograft migration in patients with challenging anatomy.
AbstractOBJECTIVE:Proximal attachment site complications continue to occur after endovascular repair of abdominal aortic aneurysms (EVAR), specifically type Ia endoleak and endograft migration. EndoAnchors (Aptus Endosystems, Sunnyvale, Calif) were designed to enhance endograft proximal fixation and...
06-10-2014AnGes Starts Global Phase III Clinical Trials of Collategene® for Critical Limb Ischemia
AnGes Starts Global Phase III Clinical Trials of Collategene® for Critical Limb IschemiaAnGes MG, Inc. (“AnGes”) announces that it has commenced the global phase III clinical trials of Collategene® with the enrollment of patients in the US.The first patient was enrolled in the study on October...
06-10-2014Renal Artery Stenting Continues to Disappoint
Dr. Frank J CriadoThe CORAL study results were presented on November 18, 2013 at the AHA 2013 Scientific Sessions in Dallas. The findings were published concurrently in the New England Journal of Medicine.The study investigators noted that renal artery stenting had increased an impressive 364% in th...
03-10-2014CFI Medical and BIOTRONIK Announce CE Mark for Zero-Gravity™ Suspended Radiation Protection System
Technology to Reduce Clinician Fatigue and Orthopedic Injuries Surpasses Partial Radiation Protection of Conventional Heavy Protective ApparelFENTON, MI, US and BERLIN, Germany, October 1, 2014 –CFI Medical, a leading manufacturer of innovative radiation protection products, announced CE (Conformi...
01-10-2014"Un sueño hecho realidad " LIVE STREAMING desde un quirófano a través de Endovascular TV
El día 10 de Septiembre 2014 desde el Hospital Clínic de Barcelona tuvo lugar la primera restransmisión LIVE STREAMING desde un quirófano a través de la plataforma educativa Endovascular TV.El equipo de Cirugía Vascular y Radiología Intervencionista liderado por el Dr. Vicente Riambau trató ...
30-09-2014
Data promote transparency into the financial relationships between health care industry, doctors and teaching hospitalsAs part of our ongoing effort to increase transparency and accountability in health care, the Centers for Medicare & Medicaid Services (CMS) released today the first round of Open P...
30-09-2014
Frank J Criado MD FACS FSVMPatient survival after ruptured abdominal aortic aneurysm (rAAA) in the United States outstrips that in English National Health Service hospitals, according to a major new study published in a recent issue of The Lancet. It shows that the odds for surviving are significant...
30-09-2014Newsletter CELA Septiembre
Bajar última revistaBajar números anteriores Newsletter CELASeptiembre 2014PresentaciónNuestra revistaCELA dijo presente en Puerto RicoInforme de la comisión científica de educaciónHistorias de Vida: Cirugía endovascular en el fin del mundoAmputación en diabéticos: 10 veces mayor en pobre...
30-09-2014
Statement HighlightsPatients should have a clear understanding of why their healthcare provider has recommended a heart imaging test and the potential benefits and risks of the test, including risks related to radiation exposure.Healthcare providers should understand the radiation risks of various t...
29-09-2014
LEOPARD Study to Enroll 600 Patients to Provide a 'Real-World'Head-to-Head Comparison of the AFX® System Versus Other Commercially AvailableEVAR DevicesIRVINE, Calif., Sept.29, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX),developer and marketer of innovative treatments for aortic disorder...
29-09-2014
IRVINE, Calif., Sept. 29, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has completed patient enrollment in the EVAS FORWARD - Global Registry. From October 2013 to September 2014, the registry en...
29-09-2014
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--ReFlow Medical, Inc. (ReFlow) today announced the initial clinical use of their Wingman35 Crossing Catheter and speX™ Shapeable Support Catheter by Dr. Andrej Schmidt at University Leipzig, Germany. The devices were recently granted European Union CE Mark app...
25-09-2014
IRVINE, Calif. and WEST LEBANON, N.H., Sept. 24, 2014 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on endovascular aneurysm repair ( EVAR ) of abdominal aortic aneurysms (AAA), has partnered with the Society for Vascular Surgery® Patient Safety Organizat...
24-09-2014MediValve, Ltd. Announces Initiation of post-Market Clinical Evaluations of the acWire™ Guidewire at Lenox Hill Hospital (New York)
The acWire™ is intended for use in peripheral vascular and heart catheterization procedures to introduce and assist in positioning diagnostic and interventional devices. The acWire may also function as an alignment tool by providing a reference plane of anatomical structure of interest (i.e., the ...
24-09-2014Medtronic CoreValve Evolut R CE Approved
23-09-2014Gore Receives FDA Approval for Endovascular Treatment of In-Stent Restenosis with the GORE® VIABAHN® Endoprosthesis
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced that the Food and Drug Administration (FDA) has approved the GORE® VIABAHN® Endoprosthesis for interventional treatment of in-stent restenosis in the superficial femoral artery (SFA). Now indicated for the trea...
22-09-2014First patient enrolled in US study of Novate's sentry IVC filter
22 September 2014 – Novate Medical announced today that Souheil Saddekni MD, Professor of Vascular and Interventional Radiology at the University of Alabama, Birmingham has enrolled the first patient in the SENTRY IDE Study.The SENTRY study is a prospective, single-arm, multi-centre study designed...
22-09-2014
Straub Medical AG announced to-day that the Brazilian Health Surveillance Agency ANVISA has approved the Rotarex®S and Aspirex®S rotational catheter systems. These endovascular rotational catheters restore blood flow in occluded blood vessels by removing occlusion material from the vessel. The cat...
18-09-2014Randomized Sham-Controlled Trial Examines Blood Pressure Effects of Renal Denervation in Patients with Mild Refractory Hypertension
Results of Symplicity Flex TrialReported at TCT 2014WASHINGTON, DC – According to a newsmall-to-modest sized but sham-controlled study, renal sympathetic denervation(RSD) used to treat mild refractory hypertension was associated with reductionsin blood pressure in secondary analyses, but missed it...
16-09-2014EXCITE ISR: Laser Atherectomy Superior to Angioplasty Alone for Femoropopliteal In-Stent Restenosis
By TCT Daily Staff Tuesday, September 16, 2014Addition of laser atherectomy provides better short-term results than balloon angioplasty alone in patients with restenosis in peripheral stents. In fact, the randomized, multicenter EXCITE ISR trial comparing both approaches was stopped early after anal...
16-09-2014CardioKinetix Releases One-Year Clinical Data From European Trial Showing Consistent, Compelling Positive Results for Patients Treated With Minimally Invasive Device for Heart Failure
MENLO PARK, Calif., Sep 16, 2014 (BUSINESS WIRE) -- CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced results of a pooled analysis study of the first-of-its-kind catheter-based Parachute® Ventricular Partitioning Device. Twelve-mon...
16-09-2014
SAN CLEMENTE, Calif., Sept. 16, 2014 /PRNewswire/ -- ROX Medical today presented positive results from the CONTROL-HTN trial, an international multi-center, prospective, randomized, controlled, blinded endpoint study of the ROX Coupler for the treatment of arterial hypertension. The CONTROL-HTN tria...
16-09-2014
TRUTH Study Demonstrates Orbital Atherectomy’s Effectiveness at Reducing and Modifying Calcified Lesions with Low Procedural ComplicationsST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII), unveiled new data about the treatment of arterial calcification at the 2014...
15-09-2014
- The ENDURE Trial to assess efficacy of the novel Drug Coated Chocolate® PTA (Chocolate® Touch)- Chocolate® Touch combines Chocolate's advantages of minimising dissections and bail-out stenting with the long-term benefits of drug coating- Reflects progression of Group's new product growth strate...
15-09-2014ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent
- Abbott's Absorb Bioresorbable Vascular Scaffold (BVS) is a revolutionary medical device, used in the heart, that functions like a stent but dissolves over time- One-year results show Absorb provides comparable results across several measures and lower rates of angina (chest pain) than a best-in-cl...
14-09-2014
Patient Follow Up Demonstrates Continued Strong Clinical Performance at Three YearsSANTA ROSA, Calif., Sept. 12, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV) presented three-year primary safety and performance metrics from the Ovation Pivotal Trial today at the 2014 Joint An...
12-09-2014Medtronic NC Euphora(TM) Coronary Balloon Receives FDA Clearance
Superior Deliverabilityi and Uncompromising Performance Distinguishes New Angioplasty BalloonNew "Cath Lab Connect" Website Will Provide Catheter Lab Professionals with Educational Resources and Best Practice Sharing PlatformMINNEAPOLIS -- Sept. 11, 2014 -- Medtronic, Inc. (NYSE: MDT) today announce...
11-09-2014
Innovative AAA Device Offers New, Less Invasive Option for Patients and PhysiciansFREMONT, CA, Sept. 10, 2014 – Cordis Corporation announced today the launch of its INCRAFT® AAA Stent Graft System (INCRAFT® System), an ultra-low profile device for use during endovascular aneurysm repair (EVAR) f...
10-09-2014
Su avanzada tecnología le convierte en el sistema EVAR de perfil más bajo y customizable disponible hasta ahora en España, Europa y CanadáEl Aneurisma Aórtico Abdominal (AAA) es un aumento anormal de la aorta. Las causas no son bien conocidas y el paciente puede no experimentar síntomas pero p...
10-09-2014
PLANO, Texas, Sept. 9, 2014 /PRNewswire/ -- Argon Medical Devices, Inc. announced today that it has acquired Promex Technologies, LLC (d/b/a US Biopsy), a manufacturer of soft-tissue biopsy products including the TLAB® Transjugular Liver Biopsy Instrument ("TLAB"). The acquisition establishes Argo...
09-09-2014
ALISO VIEJO, California and NICE, France, Sept. 8, 2014 /PRNewswire/ -- Sequent Medical, Inc. announced today the presentation of results from WEBCAST, a prospective study of the WEB™ Aneurysm Embolization System at the European Society of Minimally Invasive Neurological Therapy (ESMINT) Congress....
08-09-2014
RAYNHAM, Mass., Sept. 5, 2014 /PRNewswire/ -- Codman Neuro*, part of DePuy Synthes Companies of Johnson & Johnson, announced regulatory approval from the China Food and Drug Administration (CFDA), South Korea's Ministry of Food and Drug Safety (MFDS), and the Taiwan Food and Drug Administration (TFD...
05-09-2014
GALWAY, Ireland--(BUSINESS WIRE)--Neuravi, a developer of innovative stroke therapy, announced today that it will introduce the Neuravi Thromboembolic Initiative (NTI) during a series of workshops on “The Science of Clot” at the upcoming European Society of Minimally Invasive Neurological Therap...
05-09-2014Codman Neuro To Be Exclusive Distributor Of Minimally Invasive, Wide-Neck Aneurysm Reconstruction Device
NICE, France, Sept. 5, 2014 /PRNewswire/ -- Codman Neuro*, part of DePuy Synthes Companies of Johnson & Johnson, today announced it has reached an exclusive distribution agreement with Pulsar Vascular to market and promote that company's PulseRider®in Europe, the Middle East and Africa. PulseRider...
05-09-2014ESC 2014: New Aortic Diseases Guidelines
The 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases offer a comprehensive discussion of the acute and chronic diseases of the thoracic and abdominal aorta in adult patients. The document fills the gap between multiple ESC Guidelines on different heart conditions and on peripher...
03-09-2014
STENTYS (FR0010949404 – STNT) (Paris:STNT), a medical technology company commercializing the world’s first and only Self-Apposing® Stent to treat acute myocardial infarction (AMI), today announced that the Self-Apposing stent has been implanted over 10,000 times in patients worldwide. This mile...
03-09-2014The ReeKross™ catheter to treat long infragenicular vessel occlusion
Reekros from Salutaria ...
02-09-2014
FAMOUS-NSTEMI es elúltimo ensayo que evalúa los beneficios de la tecnología PressureWire™ de St. Jude Medical poblaciones amplias de pacientes St. PAUL, Minn & Barcelona, España, 2 de septiembre de 2014 – St. Jude Medical, Inc. (NYSE: STJ), compañía global de dispositivos médicos, anunci...
02-09-2014
Lombard Medical Launches Device inSecond Largest Standalone Endovascular Aneurysm RepairMarket Through Exclusive Distribution Partner Medico’s Hirata Irvine,CA and London, UK – September 2, 2014 – Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on Endovascular Aneurysm ...
02-09-2014
MARLBOROUGH, Mass., Sept. 2, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) closed on its previously announced agreement to purchase the Interventional business of Bayer AG. The acquisition enhances the ability of Boston Scientific to offer physicians and healthcare systems a more co...
02-09-2014Barcelona recibe al ESC Congress 2014 con un flashmob que enseña cómo realizar la RCP
Distintos puntos de Barcelona acogen, en el marco del ESC Congress 2014, actividades formativas e informativas con el objetivo deconcienciar a la población sobre la importancia de controlar los factores de riesgo cardiovascular. Así, la Sociedad Española de Cardiología (SEC) y la European Societ...
30-08-2014Secondary analysis of AMPLIFY-EXT examining predictors of hospitalisation presented at ESC congress
PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) today announced results of a pre-specified secondary analysis of the Eliquis Phase 3 AMPLIFY-EXT trial (Apixaban after the initial Management of PuLmonary embolIsm and deep vein thrombosis...
30-08-2014CELA: Hacia Barcelona 2015
Esta Comisión Directiva de CELA lleva poco más de un año de trabajo, desde el Congreso de Cancún. Nos falta casi un año de trabajo y necesitamos todo vuestro apoyo. La Sociedad CELA se formó como todo en Latinoamerica, con una idea y la participación de un grupo de pioneros, que se convirtier...
29-08-2014AORFIX Endovascular Stent Graft - There’s One Way To Expand Your On-Label EVAR Practice More Than 25%
Aorfix endovascular stent graft from Salutaria ...
29-08-2014Covidien Acquires Venous Disease Treatment Developer Sapheon, Inc.
Transaction expands Covidien’s market leading portfolio with next generation technology for treatment of varicose veinsDUBLIN, Ireland--(BUSINESS WIRE)--Aug. 28, 2014-- Covidien plc (NYSE: COV) today announced that it has acquired Sapheon, Inc., a privately-held developer of venous disease treatme...
28-08-2014Hansen Medical Announces US Commercial Availability of Magellan(TM) Transport System
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it has received U.S. Food and Drug Administration 510(k) clearance for a modified rail for the Magellan™ Robotic System, which enables the company to begin commercial introduction of the Magellan™ Tra...
27-08-2014Primer paciente inscrito en el estudio de viabilidad LSA de la endoprótesis de ramas torácicas de GORE TAG
W. L. Gore & Associates (Gore) anunció en el día de hoy que el Dr. Himanshu Patel y el Dr. David Williams, de la Universidad de Michigan, inscribieron el primer paciente en el estudio de viabilidad LSA de la endoprótesis de ramas torácicas GORE® TAG®, un estudio multicéntrico que se lleva a c...
22-08-2014
Los días 11 a 13 de Mayo de 2014, JOTEC celebró la tercera edición del EBECAI (European Brazilian Expert Conference on Aortic Interventions), el evento tuvo lugar en el Hotel Dorint de Camp de Mar (Mallorca), con más de 100 participantes.Participaron expertos de distintos países europeos (Alema...
22-08-2014
DUBLIN,Ireland--(BUSINESS WIRE)--Aug. 22, 2014-- Covidien plc (NYSE:COV) today announced it has acquired Reverse MedicalCorporation, a privately held medical devicecompany focused on expanding the management of vascular disease. Financial terms of the transaction were not disclosed.“Covidienis foc...
22-08-2014
Frank J Criado, MD, FACS, FSVMHospital size and operative volume were significantly associated with satisfaction among general surgery patients in an analysis of 171 hospitals in the United States. Surprisingly, all other safety and effectiveness measures, with the exception of low hospital mortalit...
22-08-2014
Evaluation of sex specific data in medical device clinical studies from Salutaria ...
22-08-2014DIRECT FLOW MEDICAL®, INC. receives ce mark for 23mm valve and for implantation of all sizes of its transcatheter aortic heart valve without use of contrast.
SANTA ROSA, Calif., August 21, 2014 – Direct Flow Medical®, Inc., a transcatheter heart valve innovator focused on improving patient outcomes, today announced it has received the CE Mark (Conformité Européenne) for a 23mm sized valve as part of itsDirect Flow Medical Transcatheter Aortic Valve ...
21-08-2014
Washington, D.C. – A new action plan released by the Food and Drug Administration (FDA) to increase the participation of women, minorities, and the elderly in research trials was welcomed today by four leading health organizations as taking an important step toward closing the health care disparit...
20-08-2014
In an attempt to expand its portfolio of peripheral vascular devices, Massachusetts-based LeMaitre Vascular, Inc. (LMAT - Snapshot Report) acquired Xenotis – the manufacturer and distributor of the Omniflow II vascular graft – for $7.7 million on Aug 14, 2014. Per the terms of the transaction, L...
19-08-2014SCAI Publishes Expert Consensus Recommendations for Treatment of Renal Artery Stenosis
Fourth Paper in Series Reviews Treatments for Patients Often Excluded from Clinical TrialsRenal artery stenting to open blockages in the kidney arteries may benefit patients who have historically been excluded from modern clinical trials, according to new recommendations e-published in Catheterizati...
19-08-2014
August 19, 2014 - On July 10, 2014, Cook Medical initiated a recall of 696 of its CloverSnare™ 4-Loop Vascular Retrieval Snare devices. The device was recalled because of a potential for the loop to separate from the shaft, resulting in loss of device function, potential for embolization of snare ...
19-08-2014Study Published in JACC CI Demonstrates Directional Atherectomy Effective as Frontline Therapy for Peripheral Arterial Disease Patients
Largest directional atherectomy study with independent, core lab analysis demonstrates high limb salvage in patients with critical limb ischemia and strong patency rates in both diabetic and claudicant patientsDUBLIN, Ireland--(BUSINESS WIRE)--Aug. 18, 2014-- Directional atherectomy is safe and effe...
18-08-2014
BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Medical has enrolled the first patient in the clinical study in China of its Zilver® PTX® Drug Eluting Peripheral Stent. The case was performed by one of the study’s principal investigators, Prof. Peng Liu, M.D., at the China-Japan Friendship Hospital in ...
15-08-2014Toshiba Introduces "[SURE]Subtraction Coronary" at ESC 2014
ZOETERMEER, The Netherlands, August 12, 2014 /PRNewswire/ --Exciting new development improves the diagnosis of obstructive coronary artery disease. Visualization of the coronary lumen is improved by very advanced subtraction software. This represents a major step forward in diagnosing coronary arter...
12-08-2014
Varithena® is now available in the USWest Conshohocken, PA, August 11, 2014: BTG International Inc. announces that the first varicose vein patient has been treated with Varithena® (polidocanol injectable foam), the only FDA-approved foam for the treatment of incompetent great saphenous veins (GSV...
11-08-2014Nueva campaña publicitaria de Endovascular: Doctores, Pacientes, Noticias, App, TV, Web y Redes Sociales
...
11-08-2014
Irvine, CA and London, UK – August 5, 2014 – Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAA), today announced that its lead product, AorfixTM, an endovascular stent graft to treat AAA, has received ...
05-08-2014FDA Approves the SynCardia Total Artificial Heart With SynHall Valves
TUCSON, Ariz., Aug. 5, 2014 /PRNewswire/ -- SynCardia Systems, Inc. received approval July 2, 2014 from the United States Federal Drug Administration (FDA) for the SynCardia temporary Total Artificial Heart with SynHall™ valves, giving the company control over the last key component to manufacture...
05-08-2014New Study Data Shows That Written Emergency Stroke Care Protocols May Improve Hospital Performance
COLORADO SPRINGS, Colo., Aug. 1, 2014 /PRNewswire-USNewswire/ -- New data from Vanderbilt University Medical Center (VUMC) helps prove that written care protocols can significantly improve the overall emergency care pathway for stroke, the nation's fourth leading cause of death in the US. The findi...
01-08-2014Carta a los socios de CELA y cuestionario de diagnóstico sobre las capacidades y requerimientos vasculares en Latinoamérica
Estimado socio de CELA: Para poder cumplir con los fines y objetivos establecidos en losEstatutos fundacionales de la SOCIEDAD CELA, la Comisión Directiva se encuentraabocada a desarrollar herramientas que permitan apoyar el desarrollo de losprocedimientos intervencionistas endovasculares y la capa...
31-07-2014
Cuestionario diagnostioco sobre las capacidades y requerimientos para la capacitacion from Salutaria Estimado socio de CELA: Para poder cumplir con los fines y objetivos establecidos en los Estatutos fundacionales de la SOCIEDAD CELA, la Comisión Directiva se encuentra abocada a desarrollar h...
31-07-2014Toshiba Medical Systems UK Ltd Launches First Self-Loading Relocatable MR System in the UK
CRAWLEY, England, July 29, 2014 /PRNewswire/ --Toshiba Medical Systems is the first manufacturer to offer a hydraulic self-loading relocatable MR scanner for the UKToshiba Medical Systems Ltd today unveils its latest newly launched MRI system, the Vantage Elan™ 1.5T. Previously only available in J...
31-07-2014
Lut 035 eu 2pg av bro 4 12mm cm0184-01 rev2v3 lo res from Salutaria ...
31-07-2014
Catheters that Provide Simple Access, Greater Support and Stability for Neurovascular Procedures Featured at SNISColorado Springs, CO – July 30, 2014 – Codman Neuro*, part of DePuy Synthes Companies of Johnson & Johnson, announced the launch of the ENVOY® DA XB Distal Access Guiding Catheter an...
30-07-2014
PTA balloon catheters combine angioplasty with targeted injection system in a single device for use in below the knee procedures.WAYNE, Pa.--(BUSINESS WIRE)--Jul. 29, 2014-- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has announced t...
29-07-2014
Author(s): Frank J. Criado, MD, FACS, FSVMThe initial results from the ANCHOR (Aneurysm treatment using the Heli-FX Aortic Securement System Global Registry) postmarket registry evaluating the use of the Heli-FX EndoAnchor (Aptus Endosystems) in endovascular aneurysm repair (EVAR) were presented at ...
28-07-2014Cook Medical’s Zilver® PTX® Drug-Eluting Stent Selected as a Top Emerging Health Technology in Canada
BLOOMINGTON, Ind.--(BUSINESS WIRE)--As announced at the 2014 Canadian Agency for Drugs and Technologies in Health (CADTH) symposium, the Canadian Network for Environmental Scanning in Health (CNESH) has selected Cook Medical’s Zilver® PTX® drug-eluting peripheral stent as a top 10 game-changing ...
24-07-2014CorMatrix® Reports FDA Clearance of CorMatrix® ECM® for Vascular Repair
ROSWELL, Ga.--(BUSINESS WIRE)--CorMatrix Cardiovascular announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market the CorMatrix® ECM® for Vascular Repair.“CorMatrix ECM for Vascular Repair is an innovative scaffold permitting the patient’s own stem cells ...
22-07-2014
Vascular InterventionLAKE OSWEGO, Oregon, July 22, 2014 – BIOTRONIK, a leading manufacturer of cardiovascular medical devices, today announced the completion of patient enrollment in the superficial femoral artery (SFA) arm of its BIOFLEX-I clinical trial, an FDA-approved investigative device exem...
22-07-2014
MARLBOROUGH, Mass., July 22, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has initiated full commercial launch of the new POLARIS™ Imaging System. This system will support the Boston Scientific family of intravascular ultrasound (IVUS) catheters, including coronary, peripheral a...
22-07-2014
DUBLIN, Ireland--(BUSINESS WIRE)--Jul. 22, 2014-- Covidien plc (NYSE: COV) today announced that Bryan Hanson, who currently serves as group president, Medical Devices & U.S., will be elevated to the newly created position of group president, Covidien, effectiveOct. 1. In this role, Hanson will have ...
22-07-2014
The incidence of obesity and diabetes is increasing, and with them the number of patients with peripheral artery disease (PAD) – or blockages in the arteries of the limbs. A new series of expert consensus recommendations developed by the Society for Cardiovascular Angiography and Interventions (SC...
18-07-2014BIOTRONIK Announces New Study Evaluating Efficacy of Combined Pulsar-18 Stent and Passeo-18 Lux Balloon in Treating SFA Disease
Vascular InterventionBIOLUX 4EVER Study Aims to Build on Positive Results of BIOLUX P-I and 4EVER TrialsBUELACH, Switzerland, July 17, 2014 – BIOTRONIK, a leading manufacturer of cardio- and endovascular devices, today announced that the first patient has been enrolled in the investigator-initiate...
17-07-2014Program Agenda of SCVEPR 3rd Annual Convention
Cintillo scvepr from Salutaria ...
14-07-2014
MARLBOROUGH, Mass., July 14, 2014 /PRNewswire/ -- Demonstrating its continued leadership in the development of innovative solutions for peripheral vascular disease, Boston Scientific Corporation (NYSE: BSX) has received CE Mark for the Ranger™ Paclitaxel-Coated PTA Balloon Catheter. The technolog...
14-07-2014BIOTRONIK Announces First Enrollments to BIOFLEX PEACE Registry
Vascular InterventionStudy to Observe Pulsar-18 Stent Performance in Up to 500 Patients with Extensive Subgroup Analyses with 24 Month Follow-UpBUELACH, Switzerland, July 10, 2014 – BIOTRONIK, a leading manufacturer of cardio- and endovascular devices, has announced the start of enrollment and fir...
10-07-2014
COLORADO SPRINGS, Colo., July 9, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that its wholly-owned subsidiary, AngioScore, Inc., developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, launched its new 200 mm length AngioS...
09-07-2014Multicenter iRetrieve Study Evaluates Methods to Improve IVC Filter Retrieval Rates
MULTI-CENTER STUDY EVALUATES METHOD TO IMPROVE RETRIEVAL RATE OF INFERIOR VENA CAVA FILTERS iRetrieve study uses a novel algorithm to track patients, engage physicians and improve outcomes. BEVERLY, MA (July 9, 2014)—The Heart and Vascular Outcomes Research Institute (HVORI) is collaborating with...
09-07-2014
For abdominal aortic aneurysm (AAA), endovascular aneurysm repair (EVAR) is safer than open aneurism repair (OAR), according to a study published July 9 inJAMA Surgery . The study compared minimally invasive EVAR with the invasive OAR surgery using patient safety indicators.This is the first study t...
09-07-2014
BOSTON, MA – July 8, 2014 — InspireMD, Inc.(NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic protection systems (“EPS”), today announced that it has concluded enrollment in its CARENET clinical trial. The multi-specialty (Interventional Cardiologists, Interventiona...
08-07-2014
BOSTON-- (BUSINESS WIRE)--Covidien today announced the commercial launch of its next generation TrellisTM peripheral infusion system. The redesigned system continues to be the only pharmacomechanical thrombolysis device that enables focused treatment of blood clots that lead to Post-thrombotic Syndr...
08-07-2014A Pioneering New Surgical Tool Provides Hope for Patients with Inoperable Deep Bleeding in the Brain
ALAMEDA, Calif.--(BUSINESS WIRE)--The Apollo™ System, manufactured by California-based Penumbra, Inc., was widely launched today following first-in-man clinical use at leading US hospitals.Apollo is an innovative new surgical tool that enables minimally invasive removal of deeply seated tissue and...
07-07-2014Cordis Corporation Launches SABER™ PTA Dilatation Catheter to Complement Portfolio of Peripheral Arterial Disease Treatments
FREMONT, Calif.--(BUSINESS WIRE)--Cordis Corporation announced today the launch of its SABER™ PTA Dilatation Catheter (“SABER™ Catheter”) for the treatment of patients with Peripheral Arterial Disease (PAD). The SABER™ Catheter is cleared for use and now available in Europe, the United Sta...
01-07-2014
COLORADO SPRINGS, Colo., June 30, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that it has completed the acquisition of AngioScore Inc., a leading developer, manufacturer and marketer of cardiovascular, specialty balloons, for $230 million in cash, along with ...
01-07-2014First European Experience with Innovative Guidewire at St George’s Hospital London, UK
London, United Kingdom (July 1st, 2014) – The first cases using the ProTrack Pigtail Wire (Baylis Medical) in Europe were performed last month at St George’s Hospital in London. The ProTrack Pigtail Wire is used during the transseptal procedure, a challenging minimally invasive technique used to...
01-07-2014IZASA HOSPITAL - Bolton realiza su implante número 1000 en España
Anuncio1000 from Salutaria ...
30-06-2014Nueva campaña IN.PACT Drug Eluting Balloons de Medtronic
Cvg grafica inpact_21x28cm from Salutaria ...
27-06-2014El Hospital Reina Sofía organiza un curso internacional sobre avances en válvulas cardiacas percutáneas
El encuentro, permitirá revisar las ventajas de cada modelo valvular y contará con la presencia de prestigiosos cardiólogos europeosMás de un centenar de especialistas asisten al curso internacional que estos días organiza el Hospital Universitario Reina Sofía de Córdoba para revisar la exper...
26-06-2014
Ridgefield,CT, June 26, 2014 –Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Foodand Drug Administration (FDA) has granted Breakthrough Therapy Designation toidarucizumab*, an investigational fully humanized antibody fragment, or Fab,being studied as a specific antidote f...
26-06-2013Covidien Announces European Launch of Pipeline™ Flex Embolization Device
Minimally-invasive flow diversion device for unruptured brain aneurysms designed for more accurate, controlled placement1DUBLIN, Ireland--(BUSINESS WIRE)--Jun. 24, 2014-- Further strengthening its broad line of neurovascular products to treat unruptured brain aneurysms, Covidien plc (NYSE:COV) annou...
24-06-2014New Philips NeuroSuite reveals the brain’s vascular network like never before
NeuroSuite interventional X-ray system enhances minimally invasive neurological treatmentSolution supports more effective device guidance and placement in live image-guided neuroradiology procedures, extending treatment optionsFirst installation at Karolinska University Hospital Sweden Amsterdam, th...
23-06-2014
− Precisely sized, bioresorbable gelatin beads intended for embolization of hypervascular tumors − Designed for use by interventional radiologists who currently use microspheres, PVA particles, and gelatin foam slurries − Offers physicians a new treatment option when a permanent embolic agent ...
19-06-2014
ALBANY, N.Y., June 18, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the U.S. Food and Drug Administration (FDA) has granted 510(k) cle...
18-06-2014LEADERS Free Japan Trial Enrolls First Patient
17 June 2014 – Biosensors International has announced enrollment of the first patient in LEADERS Free Japan, a ground-breaking trial involving BioFreedom™, the company's novel polymer and carrier-free drug-coated stent (DCS). LEADERS Free is the world's first prospective, randomised double-blind...
17-06-2014FDA Issues Draft Guidances for Industry on Social Media and Internet Communications About Medical Products: Designed with Patients in Mind
By: Thomas AbramsOngoing changes in technology transform medical products – and the ways that both patients and health care providers learn about those products. In today’s world, in addition to traditional sources of medical product information, patients and health care providers regularly get ...
17-06-2014
IRVINE, Calif., June 16, 2014 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that it has received United States Food and Drug Administration (FDA) approval for its Edwards SAPIEN XT transcathet...
16-06-2014Medtronic to Acquire Covidien for $42.9 billion in Cash and Stock
Creates a Medical Technology and Services Company witha Comprehensive Product Portfolio and Broad Global Reach that is Better Able toImprove Healthcare OutcomesMeaningfully Accelerates Medtronic's Core Strategiesof Therapy Innovation, Globalization and Economic ValueCombined Revenue of $27 Billion, ...
13-06-2014
Vascular InterventionJournal of Endovascular Therapy Highlights Efficacy of Pulsar-18 Self-Expanding Stent In Treating Challenging Femoropopliteal LesionsBUELACH, Switzerland,—BIOTRONIK, a leading manufacturer of cardio- and endovascular devices, announced the publication of clinical results from ...
13-06-2014Circulatory System Devices Advisory Panel Provides a Unanimous Favorable Recommendation to FDA for the Lutonix® Drug Coated Balloon
Lutonix® DCB one step closer to becoming the first FDA-approved drug coated balloon for the treatment of patients with femoropopliteal occlusive diseaseMURRAY HILL, N.J.--(BUSINESS WIRE)--Jun. 12, 2014-- C. R. Bard, Inc. (NYSE:BCR) today announced that the U.S. Food and Drug Administration’s (FDA...
12-06-2014Medtronic CoreValve® System Receives FDA Approval for Patients at High Risk for Surgery
Accelerated Approval Obtained after Clinical Outcomes with Self-Expanding Valve Prove Superior to Surgical Aortic Valve Replacement at One YearCoreValve System Now Available to More U.S. Patients than any Other Transcatheter Aortic ValveMINNEAPOLIS - June 12, 2014 - Medtronic, Inc. (NYSE: MDT) today...
12-06-2014Covidien Neurovascular Micro Catheter Receives FDA Approval
Apollo™ Onyx™ Delivery Micro Catheter with Detachable Tip Enhances Onyx™ Liquid Embolic System (LES) DeliveryDUBLIN, Ireland--(BUSINESS WIRE)--Jun. 10, 2014-- Covidien plc (NYSE: COV) today announced U.S. Food and Drug Administration (FDA) approval of its Apollo™ Onyx™ delivery micro cathe...
11-06-2014
ACCESS PTS study aims to evaluate the safety and efficacy of Ultrasound Accelerated Thrombolysis with standard thrombolytic infusion for treatment of Post-Thrombotic SyndromeBothell, WA, USA, 11 June 2014: EKOS Corporation, a BTGInternational group company (BTG plc; LSE: BTG), today announces the st...
11-06-2014
Global Leader Projects Introduction of IN.PACT Admiral Drug-coated Balloon to U.S. Market in Early FY16MINNEAPOLIS - Date - Moving toward U.S. market introduction of its novel medical device to treat peripheral artery disease, Medtronic, Inc. (NYSE: MDT) today announced that it recently submitted th...
11-06-2014Pulsar Vascular Receives FDA IDE Approval for the PulseRider® Aneurysm Neck Reconstruction Device for the Treatment of Intracranial Bifurcation Aneurysms
SAN JOSE, Calif., June 10, 2014 /PRNewswire/ -- Pulsar Vascular, the innovator and developer of the PulseRider®, a minimally invasive, aneurysm neck reconstruction device, announced today the United States Food and Drug Administration (FDA)'s approval of an Investigational Device Exemption (IDE) fo...
10-06-2014Presentado el primer documento consenso sobre la trombosis venosa en atención primaria
MEDIO MILLÓN DEEUROPEOS MUEREN AL AÑO POR LA ENFERMEDAD TROMBOEMBÓLICA VENOSA· El Capítulo Español de Flebología y Linfología de la SEACV y la Sociedad Españolade Médicos de Atención Primaria (SEMERGEN) han elaborado un Documento deConsenso sobre la Enfermedad Tromboembólica Venosa en At...
09-06-2014Editan la Primera Guía Clínica de España para prevenir y tratar los trombos en pacientes con daño cerebral adquirido y lesión medular
Referencia aseguir en las unidades asistenciales de España· La enfermedad tromboembólica venosa, que abarca tanto a la trombosis venosa profunda como el tromboembolismo pulmonar, es la tercera causa de muerte cardiovascular tras la cardiopatía isquémica y el infarto· Estas patologías venosas ...
06-06-2014
· Pradaxa® is a simple treatment option that is as effective as warfarin with significantly lower bleeding rates, a major advance for DVT and PE patients 1–4EU approval follows recent U.S. FDA approval of Pradaxa® in DVT and PE and increases access to a treatment with proven protective benefits...
06-06-2014
Bloomington,Ind. — CookMedical launched its Zilver® PTX® Drug-Eluting Peripheral Stent in Canada atthe Canadian Interventional Radiology Association (CIRA) meeting in Montreal, Canada. It’s the first drug-coated stent in Canada indicated to treatperipheral arterial disease (PAD) in the superfi...
05-06-2014El Capítulo Español de Flebología y Linfología de la SEACV edita el primer libro blanco sobre la patología venosa y linfática en el ámbito de habla hispana
Expuesto en el 22.º Congreso Nacional de Flebología y Linfología, y en el 60.º Congreso de la Sociedad Española de Angiología y Cirugía Vascular· Se trata de una obra en laque han colaborado 72 autores de cirugía vascular y otras especialidades y disciplinas (médicos rehabilitadores, radi...
05-06-2014
MINNEAPOLIS -- Jun. 4, 2014 -- Continuing to expand its market-leading portfolio ofendovascular solutions, Medtronic, Inc. (NYSE: MDT) announced today that tworecently Food and Drug Administration (FDA) approved devices will be featuredat the Society for Vascular Surgery's 2014 Vascular Annual Meeti...
04-06-2014Cardiovascular Systems Announces Coronary Data at Late-Breaker SCAI 2014 Scientific Sessions
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), presented one-year data and a new economic analysis from its ORBIT II coronary study in a late-breaker session at the Society for Cardiovascular Angiography and Interventions (SCAI) 2014 conference, which took place...
04-06-2014
Bloomington, Ind., — Cook Medical is engaged in twoclinical studies that will provide additional data on the safety and effectivenessof inferior vena cava (IVC) filters.The first study, theCook Inferior Vena Cava Filter (CIVC) study, will add to Cook’s existingclinical data on its commercially a...
02-06-2014FDA approves first implantable wireless device with remote monitoring to measure pulmonary artery pressure in certain heart failure patients
The U.S. Food and Drug Administration today approved the CardioMEMS HF System that measures the pulmonary artery (PA) pressures and heart rates of patients with New York Heart Association (NYHA) Class III heart failure who have been hospitalized for heart failure in the previous year. The device all...
02-06-2014
ST. PAUL, Minn.--(BUSINESS WIRE)-- St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced it has completed its acquisition of privately held CardioMEMS, Inc., developer of the CardioMEMS™ HF System. The acquisition was completed on May 30, 2014.The CardioMEMS HF System...
02-06-201451 Congreso Internacional de la Sociedad Europea de Flebectomía
Flebectomia triptic 2014 - Español Flebectomia triptic 2014 - Español from Salutaria Flebectomia triptic 2014 - Français Flebectomia triptic 2014 - Français from Salutaria Flebectomia triptic 2014 - English Flebectomia triptic 2014 - English from Salutaria ...
30-05-2014Japanese Postmarket Surveillance Data for Zilver PTX Presented at EuroPCR 2014
BLOOMINGTON, Ind.--(BUSINESS WIRE)--One-year follow-updata from 907 Japanese patients who received the Zilver® PTX® drug-eluting stent showed positive results inkeeping open the superficial femoral artery (SFA). The postmarket surveillance(PMS) study, designed to evaluate the stent’s performance...
29-05-2014
The U.S. Food and Drug Administration today approved the CardioMEMS HF System that measures the pulmonary artery (PA) pressures and heart rates of patients with New York Heart Association (NYHA) Class III heart failure who have been hospitalized for heart failure in the previous year. The device all...
28-05-2013
The Spectranetics Corporation (Nasdaq: SPNC) today announced that it has entered into a definitive merger agreement under which Spectranetics will acquire AngioScore Inc., a leading developer, manufacturer and marketer of cardiovascular, specialty balloons for $230 million in up-front consideration,...
27-05-2014El Dr. Vicente Riambau invitado por la JSVS (Japanese Society for Vascular Surgery)
El Dr. V. Riambau ha sido invitado por la JSVS (Japanese Society for Vascular Surgery) para impartir Seminarios en el Hospital de la Universidad de Tokio y en la sede del 42 Congreso anual de la mencionada sociedad científica, celebrado en Aomori los pasados días 22 y 23 de Mayo....
26-05-2014Influencia de la patología vascular en la demencia avanzada
Hacer click para ver noticiaFuente original: CienBlog Fundación Centro Investigación Enfermedades Neurológicas...
26-05-2014EkoSonic® Endovascular System Receives FDA Clearance for the Treatment of Pulmonary Embolism in the USA
BOTHELL, Wash.--(BUSINESS WIRE)-- 23 May 2014: EKOS Corporation, a BTG International group company (BTG plc (LSE: BTG)), today announced that the U.S. Food and Drug Administration (FDA) has cleared the EkoSonic® Endovascular System for the ultrasound facilitated, controlled and selective infusion o...
23-05-2014
ILLUMENATE First-in-Human Clinical Trial Supports the Stellarex™ Balloon with EnduraCoat™ Technology in Treating Peripheral Arterial DiseasePARIS--(BUSINESS WIRE)--May 22, 2014-- Covidien’s Stellarex™ drug-coated angioplasty balloon (Stellarex DCB) continues to be shown as safe and effective...
22-05-2014Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective
Results from the EnligHTN I, II and III trials presented during EuroPCR add to the growing body of clinical evidence supporting the benefits of EnligHTN renal denervation technologiesST. PAUL, Minn. & PARIS--(BUSINESS WIRE)-- St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today ...
22-05-2014El Instituto Cardiovascular del General incrementa su actividad un 23% en 2013
- Este Instituto está entre los tres primeros hospitales de España en número de cirugías cardiacas realizadas en 2013- Es centro de referencia nacional en cirugía reparadora compleja de válvula mitral, cardiopatías familiares y cirugía del remodelado ventricular(21/05/2014) El conseller de S...
21-05-2014
MINNEAPOLIS -- Medtronic has agreed to pay more than $1 billion to settle long-standing patent litigation with fellow medical device maker Edwards Lifesciences over replacement heart valves.The Minneapolis company also said Tuesday a heavy charge from that settlement helped drop its fiscal fourth-qu...
20-05-2014Preliminary program of VIP: Vascular International Padova Congress
Dearest Colleagues,two years after the first VIP Congress, in which the preferred guests were Latin American surgeons, North American surgeons will be at the center of the scientific scene in the 2014 edition. Asia will then play a special role during the 2016 congress.The program will focus on the ...
16-05-2014
May 15, 2014NATICK, Mass., May 15, 2014 /PRNewswire/ -- In a move to expand significantly its portfolio of leading solutions for peripheral interventions, Boston Scientific Corporation (NYSE: BSX) has entered into a definitive agreement to acquire the Interventional Division of Bayer AG for $415 mil...
15-05-2014Philips expands interventional oncology portfolio with EmboGuide to see, reach and treat tumor lesions
New live 3D image guidance tool enhances tumor embolization procedures on Philips’ interventional X-ray systems.Philips innovations detect more than twice as many tumor feeding arteries compared to standard DSA, while lesion detection is superior to standard DSA and now comparable to gold standard...
15-05-2014
SANTA ROSA, Calif., May 14, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV) today reported financial results for the three months ended March 31, 2014.Recent Accomplishments:Revenue of $7.0 million, up 139% over the first quarter of the prior yearGross margin of 47.9%, an incre...
14-05-2014
AorfixTM Sales Double Compared to Prior Year; US Launch on Track as Sales and New Physician Adoption RampIrvine, CA and London, UK - May 13, 2014 – Lombard Medical, Inc (Nasdaq: EVAR), a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal aortic aneurysms (AAA), today ...
13-05-2014Último número de la versión on line de la Revista Técnicas Endovasculares (Enero-Abril 2014)
Ya está disponible en www.endovascular.es el último número de la versión on line de la Revista Técnicas Endovasculares.Volumen XVII: Número 1 (Enero - Abril 2014)...
13-05-2014Congreso SITE+CELA Junio 2015
SITE CELA 2015 from Salutaria ...
08-05-2014LOGIMED: Be Graft Peripherial Stent Graft System
Bgraft Peripherial from Salutaria Specifications be graft peripheral from Salutaria ...
08-05-2014Veryan to Present Two-Year Results from Mimics Randomised Controlled Study of BioMimics 3D® Stent at New Cardiovascular Horizons Conference
HORSHAM, UK and GALWAY, Ireland, 8th May 2014 – Veryan Medical, a company developing highly innovative biomimetic stents with improved hemodynamics and vascular compatibility, today announced that the two-year results of the Mimics randomized controlled study with the BioMimics 3D Stent System wil...
08-05-2014BIOTRONIK Portfolio Expanded with Fortress Introducer Sheath for Peripheral Interventions
Vascular Intervention: BIOTRONIK Portfolio Expanded with Fortress Introducer Sheath for Peripheral Interventions(PresseBox) (Buelach, Switzerland, 06.05.2014) BIOTRONIK, a leading manufacturer of Vascular Intervention devices, has expanded its line of reinforced introducer sheaths. Following up on t...
06-05-2014
This safety communication updates FDA’s 2010 Initial Communication. The update provides information on recently published research and postmarket studies for these devices. There are no new safety concerns related to this update.Date Updated: May 6, 2014Date of Initial Communication: August 9, 201...
06-05-2014QT Vascular initiates Chocolate Cases in Singapore
SINGAPORE, May 6, 2014 /PRNewswire/ -- QT Vascular Ltd. (QT Vascular) is pleased to announce that it has started clinical cases with the Chocolate® PTA balloon catheter (Chocolate® PTA) in Singapore. Five cases were performed at National University Hospital (NUH) and Changi General Hospital (CGH)....
06-05-2014CLEANERXT™ Rotational Thrombectomy System Launched in the US
PLANO, Texas, May 6, 2014 /PRNewswire/ -- Argon Medical Devices, Inc. announced today that the company has begun marketing the CLEANERXT™ Rotational Thrombectomy System as a new addition to the CLEANER family of dialysis products. With increased power and torque for cleaning wall-adherent thrombus...
06-05-2014Siemens Announces FDA Clearance of Artis one Angiography System
Siemens Announces FDA Clearance of Artis one Angiography System· Highly flexible system covers most angiographic procedures and provides improved patient access· HeartSweep enables cardiac imaging from multiple projections in one sweepSiemens Healthcare has announced that the U.S. Food and Drug Ad...
05-05-2014Pie diabético no es, ni debe ser sinónimo de amputación
Por Dr. Mario Alejandro FabianiEspecialista en Cirugía CardiovascularSuele escucharse con relativa frecuencia el relato de familiares de pacientes amputados que dicen: 'si, a papá le amputaron una pierna porque él es diabético' y en esa frase se justifica uno de los hechos más aberrantes de la ...
02-05-2014¿Usted se asusta? Al escuchar stroke, aneurisma, by pass y varices
En conversaciones de amigos y familiares frecuentemente escuchamos términos como stroke, aneurisma, by pass, úlcera y várices, y la primera reacción suele ser cerrar los oídos, de la misma manera en que cerramos los ojos al ver una película con una escena violenta. Pero los oídos no tienen p...
02-05-2014
TheUS Food and Drug Administration (FDA) has approved Pradaxa (dabigatranetexilate mesylate) for the treatment of deep venous thrombosis (DVT) andpulmonary embolism (PE) in patients who have already been treated with aparenteral anticoagulant for 5 to 10 days, and to reduce the risk of recurrentthro...
02-05-2014CURRICULUM VITAE del Dr. Juan Miguel Macho Fernández
CURRICULUM VITAEDATOS PERSONALESApellidos y Nombre: Macho Fernández, Juan Miguel Centro de trabajo actual: Hospital Clinic i Provincial de Barcelona. NeuroradiologíaIntervencionistaUnidadFuncional de Patología Vascular Cerebral Categoría actual: ...
30-04-2014Programa final del SITEupdate de Barcelona
El SITEupdate 2014 se celebrará en Barcelona el 9 de Mayo en la Aula Magna, Facultad de Medicina de la Universidad de Barcelona. WEB OFICIAL: www.sitesymposium.orgA continuación se muestra el programa final: Site update final programme from Salutaria ...
29-04-2014
SANTA ROSA, Calif., April 29, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV), announced today FDA-approved changes to the indication statement for the Ovation and Ovation Prime Abdominal Stent Graft Systems (Ovation system). The expanded indication for use statement eliminates...
29-04-2014
W. L. Gore & Associates (Gore) joined with leaders across the vascular and endovascular community in honoring four European physicians as Pioneers in Performance. The biennial award acknowledges exceptional work in the field of vascular and endovascular therapy, including aortic and lower-limb bypas...
24-04-2014
Irvine, CA April 24, 2014 – Lombard Medical, Inc. announced today the pricing of the initial public offering of 5,000,000 ordinary shares at a price to the public of $11 per share. The shares will be listed on the NASDAQ Global Market under the ticker symbol “EVAR” on April 25, 2014. In additi...
24-04-2014
SANTA ROSA, Calif., April 22, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV), manufacturer of the Ovation Prime™ Abdominal Stent Graft System, today announced the closing of its initial public offering of 7,475,000 shares of its common stock at a public offering price of $12...
22-04-2014
Today, the U.S. Food and Drug Administration proposed a new program to provide earlier access to high-risk medical devices that are intended to treat or diagnose patients with serious conditions whose medical needs are unmet by current technology.The proposed Expedited Access Premarket Approval Appl...
22-04-2014
New Clinical Data from PANDORA and ENGAGE Affirm Market-Leading Medical Device's Durable, Consistent and Proven Outcomes In Endovascular Treatment of Abdominal Aortic AneurysmsMINNEAPOLIS -- April 18, 2014 -- The Endurant AAA stent graft system from Medtronic, Inc. (NYSE: MDT) continues to demonstra...
18-04-2014Reverse Medical® Corporation Announces FDA IDE Approval for the BARREL® Vascular Reconstruction Device for the Treatment of Intracranial Bifurcation Aneurysms
IRVINE, Calif.--(BUSINESS WIRE)--Reverse Medical® Corporation today announced FDA IDE approval for clinical investigation of their BARREL® Vascular Reconstruction Device (VRD). The BARREL® Vascular Reconstruction Device is designed for use with occlusive devices in the treatment of intracranial b...
15-04-2014
The IPO for TriVascular Technologies, Inc. (Nasdaq: TRIV) opened for trading at $11.35 after pricing 6,500,000 shares of its common stock at a public offering price of $12.00 per share, below the expected $12-$15 range. Shares have since recovered some of the losses; last trading at $11.80, down 1.7...
15-04-2014Ablative Solutions Receives FDA Clearance for the Peregrine System™ Infusion Catheter
KALAMAZOO, Mich., April 2, 2014 /PRNewswire/ -- Ablative Solutions, Inc., a privately-held clinical stage company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Peregrine System™ Infusion Catheter. The Peregrine System uses a unique,...
14-04-2014
DUBLIN, Ireland--(BUSINESS WIRE)--Apr. 11, 2014-- Covidien plc today announced that it has notified customers of a voluntary recall to address an issue with certain lots of its Pipeline™ Embolization Device and Alligator™ Retrieval Device where the polytetrafluoroethylene (PTFE) coating applied ...
11-04-2014FDA approves Pradaxa® for treatment and reduction in risk of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE)
· New indications for Pradaxa® offer U.S. DVT and PE patients a simple treatment option that is as effective as warfarin with significantly less bleedings1,2,3· Almost one in three DVT or PE patients die within three months; DVT-related PE is the leading cause of preventable death in hospital4,5...
08-04-2014El Dr. Juan Miguel Macho Fernández está liderando la sección de endovascular.es de Neuroradiología
El Dr. Juan Miguel Macho Fernández, jefe de la sección de Angioradiolagía del Hospital Clínic de Barcelona, está liderando la sección de endovascular.es de Neuroradiología con nuevos contenidos en la sección de pacientes....
07-04-2014
Interventional Treatment of Lower-Extremity Peripheral Arterial DiseaseWith Novel Medical Device Shows Positive Results in IN.PACT SFA TrialLONDON -- April 5, 2014 --Patients with peripheral artery disease in the upper leg experienced significantly better outcomes at 12 months after treatment with t...
05-04-2014
Presenting at the annual meeting of the European Society for Vascular Surgery (ESVS) last November, Federico Bastos Gonçalves (Utrecht University Medical Center, Utrecht, The Netherlands) recognized that additional therapy is advised if a type IA endoleak is detected on completion angiography durin...
03-04-2014Cardinal Health to Acquire AccessClosure
Company to Acquire AccessClosure, a Leading U.S. Manufacturer of Extravascular Closure Devices- Expands Cardinal Health portfolio of preferred products that meet increasing demand for high quality, cost-efficient solutions- Provides entrance to U.S. interventional cardiology area- Further aligns Car...
02-04-2014Aptus Endosystems Appoints Dr. Bart E. Muhs as Chief Medical Officer
SUNNYVALE, Calif.--(BUSINESS WIRE)--Aptus Endosystems, Inc., a medicaldevice company pioneering solutions to enhance aneurysm repair, today announcedthat it has appointed Bart Edward Muhs, M.D., Ph.D. to the position of ChiefMedical Officer. Dr. Muhs has more than 15 years of experience in the medic...
01-04-2014El Hospital Reina Sofía recibe la visita de un experto mundial nipón en el tratamiento de oclusiones crónicas coronarias
El doctor Tsuchikane, junto a los cardiólogos intervencionistas del complejo hospitalario, ha realizado dos casos clínicos de extrema complejidadEl Hospital Universitario Reina Sofía de Córdoba ha recibido la visita del cardiólogo nipón Etsuo Tsuchikane, uno de los principales expertos mundial...
01-04-2014Consigue ser madre tras implantarle una prótesis aórtica durante el embarazo
La intervención se ha llevado a cabo en el Hospital Vall d'Hebron y es la primera vez que se practica a una mujer embarazada.Barcelona. (Efe).- Una joven de 28 años con una cardiopatía congénita grave ha conseguido ser madre gracias a una intervención pionera en la que le han implantado, a las ...
31-03-2014
MINNEAPOLIS and WASHINGTON, D.C. - March 30, 2014 - Medtronic, Inc. (NYSE: MDT), announced today further analysis of six-month follow-up data from the first 1,000 patients enrolled in the Global SYMPLICITY Registry, which continue to demonstrate the safety of the Symplicity(TM) renal denervation sys...
30-03-2014
Bothell, WA, US, 30 March 2014: EKOS Corporation, a BTG International group company (BTG plc (LSE: BTG)),notes the presentation of the results of the SEATTLE II trial this afternoon at ACC.14, the 63rd Annual Scientific Session and Exposition of the American College of Cardiology in Washington, DC i...
30-03-2014ACIST Launches The RXi™ Rapid Exchange FFR System
Allows quick and easy assessment of FFR values with Ultra-Thin Navvus™ MicroCatheter that can be used over standard 0.014 inch guidewiresEDEN PRAIRIE, Minn., March 29, 2014 /CNW/ - ACIST Medical Systems, Inc., a Bracco Group company, pioneer and global market leader of advanced contrast delivery s...
29-03-2014AccessClosure Launches the Next-Generation Mynx Ace™ Vascular Closure Device at Annual ACC Meeting
Santa Clara, California – March 29, 2014 – AccessClosure Inc., the market leader in extravascular care technology, has commercially launched its Mynx Ace Vascular Closure Device, a safe and secure vascular closure product that provides consistent results with a new, easy-to-use deployment system...
29-03-2014New Health Policy Statement Defines Clinical Standards For Cardiac Cath Lab Structured Reporting
The ACC, American Heart Association and Society for Cardiovascular Angiography and Interventions, in collaboration with 14 other professional societies, have released a health policy statement that defines the clinical standards for structured reporting in the cardiac catheterization suite.The goal...
28-03-2014Abbott Announces FDA Approval of Its Supera® Stent to Treat People with Peripheral Artery Disease
March 28, 2014Abbott Park, Illinois (NYSE: ABT) — Abbott today announced that its Supera® Peripheral Stent System has received U.S. Food and Drug Administration (FDA) approval to treat people with blocked blood vessels in the upper leg caused by peripheral artery disease (PAD). PAD occurs when fa...
28-03-2014
COLORADO SPRINGS, Colo., March 27, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced early success of the EXCITE ISR clinical trial, achieving highly significant statistical superiority in both safety and efficacy. Notably, this superior outcome was achieved withou...
27-03-2014
ATLANTA, March 27, 2014 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that it has acquired the exclusive worldwide distribution rights for the ProCol Vascular Bioprosthesis ("ProCol") from H...
27-03-2014
March 26, 2014—San Diego, CA—Surefire Medical, Inc. today announced that the Coiling vs. Surefire Infusion System in Y90 (COSY) clinical trial, presented today at the Society for Interventional Radiology meeting in San Diego (SIR), showed significant reductions in fluoroscopy time, procedure tim...
26-03-2014Apertura del congreso Ventana a las Américas 2014
Juan Guillermo Barrera Carvajal MD, FACS, FSVSCo-Presidente “Ventana alas Américas 2014”Vicepresidente de ASOVASCULARPresidente Summit CELA 2014 Cartagena de Indias, DT ColombiaPatrimonio Histórico y Cultural de la Humanidad ( UNESCO 1984 )Patrimonio Tangible e Inmaterial 25 al 28 de Marzo de ...
25-03-2014TriReme Begins Enrollment In Study Of Drug Coated Chocolate Balloon
TriReme Medical LLC announced that is has begun enrollment of patients in the clinical study of its one of a kind drug coated Chocolate PTA balloon for treatment of patients with peripheral arterial disease (PAD). TriReme Medical LLC is a subsidiary of Singapore based QT Vascular Ltd.The drug-coated...
25-03-2014Y-90 Provides New, Safe Treatment for Metastatic Breast Cancer
SAN DIEGO, March 24, 2014 /PRNewswire-USNewswire/ -- A minimally invasive treatment that delivers cancer-killing radiation directly to tumors shows promise in treating breast cancer that has spread to the liver when no other treatment options remain, according to research being presented at the Soci...
24-03-2014Come and join us for the SITE@CICE session during the CICE 2014 Congress in São Paulo, Brazil
See the Preliminary Programme here: Site+cice2014 from Salutaria ...
20-03-2014Volcano Announces FDA Clearance of its Proprietary iFR® (instant wave-Free Ratio™) Modality and Immediate Commencement of U.S. Limited Market Release
SAN DIEGO, March 19, 2014 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC) a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced FDA clearance of its proprietary instant wa...
19-03-2014InspireMD Announces First Patient Enrolled Into New CGuard(TM) CARENET (CARotid Embolic protection study using microNET) Clinical Trial
BOSTON, March 19, 2014 /PRNewswire/ -- InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection systems, today announced that it has successfully enrolled the first patient into the CARENET (CARotidEmbolic protection study using microNET) multi-center European ...
19-03-2014
MURRAYHILL, NJ -- (March 18, 2014) -- C. R. Bard, Inc. (NYSE: BCR) today announcedthe enrollment of the first patient into the Lutonix® In-Stent Restenosis (ISR)Clinical Trial. Dr. Carlos Mena, Medical Director, Vascular Medicine atYale – New Haven Hospital, is the principal investigator of the ...
18-03-2014BioCardia® Receives CE Mark for Morph AccessPro™ Steerable Introducer
SAN CARLOS, Calif.--(BUSINESS WIRE) -- BioCardia®, Inc., a leader in cardiovascular regenerative medicine, today announced receipt of the CE Mark for its Morph AccessPro™ Steerable Introducer, designed for easier navigation through the vasculature during delivery of biotherapeutics and medical de...
17-03-2014Desarrollan un nuevo sistema de ayuda al diagnóstico de riesgo cardiovascular
Investigadores de la Universitat Politècnica de València, el Hospital General de Valencia y la Unidad de Oftalmología Médica de la Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Oftalmología Médica) han desarrollado un nuevo software ...
15-03-2014Survival after ruptured abdominal aortic aneurysm significantly lower in England than the USA
The care given to patients after ruptured abdominal aortic aneurysm (rAAA) in the US outstrips that in English NHS hospitals, according to a major new study published as part of a special issue of The Lancet ahead of the American College of Cardiology's 63rd Annual Scientific Session. It shows that ...
14-03-2014Chimney and Periscope Grafts to Facilitate Endovascular Treatment of Aortic Transection in a Patient With Aberrant Right Subclavian Artery
Sandra Vicente, MD1,2; Michael Glenck, MD3; Dieter Mayer, MD1; Frank J. Veith, MD4;Mario Lachat, MD1; and Felice Pecoraro, MD51Clinic for Cardiovascular Surgery and 3Interventional Radiology, University Hospital Zurich, Switzerland. 2Department of Vascular Surgery, Virgen de la Salud Hospital, Toled...
12-03-2014Charing Cross 2014: Full three-day programme dedicated to peripheral arterial disease management
The Charing Cross Symposium (5—8 April 2014, Grand Hall Olympia, London, UK) will feature three full days of peripheral arterial disease management topics this year. The programme dedicated to lower limb intervention will start with the peripheral arterial day in the Main Programme on Saturday and...
12-03-2014National Campaign Launched To Help Increase Diversity In Clinical Trials
WASHINGTON, March 12, 2014 /PRNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) and the National Minority Quality Forum today announced a first-of-its-kind national campaign to help increase diversity in clinical trials.The I'm In campaign will raise awareness about the i...
12-03-2014
Vascutek is pleased to announce the return to market of the AnacondaTM Bifurcate Body Stent Graft System. The system was voluntarily recalled in October 2013 following the identification of a potential issue with the release wire in the delivery system.Vascutek has worked closely with its UK Compete...
11-03-2014
SAN ANTONIO – March 11, 2014 – CeloNova BioSciences, Inc., today announced U.S. Food and Drug Administration (FDA) 510(k) clearance expanding the indication for their leading Embozene® microsphere product to include the treatment of uterine fibroids.This approval will give women suffering from ...
11-03-2014
ALBANY, N.Y., March 11, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the U.S. Food and Drug Administration (FDA) cleared an expanded i...
11-03-2014
London, UK and Irvine, CA, 11 March, 2014 – Lombard Medical Technologies PLC (AIM: LMT), the specialist medical device company focused on Endovascular Aortic Repair (“EVAR”) of abdominal aortic aneurysms (“AAAs”), announced today that Lombard Medical, Inc. has filed a registration statemen...
11-03-2014
ST. PAUL, Minn.--(BUSINESS WIRE)--Mar. 10, 2014-- Cardiovascular Systems, Inc.(NASDAQ: CSII) (CSI), announced today it has received FDA clearance of its new Diamondback 360® 60cm Peripheral Orbital Atherectomy Systems (OAS) for the treatment of peripheral arterial disease (PAD).“Receiving FDA cle...
10-03-2014
TriVascular Technologies, Inc. (TriVascular), manufacturer of the Ovation Prime® Abdominal Stent Graft System, today announced that is has filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to a proposed initial public offering of shares of its common st...
10-03-2014
ALBANY, N.Y., March 7, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the U.S. Food and Drug Administration granted 510(k) clearance for...
07-03-2014Biotronik's Passeo-18 Lux drug releasing balloon shows positive six-month study results
Biotronik announced on Thursday positive six-month data from the BIOLUX P-II study of the performance of the Passeo-18 Lux Drug Releasing Balloon (DRB) in the treatment of vascular occlusions of the lower extremities compared to uncoated percutaneous transluminal angioplasty (PTA) catheters. 'The re...
06-03-2014
El Dr Frank Criado está liderando la traducción de endovascular.es al inglésPróximamente los contenidos se iran publicando en el canal pacientes de endovascular.tv ...
05-03-2014Blockade MedicalTM Announces 510(k) Clearance and CE Mark of Two New Additions to the BarricadeTM Coil System
IRVINE, Calif. Blockade Medical L.L.C., a privately held company focused on the development of catheter based therapeutic devices for the treatment of cerebral aneurysms, announced today two additions to the BarricadeTM Coil System including an Enhanced Framing Coil and a new Complex Finishing Coil....
04-03-2014
Bloomington, Ind.— The first ten patients have been enrolled in Cook Medical’s VIVO clinical research study. The study is designed to evaluate the safety and effectiveness of treating symptomatic iliofemoral venous outflow obstruction with the Zilver® Vena™ Venous Self-Expanding Stent. The tr...
03-03-2014Cardiólogos del Hospital Reina Sofía revisan su experiencia en cierres percutáneos de defectos cardiovasculares
Foto: Cardiólogos del Hospital Reina Sofía, junto al especialista invitado -tercero por la izquierda- Juan Alcibar.Noticia:El complejo sanitario cordobés es pionero en la corrección de estos defectos por cateterismo, tanto en adultos como en niños, en sustitución de la cirugía.El Servicio de ...
25-02-2014BARD: nuevo partner del portal web endovascular.es
Nuestro portal endovascular.es se complace en dar la bienvenida a la compañía BARD como Patrocinador Oro.Mediante nuestro portal web endovascular.es, la compañía divulgará toda comunicación dirigida tanto a la comunidad médica como a los pacientes y sus familias, en materia endovascular.La de...
24-02-2014
FREMONT, Calif.--(BUSINESS WIRE)--Cordis Corporation announced today that it has received European CE Mark for its RENLANE™ Renal Denervation System for the treatment of patients with resistant hypertension and has completed the first successful cases in Europe. The RENLANE™ System consists of a...
24-02-2014
COLORADO SPRINGS, Colo., Feb. 24, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that the EXCITE ISR trial achieved the statistical endpoints of the adjunct analysis. The trial evaluates laser atherectomy plus Percutaneous Transluminal Angioplasty (PTA) compared...
24-02-2014
LONDON, Feb. 21, 2014 /PRNewswire/ -- Today at the 26th Annual Meeting of the American Venous Forum in New Orleans, LA, Dr. Kenneth Todd, an American College of Phlebology Committee Member from the Southeast Vein and Laser Center and a Principal Investigator for VANISH-2, presented one-year data fro...
21-02-2014
FLAGSTAFF, Ariz. & PHOENIX--(BUSINESS WIRE)--W. L. Gore & Associates (Gore) today announced that it will present the results of the Gore REVISE Clinical Study, the only randomized, controlled study of stent-grafts to investigate both stenotic and thrombotic occlusive arteriovenous (AV) access patien...
19-02-2014
FREMONT, Calif.--(BUSINESS WIRE)--Cordis Corporation announced today that it has entered into an agreement with TriReme Medical, Inc. that grants the company exclusive distribution rights for the Chocolate® PTA Balloon Catheter. Cordis’ addition of the Chocolate® PTA Balloon Catheter complements...
18-02-2014
IRVINE, Calif., February 18, 2014 --- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today the Journal of Vascular Surgery’s (JVS) e-publication of the data from the first prospective, multicenter, randomized clinical trial of a total...
18-02-2014Covidien Expands Peripheral Vascular Portfolio with New HydroFinity Hydrophilic Guidewire for Interventional Procedures
DUBLIN, Ireland -- February 17, 2014 — Expanding its comprehensive portfolio of endovascular products, Covidien plc. today introduced the HydroFinity™ hydrophilic guidewire for use in catheter placement and other procedures to treat vascular diseases.The HydroFinity guidewire is designed for eas...
17-02-2014
MINNEAPOLIS -- Feb. 13, 2014 -- Aligned with its commitment to provide innovative medical technology for the interventional treatment of peripheral artery disease, Medtronic, Inc. (NYSE: MDT) has initiated the European launch of the TOTAL across crossing catheter, which recently received the CE (Con...
13-02-2014European Vascular Surgeons in Training calls for abstracts
Send your abstract and register for free at Charing Cross SymposiumThe European Vascular Surgeons in Training (EVST) will be holding a “Stars of the Future” session during Charing Cross 2014 (5-8 April 2014) in London. Central theme of the session will be complications in vascular surgery. EVST ...
11-02-2014
MOUNTAIN VIEW, CA--(Marketwired - Feb 11, 2014) - Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it has received U.S. Food and Drug Administration (FDA) clearance for its smaller diameter Magellan™ 6Fr Robotic Catheter for peripheral vascular interv...
11-02-2014XII Curso Internacional de Actualización en Cirugía Endovascular
Durante los días 20 y 21 de febrero de 2014 se llevará a cabo el XII Curso Internacional de Actualización en Cirugía Endo- vascular en nuestro Hospital Universitario de Vall d'Hebron, que organiza el Servicio de Angiología, Cirugía Vascular y En- dovascular, en el que colaboran los Servi...
10-02-2014
IRVINE, Calif., Feb. 10, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today the United States launch of its new VELA™ Proximal Endograft System. The VELA Proximal Endograft is specifically designed for the t...
10-02-2014EHR-Based Screening Program for Abdominal Aortic Aneurysms Cuts the Number of Unscreened At-Risk Men by More than Half
PASADENA, Calif. — A screening program for abdominal aortic aneurysms, integrated into an electronic health record, dramatically reduced the number of unscreened at-risk men by more than 50 percent within 15 months, according to a Kaiser Permanente study published today in the Journal of Vascular ...
10-02-2014
Interim Outcomes in CHOCOLATE BAR Registry Demonstrate High Rates of Procedural Success and Limb PreservationPLEASANTON Calif. and SINGAPORE, February 6, 2014 /PRNewswire/ -- Interim results from The CHOCOLATE® BAR Registry conducted in the US demonstrate that use of the Chocolate® PTA balloon ach...
07-02-2014Gore launches lower profile Gore Excluder components in Australia and New Zealand
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) has announced the Australia and New Zealand launch of an expanded treatment range, including lower profile components for the GORE® EXCLUDER® AAA Endoprosthesis used to treat abdominal aortic aneurysms (AAAs). The 31 mm trunk-...
06-02-2014Boston Scientific Launches OffRoad™ Re-Entry Catheter System
System Provides Physicians New Option for Treating Complete Blockages in the Major Arteries of the LegFeb 5, 2014NATICK, Mass., Feb. 5, 2014 /PRNewswire/ -- Boston Scientific (NYSE: BSX) has announced the U.S. launch and first use of the OffRoad™ Re-Entry Catheter System, an important addition to ...
05-02-2014
BOSTON, MA – February 5, 2014 – InspireMD, Inc. (“InspireMD” or the “Company”) (NYSE MKT: NSPR), a leader in embolic protection systems, today announced that its new CGuardTM carotid embolic protection system has been successfully implanted in recent procedures, including a patient treat...
05-02-2014
Leipzig, Germany, 6 February 2014 – Two-year follow-up data presented atthe annual Leipzig Interventional Course (LINC) have shown that a nitinol stentwith unique three-dimensional helical geometry, BioMimics 3D™, developed byVeryan Medical Ltd, (Horsham, UK) provides an improvement in long-term...
03-02-2014Programa preliminar III Summit CELA
Apreciados lectores,Nos es grato informar que con motivo del III Summit CELA del próximo Marzo nuestras plataformas endovascular.es y endovascular.tv estarán presentes. Siguiendo con nuestro compromiso con CELA, dos son los objetivos de esta presencia: 1. Difundir CELA como sociedad científica e...
30-01-2014
London, UK and Irvine, CA, 30 January, 2014 – Lombard Medical Technologies PLC (AIM: LMT), the specialist medical device company focused on Endovascular Aortic Repair (“EVAR”) of abdominal aortic aneurysms (“AAAs”), announces that yesterday a team of surgeons, led by Dr. Andrej Schmidt, Ob...
30-01-2014BOLTON MEDICAL: Treovance Bolton - Bifurcated and Leg Extension Graft Delivery System Description
Vídeo de Treovance Endovascular Stent GraftTreovance Bolton - Bifurcated and Leg Extension Graft Delivery System Description...
30-01-2014
Author(s): Frank J. Criado, MD, FACS, FSVMThe Society for Cardiovascular Angiography and Interventions (SCAI) presented a substudy of CREST, the Carotid Revascularization Endarterectomy versus Stenting Trial, at the SCAI 2013 meeting in May. The substudy aimed to evaluate whether postdilatation afte...
28-01-2014Valiant Captivia Thoracic Stent Graft System From Medtronic Receives FDA Approval for Treating Aortic Dissections
MINNEAPOLIS -- Jan. 28, 2014 -- Continuing to expand the role of endovascular aortic repair, Medtronic, Inc. (NYSE: MDT) has received approval from the U.S. Food and Drug Administration (FDA) for the Valiant Captivia Thoracic Stent Graft System to be used in the treatment of type B aortic dissection...
28-01-2014Two-Year Data from INNOVATION Trial on INCRAFT® AAA Stent Graft System Continues to Demonstrate Safety and Performance in Treatment of Abdominal Aortic Aneurysms
FREMONT, Calif.--(BUSINESS WIRE)--Cordis Corporation today announced the presentation of two-year data from its INNOVATION Trial at the 2014 Leipzig Interventional Course (LINC) in Germany. Data from the study continues to demonstrate that the INCRAFT® System performs well in patients suffering fro...
28-01-2014
28 January 2014 (Flagstaff, Arizona and New Orleans)New Campaign Will Employ Awareness, Community Outreach, and Patient Screening to Fight AAAW. L. Gore & Associates, Inc. (Gore) and AAAneurysm Outreach, the nation’s only non-profit organization dedicated to the early detection of abdominal aortic...
28-01-2014
WASHINGTON, D.C. – January 28, 2014 – The U.S. Preventive Services Task Force (Task Force) today posted its draft recommendation statement and published its final evidence report on screening adults for abdominal aortic aneurysm (AAA). The Task Force is providing an opportunity for public commen...
28-01-2014
MENLO PARK, Calif., Jan. 27, 2014 /PRNewswire/ -- AtheroMed, a developer of innovative catheter technologies for treating peripheral artery disease (PAD), today announced that it has received FDA clearance to market the Phoenix Atherectomy System®, which allows physicians to treat PAD with a low pr...
27-01-2014
W. L. Gore & Associates (Gore) today announced that Himanshu Patel, MD and David Williams, MD at The University of Michigan enrolled the first patient in the Gore TAG Thoracic Branch Endoprosthesis LSA Feasibility Study, a U.S.-based, multi-center feasibility trial. The Food and Drug Administration ...
27-01-2014
Palo Alto, CA, USA and Amsterdam, The Netherlands, 27 January, 2014 -- (PR Newswire) -- ReCor Medical today announced major advances in its Paradise System™for renal denervation (RDN), confirming its commitment to lead in the treatment of patients with resistant hypertension (HTN).The Company anno...
27-01-2014TriVascular Completes Enrollment of the OVATION® European Post-Market Registry
500-patient, real-world study of innovative, lowest profile EVAR system bolsters strong library of clinical evidenceSanta Rosa, CA, January 27, 2013 – TriVascular, Inc. today announced the enrollment completion of the OVATION post-market registry, a 500-patient, 30-center European study. The multi...
27-01-2014
Jotec Cardiovascular tiene el agrado de informar que el 10 de Enero de 2014, nuestra endoprótesis E-liac ha obtenido el marcado CE.E-liac está indicada en el tratamiento endovascular tanto del aneurisma aortoilíaco como ilíaco aislado, completando así la gama de productos JOTEC para el tratamie...
24-01-2014
El SITEupdate se celebrará en Barcelona el 9 de Mayo de 2014 en la Aula Magna, Facultad de Medicina de la Universidad de Barcelona.WEB OFICIAL: http://www.sitesymposium.org/A continuación se muestra el programa oficial: Site update final programme from Salutaria ...
22-01-2014
BIOTRONIK Passeo-18 Lux(PresseBox) (BUELACH, Switzerland, 22.01.2014) BIOTRONIK, a leading manufacturer of cardiovascular devices, today announced the release of its Passeo-18 Lux Drug Releasing Balloon (DRB) in all countries accepting CE mark, following recent CE approval.The Passeo-18 Lux DRB cath...
22-01-2014
DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 21, 2014-- Covidien plc (NYSE: COV) today announced it will exit its OneShot™ Renal Denervation program. This voluntary action is primarily in response to slower than expected development of the renal denervation market.The OneShot system is an over-the-wire ...
21-01-2014
MINNEAPOLIS, Minnesota -- Vascular Solutions, Inc. (Nasdaq: VASC) today announced the U.S. market launch of ThrombiDisc topical hemostat, a thrombin-based pad used as an adjunct to manual compression to control surface bleeding from vascular access sites and percutaneous catheters or tubes. The Thr...
21-01-2014
IRVINE, Calif., Jan. 21, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that the first patient was treated in the EVAS FORWARD-IDE clinical trial, the Company's pivotal clinical trial to evaluate the safet...
21-01-2014
MIAMI BEACH, Fla. -- Peripheral artery disease (PAD) sufferers maintain improved quality of life – including being able to walk farther – three years after being treated with stents to open up their blocked leg arteries, according to the most recent results of the STROLL trial presented at the 2...
21-01-2014VÍDEO DEL MES: JOTEC - E-liac Stent Graft System
E-liac Stent Graft System ...
20-01-2014ULTIMA Study Supports EkoSonic System for PE Treatment
Miami, FL, US: 20 January 2014: EKOS Corporation, a BTG International group company (BTG plc (LSE: BTG)), located in Bothell, Washington in the United States, today announced the publication of the results of its Ultrasound Accelerated Thrombolysis of Pulmonary Embolism (PE) trial (ULTIMA) in the pe...
20-01-2014
MINNEAPOLIS - Jan. 17, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval of the self-expanding transcatheter CoreValve® System for severe aortic stenosis patients who are too ill or frail to have their aortic valves replaced through traditional ...
17-01-2014
Le invitamos a consultar el nuevo número de la revista Técnicas Endovasculares disponible ya en nuestro portal web.Volumen XVI - Número 4 EXTRA (Diciembre 2013)...
17-01-2014
PLANO, Texas, Jan. 16, 2014 /PRNewswire/ – Argon Medical Devices, Inc. announced today that the company has received clearance from the US Food and Drug Administration to begin marketing the Option™ELITE retrievable inferior vena cava (IVC) filter with a new over-the-wire delivery technique. Th...
16-01-2014Silk Road Medical appoints Sumaira Macdonald as chief medical officer
SUNNYVALE, Ca., Jan. 13, 2014 /PRNewswire/ -- Silk Road Medical, Inc., a developer of advanced devices for the treatment of Carotid Artery disease, announced today the appointment of Sumaira Macdonald, MD, PhD to the position of Chief Medical Officer effective immediately. In this new role, Dr. Macd...
13-01-2014NEW Charing Cross Open Abstract sessions
The 2014 CX Programme Board invites submission of abstracts on any vascular and endovascular topic for two new parallel sessions.Physician Presentations & PostersSubmission is open to all physicians – seniors and junior doctors. A selection of abstracts and posters will be chosen by the CX Program...
10-01-2014
Nuestro portal endovascular.es se complace en dar la bienvenida a la compañía BOLTON como Patrocinador Oro.Mediante nuestro portal web endovascular.es, la compañía divulgará toda comunicación dirigida tanto a la comunidad médica como a los pacientes y sus familias, en materia endovascular.La ...
09-01-2014
MINNEAPOLIS - January 9, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that its U.S. pivotal trial in renal denervation for treatment-resistant hypertension, SYMPLICITY HTN-3, failed to meet its primary efficacy endpoint. The trial met its primary safety endpoint, and the trial's Data Safety Mo...
09-01-2014El nuevo equipo de radiodiagnóstico del hospital Clínico permite ampliar las exploraciones
El Conseller de Sanitat, Manuel Llombart, ha visitado hoy la nueva sala del Servicio de Radiodiagnóstico del Hospital Clínico que cuenta con un nuevo equipamiento multifunción de última generación que permitirá mejoras tanto para el paciente como para el profesional.El equipo tiene un valor ap...
08-01-2014
El SITEupdate se celebrará en Barcelona el 9 de Mayo de 2014 en la Aula Magna, Facultad de Medicina de la Universidad de Barcelona.WEB OFICIAL: http://www.sitesymposium.org/A continuación se muestra el programa preliminar: New site update preliminary programme from Salutaria ...
07-01-2014
CHICAGO – Women are more likely than men to suffer complications, including death, from a minimally invasive vascular surgical procedure. The reason: surgical devices too large for women’s anatomy, according to a new study in Journal of Vascular Surgery. “This study is a call to action to decr...
07-01-2014Premio endovascular.es 2016
Bienvenidos al premio Internacional endovascular.es 2016NORMAS DE PUBLICACIÓN:Los casos clínicos se remitirán a partir del día 1 de Enero de 2015, exclusivamente a través de la web www.endovascular.es o vía email a la dirección info@salutaria.com. El tema estará centrado en la terapia endova...
01-01-2014EL EQUIPO DE ENDOVASCULAR.ES OS DESEA FELIZ NAVIDAD Y FELIZ AÑO 2014
...
24-12-2013
Author(s): Frank J. Criado, MD, FACS, FSVM, Sira Duson, MDFrom MedStar Union Memorial Hospital, Baltimore, Maryland. The success of endovascular repair is predicated on the ability of the stent-graft device to exclude the target aortic segment. Achieving optimal landing at the proximal and distal ne...
23-12-2013CELA: NCVH America Latina - Ventana a las Américas
VENTANA A LAS AMÉRICAS- Summit Cela 2014 - CELA invita a Ud. a participar del SUMMIT CELA 2014, que se realizará en Cartagena, Colombia, del 25 al 28 de marzo de 2014, en el marco del Congreso Ventana para las Américas, en conjunto con la Asociacion Colombiana de Angiología y Cirugía Vascular, ...
23-12-2013VÍDEO DEL MES: GORE® EXCLUDER® Iliac Branch Endoprosthesis Animation
...
23-12-2013
Estimados AmigosEs un honor que el presidente dela Sociedad CELA haya delegado en mi la tarea de hacerles llegar un saludo enestas fiestas. Muchos de ustedes conocen la historia de nuestra Sociedad, desus comienzos Rioplatenses casi como un club de amigos y de cómo la pasión deesos pioneros por tr...
23-12-2013
IRVINE, Calif., Dec. 20, 2013 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has received Investigational Device Exemption ("IDE") approval from the United States Food and Drug Administration("FDA") to ...
20-12-2013JOTEC: nuevo partner del portal web endovascular.es
Nuestro portal endovascular.es se complace en dar la bienvenida a la compañía JOTEC como Patrocinador Oro.Mediante nuestro portal web endovascular.es, la compañía divulgará toda comunicación dirigida tanto a la comunidad médica como a los pacientes y sus familias, en materia endovascular.La d...
17-12-2013GORE: nuevo partner del portal web endovascular.es
Nuestro portal endovascular.es se complace en dar la bienvenida a la compañía GORE como Patrocinador Oro.Mediante nuestro portal web endovascular.es, la compañía divulgará toda comunicación dirigida tanto a la comunidad médica como a los pacientes y sus familias, en materia endovascular.La de...
17-12-2013
Intact Vascular launches a multi-site study to gather data on the safety and performance of its Tack-It endovascular system for treating peripheral artery disease.Intact Vascular said it's launching a multi-center pilot study for its Tack-It endovascular system for treating peripheral artery disease...
17-12-2013
Medtronic's Second Randomized, Controlled Renal Denervation Clinical Trial in the U.S. Will Potentially Expand Access to the Symplicity(TM) Renal Denervation System for Even Larger Uncontrolled Hypertension Patient PopulationMINNEAPOLIS - December 17, 2013 - Medtronic, Inc. (NYSE: MDT), announced to...
17-12-2013Roy Greenberg (1964-2013)
Roy Kenneth Greenberg, a la temprana edad de 49 años, con su mirada transparente y su semblante calmado, nos abandonó para siempre el pasado 7 de Diciembre.Roy nació en Ithaca, NY y cursó susestudios de Medicina en la Universidad de Cincinnati, OH. Tras su residencia en Cirugía General y Vascul...
13-12-2013In Memory of Roy K. Greenberg, MD
It is with great sorrow that we announce the passing of Dr. Roy Greenberg.Roy Kenneth Greenberg, 49, died December 7, 2013 at his home on Lake Erie near Cleveland, OH.He was born in Ithaca, NY to Iris and Donald Greenberg on November 9, 1964.Roy obtained his Bachelor's degree at Cornell University a...
11-12-2013
MOUNTAIN VIEW, Calif. (December 11, 2013) The Fogarty Institute for Innovation, in conjunction with El Camino Hospital’s Norma Melchor Heart and Vascular Institute and VIVA Physicians, Inc. (VIVA), has announced that it is accepting applications for the prestigious Advanced Endovascular Training F...
11-12-2013
11 December 2013 (Flagstaff, Arizona)Flexibility and Durability to Aid Hemodialysis PatientsW. L. Gore & Associates (Gore) today announced that the Food and Drug Administration (FDA) has granted indication for the GORE® VIABAHN® Endoprosthesis to treat stenosis or thrombotic occlusion at the venou...
11-12-2013
FAIRFAX, Va.—The Society of Interventional Radiology will hold its 39th Annual Scientific Meeting March 22–27, 2014, in San Diego. SIR 2014 is the world’s most comprehensive meeting dedicated to interventional radiology and will feature more than 400 scientific presentations and 250 hours in e...
11-12-2013
Reverse Medical® Corporation has gained FDA 510(k) clearance to market its MVP®-5 Micro Vascular Plug system for peripheral vessel embolization, together with news of the first US clinical case.BackgroundReverse Medical’s MVP® Micro Vascular Plug family of products are designed to occlude vesse...
10-12-2013Medtronic’s Symplicity Spyral Multielectrode Catheter and Symplicity G3 Generator Approved in Europe and Australia
MINNEAPOLIS -- December 5, 2013 -- Medtronic, Inc. (NYSE: MDT), announced today CE Mark (Conformité Européenne) in Europe and Therapeutic Goods Administration (TGA) listing in Australia for its highly flexible 4 Fr multi-electrode Symplicity Spyral(TM) catheter and Symplicity G3(TM) radio frequenc...
05-12-2013GORE® C3 Delivery System Approved In Japan
3 December 2013 (Flagstaff, Arizona)System Enables Physicians and Interventionalists to Reposition GORE® EXCLUDER® AAA Endoprosthesis for Ideal Placement in Treating Abdominal Aortic AneurysmsW. L. Gore & Associates, Inc. (Gore) has received Shonin approval from the Japanese Ministry of Health, La...
03-12-2013
SUNRISE, FL--(Marketwired - Dec 3, 2013) - Bolton Medical, a medical device manufacturer which specializes in endovascular treatments for aortic repair, announced today it has initiated its Phase II U.S. clinical trial to study the safety and effectiveness of the Treovance Abdominal Stent-Graft with...
03-12-2013
Debates have become a near constant fixture at medical meetings and conferences. Many times they serve an important purpose highlighting or clarifying competing views and different ways of interpreting available evidence and current practice. But more often than not, such debate sessions are designe...
30-11-2013
Le invitamos a consultar el nuevo número de la revista Técnicas Endovasculares disponible ya en nuestro portal web.Volumen XVI - Número 3 (Septiembre-Diciembre 2013)...
30-11-2013VÍDEO DEL MES: LOMBARD MEDICAL - Aorfix Endovascular Stent Graft
En este vídeo se muestra el proceso y funcionamiento del dispositivo LOMBARD MEDICAL - Aorfix Endovascular Stent Graft....
29-11-2013Medtronic: Simulación endovascular a su alcance, ahora está disponible el módulo de casos reales (PRS)
MEDTRONIC SIMULACIÓN PRS from Salutaria ...
27-11-2013
London, UK, 26 November 2013: BTG plc (LSE: BTG), the specialist healthcare company, today announces that the US Food and Drug Administration (FDA) has approved Varithena™ (polidocanol injectable foam) for the treatment of patients with incompetent veins and visible varicosities of the great saphe...
26-11-2013
REGENSBURG, Germany--(BUSINESS WIRE)-- Transcatheter Technologies GmbH, an emerging medical device company that is developing a third-generation transcatheter aortic valve implantation (TAVI) system—Trinity—announced today the successful 30-day follow-up results for a pilot study of its Trinity ...
26-11-2013Reunión CELA en el congreso VEITH 2013 en Nueva York
La Comisión Directiva de CELA , Cirujanos Endovasculares de Latino América, se reunió el pasado viernes 22 de Noviembre en Nueva York, en ocasión del congreso VEITH 2013.La agenda del día contó con temas estratégicos para CELA como:1- La celebración del III SUMMIT CELA 2014 ' Actualización ...
25-11-2013El Dr. Vicente Riambau presenta en el VEITH Symposium de Nueva York, las diez recomendaciones más destacadas de las Guías Europeas para el tratamiento de la patología de la aorta torácica
El Dr. Vicente Riambau durante el transcurso del Symposium VEITH celebrado en Nueva York los días 19-23 Noviembre, ha presentado, entre otras ponencias, las diez recomendaciones más destacadas de las Guías Europeas para el tratamiento de la patología de la aorta torácica. Es el Coordinador de l...
25-11-2013
Peripheral arterial disease (PAD) can cause critical limb ischemia that is treated with amputation, and while there is much spending on interventions to try to prevent amputations, higher spending does not necessarily mean lower amputation rates, according to a study by Philip P. Goodney, M.D., M.S....
25-11-2013
The Humacyte investigational bioengineered blood vessel technology represents a research and development milestone in vascular tissue engineering.Interim data from 28 patients in a three-center, first-in-human study in Poland indicate that all of the investigational blood vessels to date remain open...
25-11-2013
Presented at VEITH, Three-Year Clinical Data from Global ENGAGE Registry Supports Innovative Device's Market-Leading Position WorldwideMINNEAPOLIS -- Nov. 25, 2013 -- Chosen for nearly one out of every two endovascular abdominal aortic aneurysm (AAA) repairs worldwide, the Endurant II AAA stent graf...
25-11-2013
FLAGSTAFF, Ariz. & NEW YORK--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced the nominees and opening of voting for the 2014 Pioneers in Performance Awards for North America. Today’s announcement came at the 2014 VEITHsymposium in New York. Each year, a distinguished group of...
21-11-2013
EXTON, Pa.--(BUSINESS WIRE)--DSM a global leader in biomedical materials science and regenerative medicine, announced it has developed a novel ultra-high-molecular-weight polyethylene (UHMWPE) membrane technology. Initial use of the proprietary membrane technology will be in peripheral stent graphs ...
20-11-2013
Chicago –Joseph Poole, M.D., Ph.D., of the Emory University School of Medicine, Atlanta,and colleagues studied whether therapy with granulocyte-macrophage colonystimulating factor (GM-CSF), an agent that functions as a white blood cellgrowth factor, would improve walking performance in patients wi...
20-11-2013
Presented at VEITH, Acute Results from Initial Trial of New Medical Technology Show Promise for Endovascular Approach to Thoracic Aortic Aneurysms Involving Left Subclavian ArteryNEW YORK -- Nov. 20, 2013 -- The first device of its kind to undergo clinical evaluation in the United States, the Valian...
20-11-2013
DALLAS - Renal artery stenting confers no additional benefit beyond optimal drug therapy for preventing adverse renal and cardiovascular events in patients with renal artery stenosis and chronic kidney disease (CKD) or hypertension, according to data from a randomized clinical trial of more than 900...
19-11-2013Alvimedica merges with CID, Italy's leading high tech company specialized in cardiology
On November 19, 2013 Alvimedica announced a merger with CID ('Carbostent & Implantable Devices'), a well- established and trusted medical devices company from Italy.Joined together under the brand name Alvimedica we aim to create ‘The New European Alternative’ in the global market for medical de...
19-11-2013Gore Launches Early Cannulation Capable GORE® ACUSEAL Vascular Graft
19 November2013 (Flagstaff, Arizona and New York)Results ofearly cannulation clinical trial presented at the 2013 VEITHsymposiumW. L. Gore &Associates (Gore) today announced the launch of the GORE® ACUSEAL VascularGraft for vascular access. Designed for early cannulation within 24 hours afterimplan...
19-11-2013
NATICK, Mass., Nov. 19, 2013 /PRNewswire/ -- Further bolstering its market-leading portfolio of peripheral embolization technologies, Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration clearance and CE Mark approval for its Direxion™ Torqueable Microcatheter.P...
19-11-2013
Apreciados colegas y amigos,Como consecuencia de los acuerdos de la pasada asamblea de CELA celebrada en Cancún, MX, el pasado mes de Julio, me es grato informarles que en el próximo número de Septiembre-Diciembre de Técnicas Endovasculares, aparece en el el cuadro de Consejos y Comisiones edito...
18-11-2013TriVascular Secures $40 Million in Equity Financing
Santa Rosa, CA, November 18, 2013 – TriVascular, Inc. today announced the close of a $40 million Series E Preferred Stock equity financing. Existing investors New Enterprise Associates, Delphi Ventures, MPM Capital, Kearny Venture Partners, Kaiser Permanente Ventures and the Redmile Group were joi...
18-11-2013
The Only FDA Approved Endovascular Stent Graft for Use in Challenging Abdominal Aortic Aneurysm Cases London, UK and Irvine, CA, November 18, 2013 – Lombard Medical Technologies PLC (AIM: LMT), the specialist medical device company focused on the treatment of abdominal aortic aneurysms (AAAs), tod...
18-11-2013Gore announces enrollment of first patient in Gore EXCLUDER iliac branch study
W. L. Gore & Associates (Gore) has announced that Dr Brian Peterson from Saint Louis University, enrolled the first patient in the Gore EXCLUDER iliac branch clinical study.The clinical study is a prospective, multi-center, non-randomized, single-arm study designed to assess the safety and effective...
15-11-2013
Lombard medical aorfix custom service from Salutaria ...
14-11-2013Cook Medical Opens New Innovation Centre in Limerick, Ireland
Bloomington, Ind. — Cook Medical has today officially opened its new state-of-the-art research and development (R&D) Innovation Centre at its plant in Limerick, Ireland.The Innovation Centre together, with the expansion of cleanrooms, packaging, storage and other facilities, represents an investme...
14-11-2013
ALISO VIEJO, Calif., and BUENOS AIRES, Argentina, Nov. 14, 2013 /PRNewswire/ -- Sequent Medical, Inc. announced today the presentation of long-term results from a retrospective study of the WEB™ Aneurysm Embolization System at the World Federation of Interventional Neuroradiology (WFITN) Congress....
14-11-2013Convocatoria del Premio Alberto Masegosa a la Mejor Publicación en Flebología y/o Linfología
El Capítulo Español de Flebología y Linfología (CEFyL),convoca el Premio a la Mejor Publicaciónen temas relacionados conla patología venosa y linfática. Recibe el nombre “AlbertoMasegosa”en honor al Ex-Presidente del Capítulo. La dotación económica es de 2.500€ y está patrocinado po...
13-11-2013Volcano Corporation Announces First Commercial Implantations of Crux® Vena Cava Filter
SAN DIEGO, Nov. 13, 2013 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced the commercial release and initial implanta...
13-11-2013DSM partners with BiO2 Medical to provide ComfortCoat® Coating for the Angel® Catheter
Exton, PA (US), 12 November 2013 Partnership offers BiO2 Medical a hydrophilic and lubricious coating to enhance ease of placement and reduce access site trauma for the Angel® Catheter, a central venous access catheter (CVC) with a permanently attached inferior vena cava (IVC) filter. DSM, a global...
12-11-2013
Uno de los problemas asociados a la diabetes más desconocidos por los enfermos es el llamado pie diabético. Se trata de una ulceración en la extremidad que si se infecta y no se trata a tiempo, puede provocar una amputación. Por eso, los más de 200 expertos reunidos en el I Symposium de Pie...
08-11-2013
Milan, Italy, November 8, 2013 – Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, announced today that the first European implant of Mitroflow Valsalva Conduit was performed by Prof. Roberto di Bartolomeo, Chief of the Cardiac Surgery Department at Sa...
08-11-2013
November 7, 2013—The final 3-year report of the SYMPLICITY HTN-1 study of percutaneous renal denervation in patients with treatment-resistant hypertension renal denervation (RDN) were published by Professor Henry Krum, MD, et al online ahead of print in The Lancet.The investigators assessed the lo...
07-11-2013
7 November 2013 (Flagstaff, Arizona)First Successful Implants Completed in Italy and the United Kingdom, Providing Endovascular Repair to Iliac ArteriesW. L. Gore & Associates (Gore) today announced the GORE® EXCLUDER® Iliac Branch Endoprosthesis, the first complete, fully engineered system (Gore ...
07-11-2013
This document is intended to provide guidance to those involved in designing clinical studies intended to support pre-market submissions for medical devices and FDA staff who review those submissions. Although the Agency has articulated policies related to design of studies intended to support speci...
07-11-2013Gore Receives FDA Approval for 25 cm GORE® VIABAHN® Endoprosthesis
FLAGSTAFF, Ariz.--(BUSINESS WIRE) -- W.L. Gore & Associates (Gore) announced today that the US Food and Drug Administration (FDA) has approved the 25 cm GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface for the treatment of symptomatic peripheral arterial disease lesions in the Superficial ...
06-11-2013
ST. LOUIS, Nov. 6, 2013 (GLOBE NEWSWIRE) -- Veniti™, Inc. has received approval to CE Mark the Veniti Vici™ Venous Stent, specifically designed for the treatment of venous obstruction. In addition, the company received CE Mark approval for their varicose vein ablation product, the Veniti Veni™...
06-11-2013
Boulder, CO -- EndoShape said Monday that is has received 510(k) marketing clearance for its MedusaTMVascular Plug. The Food and Drug Administration cleared the catheter-delivered device for arterial and venous embolization in the peripheral vasculature. The device is based on EndoShape's proprietar...
06-11-2013
- Nov. 1, 2013 - BEVERLY, MA (Nov. 1, 2013)—Patients suffering from venous disease now have a voice in their treatment and disease management thanks to a patient-driven registry. The Heart and Vascular Outcomes Research Institute (HVORI) announces its launch of the Venous Patient Outcome Registry,...
01-11-2013First patient enrolled in the EVAS Forward global registry
On 31 October, Endologix announced that the first patient was enrolled in the global registry for the Nellix Endovascular Aneurysm Sealing system. The global registry, is one of a number of clinical studies that make up the broader EVAS Forward clinical programme aimed at establishing clinical and ...
31-10-2013
·Global DEB market revenue to climb by 16% in seven years·DEB’s ability to target challenging patient populations will help ‘expand the market over the coming years,’ says analystDrug-Eluting Balloon Revenue to More than Double by 2019, Following US and Japanese DebutLONDON, UK (GlobalData),...
31-10-2013VÍDEO DEL MES: NELLIX EndoVascular Aneurysm Sealing System
En este vídeo se muestra el proceso y funcionamiento del dispositivo NELLIX EndoVascular Aneurysm Sealing System....
31-10-2013
ARTÍCULO DE ANÁLISIS Y OPINIÓN:Dr. Frank J. Criado para endovascular.esIn an important paper, “Natural History of Asymptomatic Severe Carotid Artery Ste-nosis” presented at the 2013 Vascular An-nual Meeting of the Society for Vascular Sur-gery (May 30 to June 1), Conrad et al from the Divisio...
31-10-2013
IRVINE, Calif.-(Businesswire)--Reverse Medical Corporation today announced CE Mark approval, FDA 510k clearance and initial clinical use of their ReVerse® Microcatheter product line for intracranial neurovascular use. The device has been granted European Union CE Mark approval and US FDA 510k clear...
29-10-2013New Data Continue to Show Significant and Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation System
SAN FRANCISCO, Oct. 28, 2013 /PRNewswire/ -- Patients treated with the Boston Scientific (NYSE: BSX) Vessix™ Renal Denervation System experienced a significant and sustained reduction in blood pressure, according to new data presented today at the Transcatheter Cardiovascular Therapeutics (TCT) Co...
28-10-2013Carotid Artery Stenting Appears Associated with Increased Stroke in Elderl
CHICAGO – Carotid artery stenting (CAS) was associated with an increased risk of stroke in elderly patients but the mortality risk appeared to be the same as for nonelderly patients, according to a review of the medical literature published Online First by JAMA Surgery, a JAMA Network publication....
23-10-2013
On September 24 The European Commission adopted two measures to improve the safety of medical devices fulfilling its commitment to restore patient confidence in the medical devices sector following, amongst others, the Poly Implant Prothèse (PIP) breast implants scandal. The new rules were a Commis...
22-10-2013Vascutek initiates voluntary recall of AnacondaTM Bifurcate Body Stent Graft System
Vascutek has today (Monday 21 October) issued a Field Safety Notice initiating a voluntary recall of the AnacondaTM Bifurcate Body Stent Graft System.An issue with a component of the device, the release wire in the delivery system, identified through Vascutek’s quality management monitoring system...
21-10-2013
El conseller de Sanitat, Manuel Llombart, ha señalado esta tarde en el cuarto Symposium Mediterráneo de Cirugía Vascular que organiza la Sociedad de la Comunitat Valenciana de Angiología, Cirugía Vascular y Endovascular en Benicàssim que a lo largo de 2012, el 64,2 por ciento de los 3.853 paci...
21-10-2013Curso de actualización de conocimientos en la especialidad de cardiología
Objetivo:Actualización de los conocimientos de la especialidad de cardiología para médicos especialistas y médicos en formación.Metodología:- Preparación basada en un profundo análisis de las necesidades.- Adecuación del tiempo de estudio a un marco temporal que permita un aprendizaje, memo...
18-10-2013
WESTMINSTER, CO (October 18, 2013) – Surefire Medical, Inc., today announced the launch of a new, enhanced infusion system – the Surefire Infusion System mT – designed to treat vessels as small as 2mm to 3.5mm in interventional direct-to-target embolization procedures. The mT incorporates Sure...
18-10-2013
London, UK and Irvine, CA, 17 October 2013 – Lombard Medical Technologies PLC (AIM: LMT), the specialist medical device company focused on the treatment of abdominal aortic aneurysms (AAAs), today announces it has entered into a mutually beneficial licensing agreement with Medtronic Inc.Under the ...
17-10-2013
Chimney stent grafts are proving safe and effective for patients with complex aortic aneurysms, a US and Swiss study suggests.Close to 95% of patients who underwent the chimney or periscope graft showed a drop or stabilising in aneurysm size, found the study of 77 participants with a two-year midter...
17-10-2013Oscor Introduces the Destino Twist Steerable Guiding Sheath
October 2013: Oscor Inc. is pleased to introduce the latest advancement in steerable guiding sheaths. The Destino™ Twist™ offers unidirectional deflectable tip with an ergonomic steerable handle. The Twist™ is the ultimate tool in gaining access to the most difficult to reach locations all the...
16-10-2013
Deep vein thrombosis (DVT) screening at hospitals across the country has resulted in a “significant” reduction in death rates.A major study, carried out by a team from the Quality and Outcomes Research Unit (QUORU) of University Hospitals Birmingham NHS Foundation Trust, sought to check the effe...
16-10-2013
Quebec City, October 2, 2013—Researchers from Université Laval’s Faculty of Medicine and CHU de Québec have shown that it is possible to treat venous ulcers unresponsive to conventional treatment with wound dressings made from human skin grown in vitro. A study published recently in the journa...
16-10-2013
En ocasión de la celebración en Barcelona del congreso CIRSE 2013, tuvo lugar el pasado martes 17 de septiembre la presentación del congreso SITEupdate a responsables de la industria endovascular.La respuesta de las compañías del sector endovascular fue muy positiva y el nuevo formato de evento...
15-10-2013
Reston, Va. – Several newly identified markers could provide valuable insight to predict the risk of rupture abdominal aortic aneurysms (AAA), according to new research published in the October issue of The Journal of Nuclear Medicine. Imaging with positron emission tomography/computed tomography ...
15-10-2013
ADDISON, Ill., Oct. 14, 2013 /PRNewswire/ -- ArjoHuntleigh announced today that it has launched the Dopplex® Ability, an Ankle Brachial Index (ABI) screening device that reduces the time it takes to perform ABI measurements by up to 75% vs. traditional methods.1 ABI measurements are used to predict...
15-10-2013
SAN JOSE, Calif., Oct. 15, 2013 /PRNewswire/ -- Pulsar Vascular, a leading innovator in neurovascular technology, today announced it received European CE Mark approval for its lead product, the PulseRider®. This unique implant is used to bridge the neck of cerebral aneurysms previously not amenable...
15-10-2013
Según una nueva encuesta, las personas con más posibilidad de ser testigos de un ataque cerebral no lo podrían identificarDALLAS, Octubre 15, 2013—Crystal Wall estaba teniendo una típica platica con su hermana Chassity Anderson—de repente el teléfono de su hermana se cayó al piso y su voca...
15-10-2013
According to a new survey, people more likely to witness a stroke might not know how to identify oneOctober 15, 2013 DALLAS, Oct. 15, 2013 — Crystal Wall was having a typical chat on the phone with her sister Chassity Anderson — until her sister’s phone abruptly crashed to the floor and her wo...
15-10-2013
Andover, MA. and New York; Oct. 3, 2013 – Royal Philips (NYSE: PHG AEX: PHIA) and Accenture (NYSE: ACN) today announced the creation of a proof-of-concept demonstration that uses a Google Glass™ head-mounted display for researching ways to improve the effectiveness and efficiency of performing s...
14-10-2013
DALLAS, Oct. 14, 2013 — Award-winning Get With The Guidelines®-Stroke hospitals are more likely than Primary Stroke Center certified hospitals to provide all the recommended guideline-based care for patients, according to new research in the Journal of the American Heart Association.The American ...
14-10-2013
(DALLAS, Oct. 14, 2013) — Nearly 360,000 people experience cardiac arrest outside of a hospital each year, and most of those victims die, often because bystanders don’t know how to start CPR or are afraid they’ll do something wrong. The American Heart Associationbelieves kids are the answer to...
14-10-2013MAJESTIC trial to evaluate Innova drug-eluting stent system in superficial femoral artery lesions
NATICK, Mass., Oct. 9, 2013 /PRNewswire/ -- Launching a key clinical trial expected to serve as the foundation for global regulatory approvals, a physician in Auckland, New Zealand has performed the first patient implant of the Boston Scientific Corporation (NYSE: BSX) Innova™ Drug-Eluting Stent (...
10-10-2013
MURRAY HILL, N.J.--(BUSINESS WIRE)--Oct. 10, 2013-- Today at the Vascular Interventional Advances (VIVA) meeting in Las Vegas, Nevada, Professor Dierk Scheinert, M.D., Head of theDepartment of Medicine, Angiology and Cardiology, Park-Krankenhaus Hospital, Leipzig, Germanyand LEVANT 2 Co-Primary Inve...
10-10-2013Biotronik announces new product additions to its peripheral portfolio
BUELACH, Switzerland, October 2, 2013 – BIOTRONIK announced today the launch of the Passeo-35 0.035” OTW PTA balloon Line Extension and the Passeo-35 HP high pressure PTA (percutaneous transluminal angioplasty) balloon. The Passeo-35 0.035” OTW PTA balloon is now also available in lengths of u...
09-10-2013Four-year ZILVER PTX trial data shows paclitaxel coating confers 41% reduction in restenosis vs. bare metal stenting
Las Vegas, Nev. — Four-year data from the Zilver® PTX® Randomized Controlled Trial of Paclitaxel-Eluting Stents for Femoropopliteal Disease from Cook Medical presented today at the 2013 Vascular Interventional Advances (VIVA) meeting demonstrates 75 percent primary patency in the superficial fem...
09-10-2013
Berlin, October 9, 2013 – Bayer HealthCare announced today that the United States Food and Drug Administration (FDA) has approved Adempas® (riociguat) tablets for use in two forms of pulmonary hypertension, a group of life-threatening and progressive diseases: The treatment of adults with persist...
09-10-2013
Sunnyvale, CA, October 8, 2013—Aptus Endosystems, Inc., a medical device company pioneering solutions to enhance aneurysm repair, today announced positive initial results from its ANCHOR post-market registry evaluating the use of the Heli-FX™ EndoAnchor System in endovascular aneurysm repair (EV...
08-10-2013
FREMONT, Calif.--(BUSINESS WIRE)--Cordis Corporation announced today three-year health related Quality of Life (QoL) data from the STROLL clinical trial that were presented during a Late-Breaking Clinical Trials session at the Vascular Interventional Advances (VIVA) 2013 Annual n Las Vegas. Results ...
08-10-2013
CHATTANOOGA, TN, October 8, 2013 – Advanced Catheter Therapies, Inc. (ACT), (www.acatheter.com) today announced that its Occlusion Perfusion Catheter™ (OPC) has received U.S. Food and Drug Administration (FDA) 510(k) clearance. ACT is a research and development medical device company with a port...
08-10-2013
Sunnyvale, CA, October 8, 2013—Aptus Endosystems, Inc., a medical device company pioneering solutions to enhance aneurysm repair, today announced positive initial results from its ANCHOR post-market registry evaluating the use of the Heli-FX™ EndoAnchor System in endovascular aneurysm repair (EV...
08-10-2013
Santa Clara, California (October 7, 2013) – AccessClosure, Inc., the market leader in extravascular closure devices, announced today an exclusive agreement with Ostial Corporation to distribute the Flash Ostial System Dual Balloon Angioplasty Catheter in the United States. The Flash Ostial System ...
08-10-2013
SOUTH JORDAN, Utah, Oct. 7, 2013 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has acquired the assets of Radial Assist, which include...
07-10-2013
Durante el evento celebrado en Madrid, se han presentado los últimos resultados obtenidos sobre stents bioabsorbibles, que en España suponen entre el 5-10% de los dispositivos implantados.En la XI edición del congreso Terapia Endovascular y Miocárdica (TEAM), celebrada la semana pasada en Madrid...
07-10-2013
American Heart Association Science AdvisoryOctober 07, 2013 Statement Highlights:Unhealthy habits, such as smoking, poor diet, and being overweight should be treated as aggressively as high blood pressure, high cholesterol and other cardiovascular disease risk factors.Insurance reimbursement policie...
07-10-2013
La Organización Internacional de Sociedades de Física Medica (IOMP International Organizations on Medical Physics) ha elegido recientemente al Dr. José Pérez Calatayud, jefe de la Unidad de Radiofísica en Radioterapia del Hospital La Fe de Valencia, como uno de los 50 Físicos Médicos más rel...
03-10-2013
ALBANY, N.Y., Oct. 3, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced the enrollment of the first patient at University of Miami Hospital in a ...
03-10-2013
Un equipo formado por seis enfermeras realiza esta técnica en Oncología Médica y HematologíaUn equipo formado por seis profesionales de Enfermería de los servicios de Oncología Médica y Hematología del Hospital Universitario 12 de Octubre de la Comunidad de Madrid realiza la técnica de cana...
03-10-2013
London, UK and Irvine, CA, 2 October 2013 – Lombard Medical Technologies PLC (AIM: LMT), the specialist medical technology company focused on innovative vascular products, today announces that due to increasing demand for its lead product, Aorfix, the Company is expanding its facility in Didcot, O...
02-10-2013
MENLO PARK, Calif., Oct. 2, 2013 /PRNewswire/ -- AtheroMed, a developer of innovative technologies for treating peripheral artery disease (PAD), announced that it has completed patient enrollment in the EASE clinical study. The EASE study results will be presented by Dr. Stephen Williams, Director, ...
02-10-2013
BUELACH, Switzerland, October 2, 2013 – BIOTRONIK announced today the launch of the Passeo-35 0.035” OTW PTA balloon Line Extension and the Passeo-35 HP high pressure PTA (percutaneous transluminal angioplasty) balloon. The Passeo-35 0.035” OTW PTA balloon is now also available in lengths of u...
02-10-2013
WAYNE, Pa., Oct 01, 2013 (BUSINESS WIRE) -- Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the completion of enrollment of the Tack Optimized Balloon Angioplasty (TOBA) study. The purpose of this multi-center study is to g...
01-10-2013
Durante los últimos meses, CELA se halla organizando varias comisiones de trabajo:* Económica y de secretaría* Comisión de Consensos para EVAR y TEVAR* Comisión de Congresos* Comisión de Educación y Programa de Educación para Latinoamérica* Comisión de web y revista* Comisión de acercamie...
30-09-2013
ARTICULO DE ANALISIS Y OPINION: Dr. Frank J. Criado para endovascular.es As I fly home from London after participating in theCharing Cross Vascular Symposium (35th annual edition!) and begin to reviewprominent topics presented during theevent’s intense 3 days, it becomes clear that post-EVAR type...
30-09-2013VÍDEO DEL MES: LeverEdge Contrast Injector de LeMaitre Vascular por el Dr. Omar Andrés
En este vídeo el cirujano vascular Omar Andrés nos muestra el funcionamiento del inyector LeverEdge Contrast Injector, de la compañía LeMaitre Vascular....
27-09-2013
A Abbas, V Hansrani, N Sedgwick, J Ghosh, C McCollumIn: ESVS; 18 Sep 2013-20 Sep 2013; Budapest. 2013.Introduction:CT angiography (CTA) for post-EVAR surveillance involves irradiation and nephrotoxic X-ray contrastagents. 3D CEUS is a novel imaging technique that may be more sensitive to blood flow ...
27-09-2013
Berlin, September 26, 2013 – Bayer HealthCare today announced that the U.S. Food and Drug Administration’s (FDA) Office of Orphan Products Development has granted two separate orphan drug designations for its investigational, oral medication riociguat for the treatment of pulmonary arterial hype...
26-09-2013
MINNEAPOLIS -- September 24, 2013 -- Expanding its role in the treatment of peripheral artery disease in the United States, Medtronic, Inc. (NYSE: MDT) announced today that the U.S. Food and Drug Administration (FDA) has approved the Complete SE (self-expanding) vascular stent for use in the lower e...
24-09-2013
@2011 endovascular. Última actualización: 31-03-2014
